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Polaromonas sp. strain JS666 is the only isolate capable of growth through the 
aerobic oxidation of cis-dichloroethene (cDCE).  Study of the JS666 genome, along with 
previous results from transcriptomics and proteomics studies, have suggested the 
involvement of a cyclohexanone monooxygenase gene (chmo, chnB, Bpro_5565) in the 
process.  Specifically, CHMO was hypothesized to catalyze the epoxidation of cDCE. 
We successfully inactivated the chmo gene through use of a suicide vector, and the 
resulting chmo-knockout strain (KO) was incapable of growth on cyclohexanone 
(CYHX), cDCE, ethanol (EtOH) and cyclohexanol. The overexpressed CHMO in 
Escherichia coli showed activity on CYHX; nonetheless, no activity was confirmed with 
cDCE. This suggests that CHMO is not involved in the first step of cDCE degradation, 
however, differences in cellular environments (i.e. pH, protein folding and post-
translational modification) between the E. coli and JS666 strains could have contributed 
to the outcome. Genes in the same operon with chmo, namely the adjacent, upstream 
hydrolase (chnC, Bpro_5566) and two adjacent, downstream alcohol dehydrogenases 
(chnD and chnA, Bpro_5563 and Bpro_5564, respectively) may serve important roles in 
cDCE degradation. When CYHX or EtOH was supplied as co-substrate, wild-type JS666 
(WT) quickly exhibited cDCE degradation and sustained it through multiple additions, 
but not when succinate or acetate was co-administered, suggesting that CYHX and EtOH 
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each elevate expression of proteins involved in cDCE metabolism. ChnD overexpressed 
in E. coli showed activity not only on EtOH and cyclohexanol, but also on 2,2-
dichloroacetaldehyde (DCAL), which is a hydroxylation product of cDCE by 
cyctochrome P450 (Bpro_5301), reducing it to 2,2-dichloroethanol. This suggests that 
ChnD is involved in cDCE degradation — not as a first step, but in subsequent steps. 
Changes in proteome levels during cDCE-degradation were explored using a 
quantitative shotgun proteomics technique, Isobaric Tag for Relative and Absolute 
Quantitation (iTRAQ). iTRAQ studies showed that genes adjacent to chmo were still 
translated in the KO, but with reduced protein abundance, particularly with respect to 
downstream genes. Given that we demonstrated ChnD (and possibly ChnA) acts on 
alcohol, and given that the KO lost ability to degrade alcohol and cDCE, it is therefore 
reasonable to propose that the lower abundance of ChnD (and presumably ChnA) in KO 
is the explanation for the differing behaviors of KO vs. WT strains.  Through iTRAQ 
studies, we found that cDCE increased the relative abundances of proteins involved in 
glyoxylate metabolism. Several proteins that may be involved in cDCE-degradation 
pathways were also identified, such as an aldehyde dehydrogenase (Bpro_3952) and 
enzymes that are hypothetically involved in glyoxal metabolism. This also supports a 
hypothesis of a cDCE-degradation pathway involving glyoxal formation from hydrolysis 
of cDCE-epoxide. Collectively, data gathered from these studies suggest possible roles of 
genes in the cyclohexanol operon and update our understanding on multiple pathways of 
cDCE-biodegradation in JS666. 
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CHAPTER 1 
1. INTRODUCTION 
 
Chlorinated ethenes, such as tetrachloroethene (PCE) and trichloroethene (TCE), 
are persistent in the environment because of their extensive use (as dry cleaning solvents 
and metal degreasers) and improper disposal. Accumulation of cis-dichloroethene 
(cDCE) has been reported at sites where contaminated plumes have migrated into aerobic 
zones following the incomplete reductive dechlorination of higher-chlorinated ethenes 
(i.e., PCE and TCE) in upgradient, anaerobic regions (Duba et al., 1996; Bradley, 2003). 
The United States Environmental Protection Agency (USEPA) has listed cDCE as a 
priority pollutant due to its suspected carcinogenicity and toxicity, and has enforced 70 
µg/L as the maximum contaminant level for cDCE in public drinking water systems 
(USEPA, 2011). 
Polaromonas sp. strain JS666 is the first isolated aerobic bacterium capable of 
growth on cDCE as a sole carbon and energy source (Coleman et al., 2002a). cDCE-
grown cells can transform trans-DCE (tDCE), TCE, vinyl chloride (VC), or ethene, 
although they are incapable of growth on these substrates as sole carbon source (Coleman 
et al., 2002a). This ability to transform other chlorinated hydrocarbons may be useful at 
sites where mixtures of these compounds occur. The 16S rRNA of JS666 shares 97% 
nucleotide identity with Polaromonas naphthalenivorans CJ2, a naphthalene degrader 
(Jeon et al., 2006). The genome of JS666 consists of circular chromosome (5.2 Mbp) and 
two plasmids (360 kbp and 338 kbp) (Coleman et al., 2002a). Genomic analysis revealed 
no obvious cDCE-degradation operon, rather genes potentially involved in cDCE 
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degradation, such as monooxygenases and dehalogenases, were scattered among the 
chromosome and two plasmids (Jennings et al., 2009).  Proteomic and transcriptomic 
analyses revealed genes that were upregulated during cDCE degradation (Jennings et al., 
2009). Two-dimensional gel electrophoresis identified proteins upregulated by cDCE 
(compared to the results obtained with two reference substrates) such as putative enzymes 
of glutathione S-transferase (GST, Bpro_0645) and flavin-containing cyclohexanone 
monooxygenase (CHMO, encoded by chnB, Bpro_5565). The proteomic results were 
confirmed with data from microarray studies (Jennings et al., 2009). Other transcripts 
upregulated by cDCE were genes that confer putative hydrolase (chnC, Bpro_5566), 
alcohol dehydrogenase (chnA, Bpro_5564), cytochrome P450 (Bpro_5301), heme 
peroxidase (Bpro_2396), ABC transporters and transposases (Jennings et al., 2009). 
Detection of epoxides when JS666 cells were incubated with ethene and propene 
has confirmed the activities of monooxygenases (Coleman et al., 2002a). In strain JS666, 
it is possible that CHMO catalyzes the formation of cDCE-epoxide analogous to toluene 
ortho-monooxygenase from Burkholderia cepacia G4 (Rui et al., 2004b). Besides, 
production of epoxide by chemically-synthesized methyllumiflavin supports the 
possibility of epoxidation by the hydroperoxyflavin group of flavin-containing 
monooxygenases (Bruice et al., 1983). Akin to this reaction, peracid produces epoxides 
when reacted with several chlorinated ethenes (Liebler and Guengerich, 1983; Janssen et 
al., 1988; Verce et al., 2002).  
Genes in the same operon with chmo, namely hydrolase (chnC, Bpro_5566) and 
dehydrogenases (chnD and chnA, Bpro_5563 and Bpro_5564, respectively), may also 
serve important roles, especially in detoxification of byproducts from cDCE-degradation. 
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Hydrolase is postulated to catalyze the hydrolysis of epoxide, and dehydrogenases may 
react with chlorinated alcohols or alkanals.  
In this study, we report the cloning and functional analysis of the chmo (or chnB) 
and other genes in the cyclohexanol operon of strain JS666 during aerobic cDCE-
degradation. Results from this study are used to update the cDCE-degradation pathways 
and understand the detoxification mechanism during degradation. The objectives of the 
study are laid out in the following:  
 
1.1 Objective 1: Determining the involvement of the chmo gene during 
cDCE degradation and developing a genetic system for JS666. 
The first objective of this study is to determine the involvement of the chmo gene 
during cDCE degradation by knocking out the chmo homolog of JS666, and comparing 
the abilities of the wild-type strain and the chmo-knockout mutant to degrade cDCE and 
other substrates. Results from knockout experiments will help to identify genes essential 
for cDCE degradation and may allow the inference of enzyme function through 
monitoring the accumulation of intermediates. If more than one cDCE-degradation 
pathway were present, knocking out this one putative pathway may still allow cDCE 
degradation. 
Developing a genetic system for JS666 is important in order to understand the 
cDCE-degradation pathway and to pave the way for future gene-based investigations of 
this important organism. Several steps for developing a genetic system are as follows: (i) 
successful incorporation of foreign genetic materials into JS666; (ii) knockout of a target 
gene; and (iii) reintroduction of a functional gene into a knockout mutant. 
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1.2 Objective 2: Characterizing the roles of enzymes in the 
cyclohexanol operon (Bpro_5566 to Bpro_5563) during aerobic 
cDCE-degradation. 
The second objective of this study is to characterize the functions of enzymes 
putatively associated with the cyclohexanol degradation pathway and to determine their 
roles (if any) in aerobic cDCE degradation. Out of five genes that are putatively linked to 
the conversion of cyclohexanol to adipic acid in JS666, only four are located in the same 
operon.  They are genes annotated as putative hydrolase (Bpro_5566), chmo 
(Bpro_5565), short-chain dehydrogenase (Bpro_5564) and alcohol dehydrogenase 
(Bpro_5563).  The genes will be cloned and transformed into E. coli cells as both 
individual genes and as the operon ensemble and tested with various substrates, such as 
cDCE and its metabolites.   
 
1.3 Objective 3: Understanding the translational changes in strain 
JS666 in the presence of cDCE and during cDCE degradation. 
The third objective is to study the proteome differences between wild-type and 
chmo-negative mutant strains of JS666 during identical substrate conditions. We will use 
the iTRAQ labeling method to monitor important proteins.  One issue in producing a 
knockout strain is that, even though the insert is designed to target a specific gene, 
expression of adjacent genes might have been affected by the insert. Can differences in 
substrate utilization by wildtype vs. knockout strains be confidently attributed to the 
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presence/absence of the targeted gene only? Using iTRAQ, we will quantify the relative 
productions from genes adjacent to chmo in knockout vs. wildtype strains. Several 
“missing” proteins in the cDCE-biodegradation pathways also might be recognized in 
this study, such as aldehyde dehydrogenases or hydrolases. Data from iTRAQ study can 
help us to better interpret the results from Objective 1, and can conceivably be used to 
update the cDCE-metabolic pathways in strain JS666. 
 
  
  
6 
 
CHAPTER 2 
2. BACKGROUND 
 
Accumulation of dichloroethenes (DCEs) has been observed in field and 
laboratory enrichment cultures and it is often linked to incomplete anaerobic 
dechlorination of high-chlorinated ethenes and ethanes such as tetrachloroethene (PCE), 
tetrachloroethane and trichloroethene (TCE) (Bagley and Gossett, 1990; Sharma and 
McCarty, 1996; Holliger et al., 1998a; Lorah and Olsen, 1998; Lorah and Voytek, 2004; 
Darlington et al., 2008). Several causes of incomplete reduction of PCE and TCE include: 
(i) the absence or scarcity of appropriate electron donor species required by the microbial 
populations (Holliger et al., 1993; Neumann et al., 1994); (ii) the abundance of other 
substrates that are thermodynamically favored by degraders; (iii) the absence of 
appropriate bacteria that are capable of converting past DCEs (Sharma and McCarty, 
1996; Miller et al., 1997; Holliger et al., 1998a; Holliger et al., 1998b; Harkness et al., 
1999); (iv) slow removal of DCEs (Rosner et al., 1997); and (v) migration of 
contaminated plumes from anaerobic to aerobic zones (Duba et al., 1996; Bradley, 2003). 
Aerobic oxidation of less-chlorinated ethenes is common, and these compounds 
can be degraded by microorganisms either growth-coupled or co-metabolically. Bacteria 
such as Mycobacterium spp., Nocardioides sp. JS614, Pseudomonas aeruginosa MF1 can 
easily utilize vinyl chloride (VC) as carbon and energy source under aerobic conditions 
(Hartmans and De Bont, 1992; Verce et al., 2000; Coleman et al., 2002b; Gossett, 2010). 
Numerous aerobic bacteria are capable of co-metabolizing chlorinated solvents, including 
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bacteria that oxidize ammonia (Vannelli et al., 1990), ethene or ethane (Coleman et al., 
2011), methane (Janssen et al., 1988; Little et al., 1988; Oldenhuis et al., 1989) and 
toluene (Nelson et al., 1987; Wackett and Gibson, 1988).  Several microbial populations 
can co-metabolize DCEs in the presence of other substrates (Gao and Skeen, 1999; Verce 
et al., 2002; Elango et al., 2011), and this is usually associated with the activity of 
monooxygenases (Ensign et al., 1992; van Hylckama Vlieg et al., 1996; Vancheeswaran 
et al., 1999; Kim and Semprini, 2005). However, co-oxidation of chlorinated compounds 
can be detrimental to cells or enzymes due to the toxicity of substrates (at high 
concentrations) or the presence of intermediates, thus reducing or inhibiting degradation 
activity (Alvarez-Cohen and McCarty, 1991; Oldenhuis et al., 1991; Landa et al., 1994). 
Furthermore, the bacteria may not possess genes capable of handling metabolites and 
byproducts of chlorinated compounds, such as chlorinated epoxides, alkanals (aldehydes) 
and alcohols. TCE and its degradation products were found to be toxic to methane-
oxidizing Methylosinus trichosporium OB3b due to non-specific conjugation of 
metabolites to the cellular proteins (Oldenhuis et al., 1991).  Competitive enzyme 
inhibition can occur with the presence of multiple substrates. The competition between 
primary substrate (growth substrate) and the substrate of interest (co-metabolic substrate 
or targeted contaminant) for the enzyme’s primary active site will decrease the enzyme’s 
affinity for each substrate, consequently reducing transformation rates. Toluene/o-xylene 
monooxygenase from Pseudomonas stutzeri OX1, for example, not only can hydroxylize 
toluene, but also a number of other substrates, such as styrene, naphthalene, 1,1-DCE and 
TCE (Chauhan et al., 1998), and the presence of mixtures of chlorinated ethenes affects 
the degradation rates of individual substrates (Shim and Wood, 2000). 
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2.1 Polaromonas sp. strain JS666 
Several studies have demonstrated that microorganisms can utilize cDCE as sole 
carbon and energy source for growth (Bradley and Chapelle, 1999; Coleman et al., 2002a; 
Schmidt et al., 2010).  Bacterial populations from black-water stream sediments have 
shown the ability to degrade cDCE under aerobic conditions; although no cDCE-degrader 
was isolated (Bradley and Chapelle, 1999). Coleman et al. (2002b) successfully isolated 
several aerobic bacteria capable of degrading VC,  but only one unique isolate capable of 
utilizing cDCE as sole source for carbon and energy (2002a). Polaromonas sp. strain 
JS666 was isolated from an enrichment culture that was inoculated with granular 
activated carbon from an industrial plant that processed contaminated groundwater. Due 
to its ability to degrade cDCE — and since growth-coupled oxidation of cDCE does not 
appear to be common at field sites — strain JS666 is a prime candidate for 
bioaugmentation at sites where cDCE has accumulated in aerobic zones (Coleman et al., 
2002a; Giddings et al., 2010).  
The minimum doubling time of strain JS666 grown solely on cDCE is 73 ± 7 
hours, and its growth yield is 6.1 g protein/mole cDCE at 20°C. The optimum growth 
conditions for cDCE degradation are 20 – 25°C and pH 7.2. Complete dechlorination of 
cDCE occurs during growth producing 1.94 mol of Cl- per mol of cDCE degraded. The 
half-velocity constant of JS666 during cDCE metabolism is 1.6 ± 0.2 µM and the 
maximum specific substrate-utilization rate ranges from 12.6-16.8 nmole/min/mg of 
protein at 20°C (Coleman et al., 2002a). According to Coleman et al. (2002a), strain 
JS666 is incapable of growth on trans-DCE (tDCE), TCE, VC, 1,2-dichloroethane (DCA) 
or ethene as carbon source, but cDCE-grown cells can transform these substrates. Further 
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investigation has determined that strain JS666 can grow on DCA and has a complete set 
of DCA catabolic genes (Mattes et al., 2008). The ability to transform other chlorinated 
hydrocarbons may be useful at sites where mixtures of these compounds occur. 
The 16S rRNA gene of JS666 shares 97% nucleotide identity with Polaromonas 
vacuolata, an Antarctic marine isolate (Irgens et al., 1996) and Polaromonas 
naphthalenivorans CJ2, a naphthalene degrader incapable of cDCE degradation (Jeon et 
al., 2006). The genome of strain JS666 has been fully sequenced by the Joint Genome 
Institute (Copeland et al., 2006) and consists of a circular chromosome (5.2 Mbp) and 
two circular plasmids, pPol360 (360 kbp) and pPol338 (338 kbp). These two plasmids 
persist in strain JS666 despite an extended enrichment and isolation process (Coleman et 
al., 2002a). Genomic analysis revealed no obvious cDCE-degradation operon, rather 
genes potentially involved in cDCE degradation, such as monooxygenases and 
dehalogenases, are scattered among the chromosome and two plasmids (Jennings et al., 
2009). 
Strain JS666 has shown two phenotypical behaviors during cDCE-degradation: (i) 
so-called “good behavior,” which has high maximum specific degradation rate and is 
characterized by growth-coupled degradation; and (ii) “bad behavior,” which is slower, 
cometabolic-like, and exhibits a transformation capacity (Jennings, 2005). H+ 
accumulation as a result of cDCE degradation has caused significant decrease in cDCE-
degradation rates, and degradation resumed when pH was restored to the initial neutral 
value.  Nevertheless, low pH is not the only condition that causes the degradation to 
decline. High levels of oxygen and previously growth on alternative substrates, such as 
succinate, acetate or glycolate, can also promote the bad phenotypical behavior (Jennings, 
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2005). Our colleagues at Georgia Institute of Technology found the accumulation of 
chloride ion to be an issue and were only able to grow JS666 to high density by exchange 
with fresh medium (Nishino, personal communication).   
The inconsistent behaviors observed during the culturing of strain JS666 may be 
due to the involvement of many enzymes in the initiation of cDCE-degradation and the 
presence of multiple degradation pathways, suggesting that the strain might have limited 
regulation of a newly acquired pathway.  Support for this comes from observation that 
there are 55 genes from different types of transposable elements present in the genome 
(Mattes et al., 2008). The production of the expected cis-1,2-dichloroepoxyethane 
(cDCE-epoxide) intermediate might be detrimental to the cells and detoxification 
mechanisms are poorly established.  Other metabolites, such as chlorinated alkanals and 
alcohols, may contribute to poor cDCE-degradation performance as well.      
 
2.2 Exploring bacterial behavior through omics-based approaches 
Comparative genomic studies have shown shared genes (68.21%) in the 
chromosomes of JS666 and CJ2 strains, as well as genes that are totally unique to each 
strain. It may be more likely that genes present in strain JS666 but not in strain CJ2 are 
involved in cDCE degradation (Jennings, 2009; Yagi et al., 2009). There are 55 genes 
from different types of transposable elements present in the genome, and transposons are 
often associated with evolution of pathways involved in xenobiotics-biodegradation or -
detoxification. The presence of several catabolic genes located near mobile genetic 
elements suggests that they were recently acquired (Mattes et al., 2008). Other genes that 
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may be involved in xenobiotic or hydrocarbon metabolism in strain JS666 are 59 
oxygenases, 21 glutathione S-transferases, 111 hydrolases, 27 hydratases and 9 
dehalogenases (Mattes et al., 2008). The genome contains complete glycolytic and 
Entner-Doudoroff pathways and the tricarboxylic acid (TCA) cycle. Genes involved in 
the glyoxylate pathway are present, such as the gene that confers isocitrate lyase (aceA, 
Bpro_2101), which is expected for an organism isolated on a C2 compound (i.e. cDCE) 
(Mattes et al., 2008).  
Proteomic and transcriptomic techniques were utilized to identify induction of 
genes as clues of JS666’s response to growth on cDCE, versus non-chlorinated substrates 
such as glycolate and acetate (Jennings et al., 2009). For proteomic analysis, proteins 
from cultures grown in cDCE and acetate or glycolate were extracted and compared by 
overlaying the individual two-dimensional (2D) gel separations. Subsequently the 
proteins that were differentially expressed in cDCE gel were excised and analyzed using 
liquid chromatography (LC) and tandem mass spectrometry (MS/MS) and identified 
using the NCBI database. The analysis revealed induction of genes annotated as encoding 
glutathione S-transferase-like protein (gst, Bpro_0645), cyclohexanone monooxygenase 
(chnB or chmo, Bpro_5565) and haloacid dehalogenase (had, Bpro_5186) (Figure  2.1 and 
Table  2.1).  These findings were confirmed by DNA microarray experiments. 
Upregulated transcripts include gst, pyridoxamine 5’-phosphate oxidase (pnpox, 
Bpro_0646), chmo, cytochrome P450 (p450, Bpro_5301), ABC transporters and two 
haloacid dehalogenases (Bpro_0530 and Bpro_5186). Selected upregulated transcripts in 
strain JS666 when grown on cDCE versus the reference substrate glycolate are 
summarized in Table  2.2. 
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Overall, 2D gel analysis and the microarray approach were not sufficient to 
elucidate the cDCE-degradation pathways in strain JS666. Several involved proteins may 
be overlooked due to their highly acidic or basic properties. The upregulation of 
transcripts (mRNAs) does not always reflect the activity of the corresponding proteins. 
For example, the transcripts of p450 were upregulated by cDCE less than the transcripts 
of chmo or gst (Table  2.2);  nevertheless a study by Shin (2010) showed that P450 
initiates attack on cDCE, and no activity on cDCE has yet been demonstrated for CHMO 
(Alexander, 2010) or GST (Jennings et al., 2009).  
 
 
Figure  2.1. Overlays of 2D gel images comparing proteins extracted from cDCE-
grown (blue) cells to proteins extracted from acetate-grown (red) cells (A) and 
proteins extracted from cDCE-grown (blue) cells to proteins extracted from 
glycolate-grown (red) cells (B). Differentially expressed spots in cDCE gels that were 
subsequently analyzed by MS are circled and reported in Table  2.1. Adapted from 
Jennings et al. (2009). 
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Table  2.1. Proteins upregulated in cells grown on cDCE compared to cells grown on 
acetatea Adapted from Jennings et al. (2009). Sample numbers correspond to the 
numbers in Figure  2.1. Corresponding transcripts reported in Table 2.2 are bolded. 
Sample Locus tag Putative enzyme functionb Protein scorec 
Peptide 
countd 
1 Bpro_0645 GST-like protein 115 1 
2 Bpro_0645 GST-like protein 181 1 
2 Bpro_3647 3-Oxoacyl-(acyl carrier protein) reductase 143 1 
3 Bpro_4563 2-Hydroxy-3-oxopropionate reductase 547 4 
4 Bpro_4562 Hydroxypyruvate isomerase 435 5 
4 Bpro_2567 Short-chain dehydrogenase/reductase 144 2 
4 Bpro_4841 Peroxidase 126 1 
5 Bpro_5186 HAD, type II 110 1 
6 Bpro_0646 PNPox-related protein 85 1 
10 Bpro_0650 DEAD/DEAH box helicase-like protein 256 2 
12 Bpro_4561 Glyoxylate carboligase 614 6 
13 Bpro_4561 Glyoxylate carboligase 564 4 
a There were no significant JS666 hits for samples 7 to 9, 11, 14, and 15. 
b Annotations were derived from the DOE JGI Integrated Microbial Genomes database. 
c The protein score (or Mowse score) is -10log (P), where P is the probability that the observed 
match is a random event. 
d Number of peptides with an expectation value of 0.01 as identified using LC-MS/MS. The 
expectation value corresponds to the number of matches that are expected to occur by chance 
alone. 
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Table  2.2. Selected transcripts upregulated in cells grown on cDCE compared to 
cells grown on glycolate (Jennings et al., 2009). 
Locus tag P value Change (fold) Region or putative enzyme function 
Bpro_3336 0.005 111 ABC transporter, extracellular receptor 
Bpro_0645 0.012 99.8 GST-like protein 
   Bpro_0646 0.012 87.5 PNPox-related protein 
  Bpro_3335 0.009 70 ABC transporter, inner membrane translocator 
 Bpro_0530 0.011 53.3 HAD, type II 
    Bpro_5186 0.013 51.5 HAD, type II 
    Bpro_0532 0.007 42.7 Hypothetical protein 
   Bpro_0531 0.015 40.9 Sodium/solute symporter 
  Bpro_5185 0.017 39.2 Sodium/solute symporter 
   Bpro_3334 0.010 30.8 ABC transporter, inner membrane translocator 
 Bpro_3333 0.013 27.1 ABC transporter, ATPase component 
 Bpro_0529 0.013 24.3 Conserved hypothetical protein 
 Bpro_5184 0.004 19 Predicted membrane protein 
  Bpro_3332 0.005 18.3 ABC transporter, ATPase component 
 Bpro_2731 0.016 17.9 Conserved hypothetical protein 
 Bpro_2396 0.017 14.8 Heme peroxidase 
   Bpro_0577 0.025 10.4 CO dehydrogenase 
   Bpro_5565 0.024 10.1 CHMO 
    Bpro_5566 0.056 7.3 Hydrolase 
    Bpro_5564 0.010 6.3 Short-chain dehydrogenase 
  Bpro_3866 0.027 3.6 Universal stress protein  
 Bpro_5301 0.010 3.5 Cytochrome P450 
   Bpro_2732 0.018 3.4 Transposase 
   Bpro_4792 0.030 3.2 Transposase 
   Bpro_4575 0.024 3.1 Transposase 
   Bpro_3227 0.040 3 Universal stress protein    
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The complexity of bacterial metabolic pathways and identification of stress-
related proteins can be studied through isobaric tags for relative and absolute quantitation  
(iTRAQ). This multiplexed isobaric tagging method uses a set of isobaric mass labels as 
reporters at the N terminal and lysine side chains of peptides. The labels containing the 
reporter groups range in mass from m/z 114.1 to 117.1, and the balance group of each is 
formulated such that the combined mass is 145.1 Da for each of the four reagents, 
thereby minimizing analytical bias. Four different samples, each containing digested 
proteins from cells grown under a different condition, can each be labeled with one of the 
four tags, and the four samples are subsequently combined. The derivatized peptides in 
the mixture are then identified and quantified chromatographically.  One sample type is 
chosen as the basis for comparison (the denominator in calculated ratios).  The ratio of a 
particular peptide’s abundance in any other sample type to that in the basis sample is then 
presumed to be the same as the ratio of their observed, tag-types associated with that 
peptide (Ross et al., 2004). This approach has been successfully used to monitor 
variations in protein abundance level in a particular bacterial species under different 
biological conditions, such as in the study discussed in the following. 
An Escherichia coli strain was engineered to metabolize cDCE through 
expression of an evolved toluene ortho-monooxygenase (TOM-Green) from 
Burkholderia cepacia G4, which consists of a mutated hydroxylase subunit, a NADH-
oxidoreductase and an electron-transfer protein. The mutation in the hydroxylase resulted 
in an improved activity towards chlorinated ethenes, producing corresponding epoxides 
(Canada et al., 2002a). The research continued with the detoxification of epoxides using 
an epoxide hydrolase, EchA, from Agrobacterium radiobacter AD1 and several of its 
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mutated enzymes (Rui et al., 2004a). In another study, the cDCE-epoxide generated by a 
similar monooxygenase was subsequently catalyzed by a GST system (IsoILR1) (Rui et 
al., 2004b).  
iTRAQ was used to monitor the proteome changes in these metabolically 
engineered E. coli strains during aerobic mineralization of cDCE. TOM-Green was 
utilized to initiate attack on cDCE, producing cDCE-epoxide, which was then detoxified 
by either a glutathione system or an epoxide hydrolase. The monooxygenase-and-
glutathione system demonstrated induction of proteins involved in an oxidative defense 
mechanism, pyruvate metabolism and glutathione synthesis. On the other hand, fatty-acid 
synthesis, gluconeogenesis and the TCA cycle were repressed.  In the same study, the 
researchers compared the evolved EchA and its wild-type analog, yet no as conclusive 
result was reported (Lee et al., 2006).   
In addition to the proteomic analysis, Lee et al. (2010) performed a whole-
transcriptome study to determine the impact of cDCE degradation in engineered E. coli 
strains.  More than 4200 transcripts were identified compared to 364 proteins in the 
quantitative proteome study. In the monooxygenase-and-glutathione system (compared to 
a strain with no cloned genes), eight out of 46 significantly upregulated proteins were 
also induced in the whole-transcriptome analysis. 30 stress-related genes were identified 
in the transcriptomic study while only five stress response proteins were identified in 
their previous study.  
In the strain with an epoxide hydrolase (EchA) addition (compared to a strain 
with monooxygenase only), the effects of epoxide hydrolysis were studied. 21 stress-
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related genes as well as genes involved in glyoxylate metabolism were among those that 
were induced. The induction of gloA (encodes glyoxalase I) and glxA23 genes (encode 
ureidoglycolate hydrolase and a repressor) in this strain support the hypothesis of glyoxal 
formation from 1,2-dichloroethane-1,2-diol (Rui et al., 2004a). The monooxygenase-and-
hydrolase system demonstrated a strong stress response similar to heat shock and 
oxidative stress. Transcriptome analysis revealed inductions of genes that encode stress-
related proteins, heat shock proteins, ribosomal proteins and several hypothetical proteins. 
Other stress-related genes were further studied by whole-transcriptome analyses of 
single-gene knockout mutants [Keio Collection (Baba et al., 2006)] (Lee et al., 2010).  
 
2.3 Monooxygenases 
A monooxygenase incorporates one oxygen atom into substrates using NADH or 
NADPH as a donor by utilizing variety of enzymatic reaction mechanisms. Many 
xenobiotic-degrading bacteria contain multiple oxygenases. Mycobacterium chubuense 
strain NBB4, for example, contains several monooxygenases, such as ethane 
monooxygenase (etnABCD), propene and propane monooxygenases, butane 
monooxygenase, alkene monooxygenase (alkB) and P450 (Coleman et al., 2011).  
Genomic analysis revealed that JS666 has 16 monooxygenases, 4 P450s and 43 
dioxygenases (Mattes et al., 2008), though few of these putative annotations of function 
have been confirmed. Flavin-containing monooxygenase (FMO) and P450 act on diverse 
substrates including alkanes, aromatics and heterocyclics. FMO catalyzes oxidation of 
various compounds through Baeyer-Villiger oxidation, which is commonly known for 
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conversion of ketones to esters or cyclic ketones into lactones by peroxy acids, such as 
potassium monopersulfate or meta-chloroperoxybenzoic acid (mCPBA) (Baeyer and 
Villiger, 1899; Meunier, 1992). The production of epoxide from alkene’s reaction with 
peracid is also well-established (Prileschajew, 1909). During ethene transformation by 
strain JS666, the formation of epoxyethane was reported (Coleman et al., 2002a), and we 
observed cDCE-epoxide during the growth of strain JS666 on cDCE (for details on 
chemically synthesized cDCE-epoxide, see Appendix B), which suggests activity of 
monooxygenases (Guengerich, 1991; Ensign, 2001) that may include P450s and/or FMOs. 
This enzymatic epoxidation mechanism may mimic the oxidation mechanism by peracid.   
 
2.3.1 Cyclohexanone monooxygenase (CHMO) 
CHMO (EC: 1.14.13.22) is a flavin-containing enzyme capable of converting 
cyclohexanone (CYHX) to ε-caprolactone (CAP) via Baeyer-Villiger oxidation. CHMO 
from Acinetobacter sp. NCIMB 9871 is the most studied CHMO and has been tested on 
numerous chemical compounds (Donoghue and Trudgill, 1975). The versatility of 
CHMO from Acinetobacter sp. has been shown through various reactions, such as the 
asymmetric sulfoxidation of alkyl aryl sulfides (Colonna et al., 1996), 1,3-dithioacetals 
(Colonna et al., 1995) and dialkyl sulfides (Colonna et al., 1997).  
  The first epoxidation of an alkene by CHMO was reported by Colonna et 
al. (2002). CHMO from strain 9871 was overexpressed in Escherichia coli, purified, and 
the enzymatic reaction was conducted in Tris-HCl buffer (pH 8.6) containing NADPH, 
glucose-6-phosphate and glucose-6-phosphate dehydrogenase for NADPH regeneration. 
  
19 
 
The enzyme was tested on dimethylvinylphosphonate, an olefein that resembles 
fosfomycin (Figure  2.2a). In another enzymatic assay study, CHMO from Xanthobacter 
sp. ZL5 catalyzed the epoxidation of a bicyclic ketone, instead of the usual conversion 
into its corresponding lactone (Figure  2.2b) (Rial et al., 2008). BLASTP results for the 
CHMO from strain JS666 give 62% and 61% identity to CHMOs of Acinetobacter sp. 
and Xanthobacter sp., respectively.  
 
 
PO(OCH3)2
PO(OCH3)2
O  
(a) 
O
O
O
O
O
 
(b) 
Figure  2.2. (a) Epoxidation of dimethylvinylphosphonate by CHMO from strain 
9871 (Colonna et al., 2002) and (b) a mesobridge bicyclic ketone by recombinant E. 
coli cells expressing a BVMO from Xanthobacter sp. ZL5 (Rial et al., 2008). 
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The amino acid sequence of CHMO from strain JS666 is shown in Figure  2.3.  
Classification as a Baeyer-Villiger monooxygenase can be recognized by the 
FxGxxxHxxxWP motif sequence, located at the start of NADP-binding sequence. Studies 
of protein structure and conformational changes enable researchers to understand 
CHMO’s ability to accept various substrates (Mirza et al., 2009). CHMOs share 
conserved substrate binding pocket residues and the differences in the amino acid 
sequence around the binding pocket may account for the flexibility of CHMOs in 
accommodating various types of compounds. Tryptophan W479 (at the mobile loop 
region, residues 474 – 491) is a conserved residue common to CHMOs, and mutation on 
that residue to alanine (of a CHMO from Rhodococcus strain) decreased  by 86% the 
activity on CYHX (Mirza et al., 2009). Strain JS666 has three glycine residues in the 
mobile loop while other CHMOs have resides with larger side groups, such as glutamate, 
asparagine and alanine, which better allows movement of substrates (Alexander, 2010). 
Because of similarities among these enzymes and the structure of the protein, it is 
possible that CHMO from strain JS666 could serve an identical role of alkene 
epoxidation. 
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Figure  2.3. The protein sequence of CHMO from strain JS666. The motif 
FxGxxxHxxxWP identifies it as Baeyer-Villiger Monooxygenase Type I (Fraaije et 
al., 2002). Binding motif for adenosine moiety of FAD is GxGxxG at the beginning 
of the sequence (Hasegawa et al., 2000; Fraaije et al., 2002). NADP+ co-factor binds 
at a GxxGxG motif site (Mirza et al., 2009). A conserved peptide sequence that is 
common to FAD- and NADPH-binding proteins (385-ATGFDA-390) is also found in 
CHMO (Vallon, 2000). Underlined and italicized is the mobile loop region 
(Alexander, 2010). 
 
2.3.2 Overexpression of CHMO. 
In the original study, CHMO from strain 9871 was expressed in its native state 
(Donoghue et al., 1976). Chen et al. (1988) continued the work by identifying the 
nucleotide sequence of the chmo gene and subsequently overproducing the enzyme in E. 
coli. Study of CHMO continued with resequencing and identification of several enzymes 
associated with CHMO in the cyclohexanol catabolic pathway (Iwaki et al., 1999). 
Cheesman and coworkers (2001) successfully purified and characterized a hexahistidine-
tagged CHMO in both E. coli and Saccharomyces cerevisiae. Since the initial work, 
several studies have been conducted on other bacterial CHMOs, namely from 
Acinetobacter sp. SE19 (Cheng et al., 2000), Arthrobacter sp. BP2, Rhodococcus sp. PH1, 
Rhodococcus sp. PH2 (Brzostowicz et al., 2003) and Xanthobacter sp. ZL5 (Van Beilen 
et al., 2003).    
 
MTLATQDSHPTQTDYDAVVVGAGFGGLYMLHKLRNELGMNVRVFDKAGDVGGTWYWNRYP 
GALSDTESFVYCYSFDKALLQEWQWDTRYVTQPQILSYLNHVADRLDLRRDIEFNTGVTG 
ARFDEKRNLWEIQTDTDKTVTARYLITALGLLSATNVPNIKGIETFQGAQYHTGAWPEGV 
DFKGKRVGVIGTGSTGLQVITALAPQASHLTVFQRSPQYSVPVGNGPVSPDYVKSVKQNY 
EQIWKDVRSSVVAFGFKESSVPAMSVSEEERRAVYQKAWDTGGGFRFMFETFCDIATSEE 
ANETAAAFIRGKIAEIVKDPETARKLTPTDLYAKRPLCDSGYYAIYNRDNVALVDVKATP 
ITEITPRGIKTSDGVEHELDVLIFATGFDAVDGNYTKIDLRGRNGKTIKDKWKAGPTSYL 
GVASADYPNLFMILGPNGPFTNLPPSIETQVEWISDLIKHMNDTGRQLVEATHEGEDGWT 
ATCNEIAGYTLFPKADSWIFGANIPGKARTVMFYLAGLGAYTQKLNEVTSTGYPGFEIR 
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Heterologous gene expression in E. coli has been routinely used to produce a 
high-amount of protein, although it tends to yield insoluble and inactive protein. To 
minimize the production of inclusion bodies, CHMO from strain 9871 was co-expressed 
with molecular chaperones or foldases in E. coli and has displayed an improvement of 
up-to 38-fold in the enzyme’s activity (Lee et al., 2004). Another solution is to conduct 
enzymatic assays in whole-cell E. coli. Iwaki et al. (2002b) conducted whole-cell 
experiments on overexpression of cyclopentanone 1,2-monooxygenase from Comamonas 
sp. NCIMB 9872 in LB broth, supplemented with 2% glucose at 30°C. Substrates were 
added directly to the media after induction with isopropyl β-D-1-thiogalactopyranoside 
(IPTG). The other genes in the cyclopentanol operon were assayed in cell-free extracts.  
Using a low amount of inducer leads to more production of soluble protein. Lee 
and coworkers (2005) found that the yield of CHMO can be increased by inducing the 
overexpression with a low concentration of IPTG (0.01 mM) at 30°C. The dissociation 
value for flavin adenine dinucleotide (FAD) binding of CHMO from Acinetobacter sp. is 
40 nM, suggesting that flavin dissociation would likely occur and destabilize the flavin-
containing enzyme (Donoghue et al., 1976). The addition of riboflavin, a precursor of 
FAD, to the media ensures enough supply of FAD for the flavoprotein as conducted in 
the overexpression study of CHMOs from Brevibacterium isolate (Brzostowicz et al., 
2000). An improvement was also observed in NADPH-dependent CHMO activity by 
non-growing E. coli cells when riboflavin was added at the start of the reactions (Walton 
and Stewart, 2004).  
Alexander (2010) studied the overexpression of CHMO from strain JS666. 
Whole-cell experiments were conducted, and when E. coli cells were actively growing, 
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the inducer and the substrates were supplied to the cells. Yet, no activity of CHMO was 
observed on cDCE or ethene. 
 
2.3.3 Oxidation mechanism of CHMO. 
The CHMO-catalyzed oxidation has been shown to proceed in the same manner 
as a chemical Baeyer-Villiger reaction (Figure 2.4). In CHMO-catalyzed CYHX 
oxidation, the FAD molecule (molecule 2.4.1) undergoes reduction by NADPH before 
reacting with molecular oxygen to form a C4a-peroxyflavin intermediate (molecule 2.4.2). 
This peroxyflavin intermediate serves as a nucleophile, attacking the carbonyl carbon of 
the CYHX. This step forms the Criegee intermediate (molecule 2.4.3) that successively 
produces C4a-hydroxyflavin and CAP. Subsequently, the hydroxyflavin intermediate is 
transformed into an oxidized FAD by eliminating a water molecule.  
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Figure  2.4. Proposed mechanism for CYHX-lactonization with CHMO of 
Acinetobacter sp. Adapted from Mirza et al. (2009). 
 
The mechanism for reaction of CYHX with mCPBA to yield CAP is proposed in 
Figure  2.5. The reaction is an adaptation of the lactonization of substituted CYHX by 
peracid, such as methylcyclohexanone (Corma et al., 2001) and silyl ketones (Hudrlik et 
al., 1980). The hydroperoxyl group of mCPBA acts in a manner analogous to that of a 
peroxyflavin intermediate. Chemically synthesized 4a-hydroperoxy-5-ethyl-3-
methyllumiflavin produced an epoxide when reacted with 2,3-dimethyl-2-butene in 
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chloroform, though the reaction with ethene was not tested (Bruice et al., 1983). This 
supports the evidence of possible epoxidation capability by the hydroperoxyflavin group 
of flavin-containing monooxygenases. 
Peracid epoxidation of chlorinated ethenes has been commonly utilized in many 
studies to prepare authentic materials for use in confirming peak identities in gas 
chromatography. TCE and DCEs have been reacted with mCPBA to produce their 
corresponding epoxides (Liebler and Guengerich, 1983; Cai and Guengerich, 1999). 1,1-
DCE-epoxide was chemically synthesized by reacting its parent compound with mCPBA 
at 60°C for 3 hours (Liebler and Guengerich, 1983).  A similar approach was used to 
synthesize tDCE-epoxide (Janssen et al., 1988) and cDCE-epoxide (Verce et al., 2002).  
Epoxides can also be synthesized at low temperature, such as the synthesis of octene-1,2-
oxide at 0°C (Guengerich and Mason, 1980).  
 
O OO
H O
O Cl
O
O
OH
O
Cl
mCPBA
Criegee intermediate
 
Figure  2.5. Theoretical lactonization of CYHX by peracid (mCPBA), resulting in 
CAP and chlorobenzoic acid. Adapted from Corma et al. (2001).  
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2.3.4 Cytochrome P450. 
In strain JS666, a cytochrome P450 system exists which consists of P450 itself, an 
iron-sulfur electron carrier (ferredoxin), and an FAD-containing reductase (ferredoxin 
reductase). Studies of similar P450 systems in other bacteria have shown them to be 
involved in reactions on a broad range of substrates, viz. alkanes, alkenes and alcohols 
(Wackett et al., 1989; Fulco, 1991). Scheps and coworkers (2011) cloned and 
overexpressed P450 (Bpro_5301) in E. coli and supplemented the growth of whole cells 
with FeSO4. The purified enzyme catalyzes reactions with alkanes and alcohols, which 
oxidize to alcohols and diols, respectively. Shin (2010) has successfully overexpressed 
the P450 system (P450, its adjacent genes and its promoter region, Bpro_5299 – 
Bpro_5301) from strain JS666 in E. coli and tested the whole cells with cDCE. During 
P450 reaction with cDCE, a percentage of loss in the mass balance was reported that may 
be due to the production of a suicidal complex (a dead-end product due to an irreversible 
porphyrin N-alkylation with one carbon atom of the ethenes (de Visser et al., 2004)), in 
addition to the cDCE-epoxide and 2,2-dichloroacetaldehyde (DCAL) produced (Shin, 
2010). Another possible outcome from P450 catalysis is the production of 
chloroacetylchloride, which will be rapidly decomposed into chloroacetate and hydrogen 
chloride. Abiotic breakdown of cDCE-epoxide has been shown to release chloride ions. 
The activities of TOM-Green on chlorinated ethenes were calculated by measuring the 
chloride concentrations 24 hours after the enzymatic reactions were stopped (Canada et 
al., 2002a). However, cDCE-epoxide is relatively stable, with a half-life of about 72 
hours (Janssen et al., 1988), as opposed to the half-lives of VC-epoxide and TCE-
epoxide, which are 78 and 21 seconds, respectively (van Hylckama Vlieg et al., 1996).    
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The relationships between FMO and P450 have been studied in eukaryotes. Both 
enzymes catalyze transformation of various xenobiotic compounds, and their substrate 
specificities may overlap (McManus et al., 1987; Williams et al., 1990; Morgan et al., 
2001; Attar et al., 2003). There are several key differences between the enzymes, namely: 
(i) substrate metabolism; (ii) catalytic mechanism and protein structure; and (iii) 
regulation (Cashman, 2005). During substrate metabolism, both enzymatic activities can 
be distinguished in vitro by difference in their optimal pHs — i.e. P450 is active at pH 
7.4, while FMO at pH 9. The use of inhibitors, such as metyrapone and methimazole, 
selectively inhibit the activity of P450 and FMO, respectively (Williams et al., 1990). 
The catalytic nature of both enzymes is also different. As previously discussed, in FMO, 
molecular oxygen is added to the reduced FAD, forming a C4a-hydroperoxyflavin, which 
initiates a nucleophilic attack on the substrates, whereas P450 forms a ferrous-O2 
complex that eventually generates hydrogen peroxide. While P450 and FMO may 
catalyze similar compounds, the result may be different products.  
 
2.4 Possible roles of other genes in the cyclohexanol operon 
Several bacteria capable of biodegrading cyclic alcohols and their associating 
ketones have been isolated (Griffin and Trudgill, 1972; Donoghue and Trudgill, 1975; 
Davey and Trudgill, 1977), and researchers have been interested in characterizing the 
gene clusters involved in their metabolism (Donoghue et al., 1976; Cheng et al., 2000; 
Kostichka et al., 2001; Iwaki et al., 2002b). Biodegradation of cyclohexanol and its 
byproducts by strain 9871 has been extensively studied (Donoghue et al., 1976; Iwaki et 
al., 1999). Most researchers focus on identifying and characterizing CHMO due to its 
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mechanism of enzymatic Baeyer-Villiger oxidation.  Nevertheless, genes downstream of 
this step have been characterized (Iwaki et al., 1999) and most, if not all, enzymes in 
cyclic alcohol metabolism can be used for the purpose of biocatalysis.  
The biochemical steps of cyclohexanol degradation by Acinetobacter sp. NCIMB 
9871 are illustrated in Figure  2.6 (Donoghue and Trudgill, 1975).  Cyclohexanol is 
transformed into its dicarboxylic acid through a five-step conversion: cyclohexanol is 
oxidized to CYHX by a dehydrogenase (ChnA). CYHX is then oxidized to CAP via 
Baeyer-Villiger oxidation by a flavin-containing monooxygenase (ChnB). The cyclic 
lactone is then hydrolyzed by an α/β hydrolase-fold coding sequence homolog of CAP 
lactonase (hydrolase, ChnC) into 6-hydroxyhexanoic acid (6-HHA), before being 
converted into 6-oxohexanoic acid by a dehydrogenase (ChnD). 6-oxohexanoate 
dehydrogenase (ChnE) converts 6-oxohexanoic acid into adipic acid, which is further 
oxidized to acetyl-CoA and succinyl-CoA through a β-oxidation pathway.  
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Figure  2.6. Biodegradation of cyclohexanol in Acinetobacter sp. NCIMB 9871. Adapted from Donoghue and Trudgill (1975). 
CYHX = cyclohexanone; CAP = ε-caprolactone; 6-HHA = 6-hydroxyhexanoic acid. 
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2.4.1 Genetic organization 
After the isolation of strain JS666 and the sequencing of its genome (Coleman et 
al., 2002a), all genes necessary for cyclohexanol metabolism were found to be 
represented (Mattes et al., 2008). In Acinetobacter spp. NCIMB 9871 and SE19, the 
organization of chnBER is identical, while the organization of chnACD (Iwaki et al., 
2002a) is slightly different. In strain JS666, the genes are organized in a single operon, 
where chnCBAD genes are clustered together in one of its two megaplasmids while chnE 
is in its chromosome (Mattes et al., 2008) (Figure  2.7). Brevibacterium epidermidis HCU 
contains two gene clusters involved in cyclohexanol degradation and neither cluster 
contains a homolog of chnE (Brzostowicz et al., 2002).  There is only one copy of chnB 
(chmo) gene in strain JS666. The transcription termination sequence (i.e. palindromic 
sequence) for the operon is in a position 30 bp after the stop codon sequence of the chnD 
gene. 
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Figure  2.7. Genetic organization of the genes that catalyze cyclohexanol biodegradation in Polaromonas sp. JS666, 
Acinetobacter spp. SE19, NCIMB 9871 and Rhodococcus sp. Phi2. JS666 gene numbers (Bpro) are shown above the genes and 
percentage amino acid identities are shown under other bacterial genes (Iwaki et al., 2002a; Brzostowicz et al., 2003; Mattes et 
al., 2008). chnR encodes the transcriptional activator. R1 is the Fis-family transcriptional regulator. Adapted from Mattes et al. 
(2008). 
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2.4.2 Hydrolase 
Hydrolase catalyzes the addition of a water molecule to its substrate. Strain JS666 
contains 111 hydrolases. Transcriptomic analysis revealed that putative chnC gene 
(Bpro_5566) was upregulated 7.5-fold by cDCE. This enzyme shares 71% amino acid 
sequence identity with a CAP-hydrolase from strain 9871 and catalyzes the hydrolysis of 
CAP to 6-HHA, cleaving the C-O bond. It is possible that this enzyme possesses similar 
function akin to an epoxide hydrolase, cleaving the C-O bond and transforming the 
epoxide into a corresponding diol (Figure 2.8).  
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Figure  2.8. cDCE-epoxide transformation into its corresponding diol by an epoxide 
hydrolase as proposed by van Hylckama Vlieg and Janssen (2001). The formation to 
glyoxal is a spontaneous reaction. 
 
An epoxide hydrolase from A. radiobacter AD1 (EchA) is capable of 
metabolizing epoxides (Rui et al., 2004a). The overexpressed EchA transformed cDCE-
epoxide to its corresponding diol (1,2-dichloroethane-1,2-diol), which is proposed to be 
rapidly transformed into glyoxal (van Hylckama Vlieg and Janssen, 2001). The 
accumulation of chloride ions served as an indication of cDCE-epoxide mineralization, 
even though the formation of glyoxal was not reported. BLASTP search of EchA against 
strain JS666’s genome resulted a match with an α/β hydrolase-fold coding sequence 
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homolog of haloacetate dehalogenase (Bpro_4478) with 29% amino acid identity 
(Figure  2.9). This hydrolase has been screened, overexpressed, purified and tested, and 
found capable of dehalogenation of haloacetates (Chan et al., 2010), thus sharing similar 
function to haloacid dehalogenases (Bpro_0530 and Bpro_5186). 
 
 
Figure  2.9. Phylogenetic relationships of amino acid sequences of bacterial CAP-
hydrolases and other hydrolases. Sequences were aligned based on 324 amino acid 
sequences using ClustalX 2.1 and the phylogenetic tree was drawn using Ugene, 
where the length of branch is proportional to the evolutionary distance. Both 
Bpro_5566 (300 a.a) and Bpro_4478 (317 a.a) are hydrolase proteins from strain 
JS666. DhlA is haloalkane dehalogenase, DehH1 is haloacetate dehalogenase and 
EchA is epoxide hydrolase.  
 
2.4.3 Alcohol dehydrogenases 
Dehydrogenases are enzymes that facilitate the transfer of hydrogen from electron 
donor to electron acceptor, such as NAD+. Alcohol dehydrogenases catalyze the 
interconversion between alcohols and aldehydes or ketones. The resulting aldehydes can 
be further oxidized by dehydrogenases into carboxylic acids.  Jennings et al. (2009) 
reported elevated expression levels of putative alcohol dehydrogenase (encoded by chnA, 
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Bpro_5564), which was upregulated 6-fold by cDCE. It is a putative alcohol 
dehydrogenase related to the short-chain dehydrogenase/reductase (SDR family). This 
protein shares 70% amino-acid identity with a cyclohexanol dehydrogenase of 
Xanthobacter flavus and 69% amino acid identity with a cyclopentanol dehydrogenase of 
Comamonas testosteroni.  
An adjacent gene, downstream of Bpro_5564, is another putative alcohol 
dehydrogenase (Bpro_5563 or ChnD). It is a zinc-binding alcohol dehydrogenase that 
attacks the hydroxyl group of 6-HHA and converts it to an aldehyde group. This enzyme 
shares 40% amino acid identity with 6-HHA dehydrogenase from strain 9871. 6-HHA is 
an ω-hydroxy acid, which is a carboxylic acid substituted with a hydroxyl group at the far 
carbon.  
Alcohol dehydrogenases are also capable of reducing an alkanal (or aldehyde) to 
an alcohol, which is seemingly counterproductive to bacterial growth. The upregulation 
of alcohol dehydrogenases in the omic studies may be due to the presence of chlorinated 
ethanal, which normally exists in hydrate (acetal) form. The production of 2,2-
dichloroethanol (DCET) was observed in hepatic microsomal P450 assay with DCE 
isomers (cis and trans) (Costa and Ivanetich, 1982). P450 produced DCAL and its 
transformation to DCET may be catalyzed by alcohol dehydrogenase in hepatic 
microsomes. In the preliminary work with the isolated perfused rat liver with cDCE, up 
to 10% DCAL transformation to DCET was observed compared to 1 – 3% transformation 
to dichloroacetic acid (DCAA) (Bonse et al., 1975). The metabolism of cDCE in rat 
hepatocytes resulted in production of DCET and smaller amount of DCAL and DCAA 
(Costa and Ivanetich, 1984). DCET was also detected when hepatocytes were incubated 
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with 1,1-DCE and tDCE. In similar study, the researchers observed that when the rate of 
DCAL production was low (from tDCE and 1,1-DCE metabolism), DCAA was the major 
metabolite. On the contrary, DCET was the major dichlorinated metabolite when the 
DCAL rate production was high (from cDCE metabolism). This was supported by the 
relatively lower Km and Vmax values of DCE transformation to DCAA than that of DCE 
transformation to DCET (Costa and Ivanetich, 1984). The haloalcohol formation is 
estimated to be favored by the cellular redox potential (Dolfing and Janssen, 1994; Bull 
et al., 2006). 
In another example, one of the primary byproducts of TCE metabolism by 
mammalian P450 is 2,2,2-trichloroacetaldehyde (TCAL), which is rapidly converted into 
chloral hydrate in water. The hydrate can be readily reduced by alcohol dehydrogenase 
into 2,2,2-trichloroethanol (TCET, Figure  2.10) (Forkert et al., 2005). During the 
degradation of TCE by Methylosinus trichosporium OB3b cells, low levels of TCAL and 
TCET were identified (Oldenhuis et al., 1989). The cells also partially converted TCAL 
to TCET and vice versa. In mammals, DCET and TCET may be rapidly glucuronidated 
by glucuronidase and excreted in urine (Hutson et al., 1971; Miller and Guengerich, 
1983). The addition of ethanol (EtOH) could alter the NAD+/NADH ratio in bacterial 
cells, resulting the shifting of metabolism pathways. When EtOH was co-administered 
with TCE in hepatocytes, the trichloroacetic acid levels in blood was decreased and the 
ratio of TCET to trichloroacetic acid in urine was increased (Larson and Bull, 1989).  
One of many applications of dehydrogenases is to generate NADPH or NADH, 
which has been used up extensively during monooxidation of xenobiotic compounds. It 
has been observed that, if the supply of NADPH for the initial metabolic step is lower 
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than the demand, biodegradation is stalled (Johnson et al., 2006). In strain JS666, 
NADPH or NADH can be generated by dehydrogenation of 6-phosphogluconate into 
ribulose-5-phosphate or by a putative alcohol dehydrogenase (such as Bpro_5563), 
respectively. The genome of strain JS666 also contains a pentose phosphate pathway 
system which enables the strain to recycle cofactors (Mattes et al., 2008).  
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Figure  2.10. The fate of chloral during TCE metabolism. Chloral (or TCAL) is 
reduced to TCET and oxidized to trichloroacetic acid (Newman and Wackett, 1991; 
Forkert et al., 2005). 
  
2.5 Gene inactivation using a suicide vector 
Suicide vectors have been utilized to disrupt genes of interest by integrating an 
entire vector through homologous Campbell-type recombination at a specific targeted site. 
The vector contains the vegetative replication origin of plasmid R6K but lacks its pir 
gene, and therefore replicates only in strains that contain pir on a separate replicon. The 
plasmid also contains the origin of conjugal transfer of plasmid RP4 and therefore can be 
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mobilized by the transfer system of that plasmid. Translational fusions are created as a 
consequence of integration of the entire plasmid into the target gene. It is important to 
ensure that the fragment of the target gene that is fused to the reporter does not retain any 
of the functions of the wild-type gene. The presence of an antibiotic resistance gene in the 
vector is useful for colony selection. As a result, recipient cells will only maintain the 
plasmid when it is integrated into the chromosome and grown on media containing 
antibiotic (Kalogeraki and Winans, 1997).   
Cyclopentanol metabolism in Comamonas sp. strain NCIMB 9872 was studied by 
inactivating its cyclopentanol 1,2-monooxygenase gene (cpnB) via insertion of a cassette 
containing a promoterless lacZ gene and a kanamycin resistance gene (Iwaki et al., 
2002b). Furthermore, overexpressed CpnB in E. coli demonstrated its capability to 
transform various ketones, including cyclopentanol and CYHX. The knockout mutant 
strain failed to transform cyclopentanol, cyclopentanone, cyclohexanol or CYHX. 
Genetic organization showed that cyclopentanol dehydrogenase is located directly 
downstream of the cpnB gene; knocking out cpnB disrupted both genes (Iwaki et al., 
2002b). 
In Polaromonas sp. strain CJ2, the method of knocking out genes using suicide 
vectors was utilized to investigate the roles of the naphthalene catabolic genes. 
Researchers found two gene clusters, a large and a small gene cluster controlled by LysR-
type (nagR) and MarR-type (nagR2) regulators, respectively. A mutant strain was 
constructed to create a polar knock-out of nagR2. The suicide plasmid also contained the 
lacZ gene that could be utilized as a transcriptional assay. A strain with a nagR2::lacZ 
fusion was constructed, and lacZ reporter assays concluded that nagR2 is a negative 
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regulator (Jeon et al., 2006). An initial BLAST homology search indicated that a gene in 
the small gene cluster (of strain CJ2) encodes a putative salicylate 5-hydroxylase, and 
further investigation concluded that it encodes 3-hydroxybenzoate 6-hydroxylase. In that 
work, a suicide plasmid containing a kanamycin-resistance gene and a sacB gene was 
used to inactivate the targeted gene, nagX (Park et al., 2007). sacB encodes levansucrase 
from Bacillus subtilis, catalyzing the hydrolysis of sucrose and producing considerable 
amounts of levan that may be lethal to the cells (Gay et al., 1983). nagX was inactivated 
by plasmid insertion, producing a mutant strain resistant to kanamycin. Its deletion was 
acquired by further growing the kanamycin-resistant strain in media containing sucrose. 
One colony with truncated nagX gene (with a 2-bp deletion) was obtained and three 
colonies reverted to the wild-type nagX  (Park et al., 2007). Recently, three copies of the 
nagI gene, which encodes gentisate dioxygenase, were successfully inactivated using a 
similar approach (Lee et al., 2011).  
 
2.6 Starvation studies in other monooxygenase-expressing bacteria 
Carbon deficiency in the subsurface is common and can significantly affect rates 
of biodegradation of targeted contaminants. In the past, the effects of carbon starvation 
have been studied in several oxygenase-expressing bacteria.  The degradation rates of 
these bacteria were reduced exponentially as carbon starvation time increased (Johnson et 
al., 2006; Mattes et al., 2007; Park et al., 2008). Lag-phase for VC degradation has been 
observed in VC-degrading bacteria. In Nocardioides sp. strain JS614, a lag period 
exceeding 40 days was reported after carbon starvation for one day (Coleman et al., 
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2002b). Singh et al. reported a decreasing degradation rate after the mixed cultures were 
starved for 150 days (Singh et al., 2004). Nevertheless, another VC-degrader, 
Mycobacterium rhodesiae strain JS60, did not suffer any lag period after 7-days of 
carbon starvation (Verce et al., 2000). Schmidt et al. (2010) conducted a study where an 
enrichment culture, which was obtained from a groundwater microcosm, was subjected to 
cDCE-starvation up to 250 days. The culture started to degrade 3 mg/L (0.03 mM) cDCE 
after 15 days.  
The oxidation of chlorinated ethenes yields reactive epoxides that could be 
damaging to the bacteria that produce them. A starvation period could possibly disrupt 
regulation of the cell’s epoxide-detoxification mechanism, leading to an imbalance 
between epoxide formation and epoxide degradation, resulting in their accumulation 
when previously starved cells are resupplied with the chlorinated-ethene substrate. In 
Mycobacterium aurum L1, short interruption of vinyl chloride feed led to accumulation 
of VC-epoxide. The reactive epoxide was not observed when the culture was 
continuously fed (Hartmans and De Bont, 1992).  
In strain JS614, decreased lag periods for VC- or ethene-degradation were 
observed when co-administered with small concentrations of other carbon sources such 
as acetate and glucose after starvation. However, acetate addition gave mixed results, 
depending upon previous culture conditions. Small concentrations of acetate (provided 
along with VC or ethene) improved VC- or ethene-degradation after a period of 
starvation, if cells had been grown on VC or ethene, but not if they had been grown on 
acetate. This suggests that these small amounts of acetate provide ATP and/or NADH 
used to initiate oxidation (i.e., “prime the pump”), but there is also a need to induce 
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expression of genes that are required for VC- or ethene-degradation, such as 
monooxygenase and epoxyalkane:coenzyme M transferase (Mattes et al., 2007).  
 
2.7 Multiple aerobic cDCE-degradation pathway(s). 
Consistent with the proteomic and transcriptomic studies of JS666 — and with the 
two phenotypical cDCE-degradation behaviors observed — there are several possible 
cDCE-degradation pathways that may be operating in JS666.  These include:  (i) cDCE-
dehalogenation catalyzed by GST, followed by dehydrogenase- and dehalogenase-
catalyzed formation of glycolate; and (ii) cDCE-epoxidation catalyzed by 
monooxygenase(s), followed by formation of glyoxylate (Jennings et al., 2009). The 
levels of expression of enzymes predicted to be involved in the GST-catalyzed 
dehalogenation pathway were higher than of the enzymes predicted to be involved in the 
monooxygenase-catalyzed epoxidation pathway. Initial results thus suggested that the 
former is the primary cDCE-degradation pathway in JS666, and the latter is a less 
important transformation pathway, which also agrees with compound specific isotope 
analysis (CSIA) (Jennings et al., 2009). The change in ratio of heavy to light isotopes 
(13C/12C) that occurs during biological degradation can suggest the type of bond that is 
initially broken. Fractionation values associated with VC epoxidation (cleavage of C=C 
bond) are between -8.2 ± 0.1 ‰ to -7.0 ± 0.3 ‰ (Chu et al., 2004; Chartrand et al., 2005), 
whereas reductive dehalogenation of VC (cleavage of the C-Cl bond) is much lower, 
between -31.1 ‰ and -21.5 ‰ (Bloom et al., 2000; Hunkeler et al., 2002).  
  
41 
 
The reported fractionation value from aerobic enrichment cultures that co-
metabolize cDCE is -9.8 ± 1.7 ‰ (Tiehm et al., 2008) and values for anaerobic reductive 
dehalogenation of cDCE range between -29.7 to -14.1 ‰, which akin to VC 
dechlorination (Bloom et al., 2000; Lee et al., 2007). cDCE-degradation in 
monooxygenase-containing M. trichosporium OB3b cultures yielded a value of -0.4 ± 0.5 
‰ (Chu et al., 2004). In one study with JS666, a fractionation value of -8.5 ± 0.1 ‰ was 
reported for cDCE-oxidation, suggesting that epoxidation is the initial step (Abe et al., 
2009). Opposing this, another study with JS666 found much lower fractionation values 
for cDCE degradation (-17.4 to -22.4 ‰), suggesting anaerobic dechlorination or C-Cl 
bond breakage as the initial step (Jennings et al., 2009). Reports of two quite different 
extents of fractionation support the hypothesis of two distinctly different cDCE metabolic 
pathways within JS666. A study with groundwater microcosms during aerobic cDCE 
biodegradation reported an average stable carbon isotope enrichment factor of -15.2 ± 0.5 
‰, which agrees with Jennings et al. (Schmidt et al., 2010). Figure  2.11 depicts the 
proposed cDCE-biodegradation pathways. The conversion of chloroacetaldehyde to 
chloroacetate was confirmed in cDCE-grown JS666 crude extracts, but the identity of the 
specific chloroacetaldehyde dehydrogenase gene is still not known (Jennings, 2009).  
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Figure  2.11. GST-catalyzed dehalogenation and monooxygenase-catalyzed 
epoxidation pathways of cDCE by strain JS666. CAD: chloroacetaldehyde 
dehydrogenase; HAD:  haloacid dehalogenase; CO DHase: Carbon monoxide 
dehydrogenase. Adapted from Jennings et al. (2009). 
 
 
Recent studies demonstrating activity of P450 on cDCE, on the other hand, might 
favor the importance of a monooxygenase-catalyzed pathway followed by 
dehydrogenase- and dehalogenase-catalyzed formation of chloroglycolate and formation 
of glyoxylate (Shin, 2010). These findings did not rule out oxygenation roles for other 
monooxygenases, such as FMOs. In cDCE- and DCA-degradation pathways of strain 
JS666, multiple enzymes possess similar catalytic specificity, such as HADs and 
hydrolase (Bpro_4478). Both types of enzymes have shown activities on haloacetates, 
cleaving one or more halogens (Chan et al., 2010). The conversion of cDCE by P450 
revealed the formation of DCAL, apart from cDCE-epoxide.  P450-cDCE suicide 
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complex formation was proposed to counter the missing mass balance from the 
transformation (Shin, 2010). Figure  2.12 shows the updated cDCE-biodegradation 
pathways.  
 
Cl Cl
H H
OH
Cl
Cl
H
O
ClCl
HH
H
ClCl
OHOH
H
OH
Cl OH
Cl
OH
OH OH
Cl
O
O OH
HO
O
H
H
Cl
ClOH
SG
H
H
Cl
O
SG
H
H
OH
O
SG
H
H
cDCE
cDCE-epoxide
DCAL dichloroacetate chloroglycolate
glyoxylateglyoxal1,2-dichloroethane-1,2-diol
NAD(P)H
O2
P450
HADDCAL
dehydrogenase
glutathione conjugates
 
Figure  2.12. Proposed cDCE-degradation pathways updated by Shin (2010). DCAL 
is dichloroacetaldehyde. 
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2.8 Summary 
The formation of epoxides during bacterial growth on cDCE and ethene is linked 
to the activity of monooxygenases, such as P450 and CHMO. Proteomic and 
transcriptomic analyses revealed the induction of these enzymes by cDCE. P450 has been 
demonstrated to catalyze the epoxidation of cDCE, nevertheless there are several 
examples where the functions of P450 and FMO may overlap. Production of epoxide by 
chemically-synthesized methyllumiflavin supports the possibility of epoxidation by 
hydroperoxyflavin group of FMOs. Akin to this reaction, peracid has also shown ability 
to epoxidize several chlorinated ethenes.  
Genes in the same operon with chmo, namely hydrolase and dehydrogenases, may 
serve important roles, especially in detoxification of byproducts from cDCE-degradation. 
Hydrolase is postulated to catalyze the hydrolysis of epoxide, and dehydrogenases may 
react with chlorinated alcohols or aldehydes.  
In this study, we will look at the involvement of the chmo gene and the roles of 
other genes in the cyclohexanol operon of strain JS666 during aerobic cDCE-degradation. 
Results from this study will be used to update the cDCE-degradation pathways and 
understand the detoxification mechanism during degradation. 
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CHAPTER 3 
3. MATERIALS AND METHODS 
3.1 Chemicals 
cDCE (99%, stabilized with hydroquinone monomethyl ether (MEHQ)) and DCA 
(99.5%) were obtained from TCI America. Cyclohexanol (98%, Fisher), CYHX (99.8%, 
Acros), and CAP (99%, Acros) were reagent grade. TCE (100%, Fisher), VC (99.5%, 
Sigma-Aldrich), 1,1-DCE (99%, Aldrich), tDCE (99.7%, stabilized with MEHQ, Acros), 
ethene (99.999%, Matheson, inc.) and epoxyethane (99.5%, Aldrich) were used in 
various experiments. Other chemicals used include ethanol (EtOH, 99.5+%, Acros), 
acetaldehyde (99.5%, Acros), succinate (disodium salt, 99%, Fisher), acetate (sodium salt, 
anhydrous, 100%, Fisher), sodium chloride (99.57%, Fisher), glycolic acid (70% in water, 
TCI America), 6-HHA (95%, Acros), DCET (99%, Aldrich), DCAL hydrate (90%, TCI 
America), DCAA (99%, Sigma-Aldrich), chloroacetic acid (99%, Acros), styrene (99.5%, 
Acros) and styrene oxide (97+% Acros). Ethyl acetate (EtOAc, 99.9%), diethyl ether 
(Et2O, 95%) and acetonitrile (99.9%) were obtained from Fisher scientific. 3-
chloroperoxybenzoic acid (mCPBA, 70 – 75% in water) and d-chloroform (99.6+% 
deuterium atom) were obtained from Acros. Sodium hydroxide pellets (NaOH, 97%, 
Fisher) were dissolved in deionized distilled water, used as eluents in the ionic 
chromatography.   
For maintenance and propagation of E. coli in molecular biology procedures, 
Lysogeny Broth, Miller (LB, 10 g/L tryptone, 5g/L yeast extract, 10 g/L NaCl) was used 
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and obtained from Fisher. D-glucose (99%, Fisher) or riboflavin (98%, Acros) were 
supplemented when needed. A 1M stock solution of isopropyl β-D-1-
thiogalactopyranoside (IPTG, dioxane-free, 95%, Fisher) was used in the enzymatic 
assays as the inducer when required.  A list of antibiotics used in our study: ampicillin 
(sodium salt, 95%, Fisher), rifampicin (95%, Fisher), kanamycin sulfate (95%, Acros), 
streptomycin sulfate (95%, Acros), chloramphenicol (98 – 102%, Acros) and tetracycline 
(98%, Fluka).   
cDCE- and tDCE-epoxides were chemically synthesized by reacting 0.86 mL of 
cDCE or tDCE with 1.6 g mCPBA dissolved in 6 mL of an organic solvent, such as d-
chloroform or acetonitrile, and heating at 50°C – 60°C for 8 – 12 hours. The cDCE-
epoxide peak was identified by gas chromatography-mass spectrometry (GC-MS; 
HP6890) using a DB-5ms column (30 m × 0.25 mm, 0.25-μm film thickness; J&W 
scientific). See Appendix B for detailed discussion of the issues with epoxide 
identification. For enzymatic assay purposes, cDCE-epoxide synthesized in acetonitrile 
was used. 
DCAL monomer is not commercially available. Our colleague (Shirley Nishino) 
at Georgia Institute of Technology (Atlanta, GA) prepared DCAL monomer from DCAL-
hydrate by reacting the hydrate with series of sulfuric acid treatments (Wakasugi et al., 
1993). DCAL and its hydrate turned out to be indistinguishable by GC-MS (Nishino, 
2011). Therefore, when DCAL was required in our studies, its hydrate was dissolved in 
water creating a 100-mM stock solution.  
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3.2 Bacterial strains, plasmids and culturing techniques. 
All bacterial strains, vectors, plasmids and primer sets used in the present study 
are listed in Table  3.1. The culture techniques for strain JS666 which best ensure 
sustained cDCE-degradation were previously described by Jennings et al. (2009). In brief, 
strain JS666 cultures were grown in 160-mL serum bottles sealed with Teflon®-coated 
butyl rubber septa containing 100 mL of minimal salts medium (MSM, containing among 
other constituents 20 mM phosphate, 10 mM ammonium, trace metals, and 0.02 mM 
chloride) as previously described (Coleman et al., 2002a). 4 µL of cDCE was injected to 
obtain a nominal concentration of 520 µM, and the bottle was left in inverted position on 
an orbital shaker at 23°C. After 2.5 – 3.5 additions of cDCE were degraded, 5% of the 
culture volume was transferred into fresh MSM. JS666 was streaked on ¼-strength 
trypticase soy agar (¼-TSA) plates for purity check (i.e., to look for anomalous colony 
morphologies on this rich medium). JS666 wild-type (WT), chmo-knockout (KO), and 
chmo-complement strains were also grown in ¼-strength trypticase soy broth (¼-TSB) 
and streaked on ¼-TSA plates with appropriate antibiotics. All E. coli strains were grown 
in LB broth at appropriate temperature (depending on the enzymatic studies, but usually 
30°C) in a rotary-shaking incubator, and appropriate antibiotics were provided when 
required to maintain plasmids.  
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Table  3.1. The bacterial strains, vectors and primers used in this study. 
 
 
 
 
 
 
 
 
 
  
a nucleotide sequences for restriction enzyme sites are underlined 
b bp: resulting amplicon sizes in base-pairs. 
amp = ampicillin; kan = kanamycin; tet = tetracycline 
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Table 3.1 (continued) 
 
Name of strain, plasmid, or 
primer 
 
Relevant characteristics or sequence 
 
Source or reference(s) 
 
 
Strains 
   Polaromonas sp. 
      JS666 
      JS666 ∆chmo::kan 
      JS666 ∆chmo::kan, chmo 
    
   E. coli  
      SY327 λpir 
      S17-1 λpir 
      Rosetta 2 (DE3) 
      BL21 Star™ (DE3) 
 
 
 
 
cDCE aerobic degrader (WT) 
chmo-knockout strain (KO) 
chmo-complement strain 
 
 
Host for pVIK110, contain λpir for pir plasmids 
Contains λpir for pir-dependent plasmids, conjugal donor;  
Host for gene expression 
Host for gene expression 
 
 
 
 
This study 
This study 
This study 
 
 
Madsen, E. 
Madsen, E. 
Novagen 
Invitrogen 
 
Plasmids or vector 
   pVIK110 
   pVcmo 
   pET101/D-TOPO® 
   pCOLADuet™-1 
   pET21(a)+ 
   pJB866 
   pJcmo 
   p15TV-L 
   pJS597 
   p66H 
 
 
lacZY for translational fusions, R6K oriV, suicide vector; kanR 
Suicide vector construct containing fragment of chmo gene 
Expression vector, ampR 
Expression vector, kanR 
Expression vector, ampR 
Expression vector, tetR 
Expression vector (pJB866) with Bpro_5565, tetR 
Expression vector with Bpro_4478, ampR 
Expression vector with Bpro_5299 – Bpro_5301, ampR 
Expression vector (pET101D) with Bpro_5566, ampR, His6-tagged 
 
 
Madsen, E. 
This study 
Invitrogen 
Novagen 
Novagen 
NBRP-E.coli at NIG, Japan 
This study 
Chan et al. (2010) 
Shin (2010) 
This study 
  
a nucleotide sequences for restriction enzyme sites are underlined 
b bp: resulting amplicon sizes in base-pairs. 
amp = ampicillin; kan = kanamycin; tet = tetracycline 
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Table 3.1 (continued) 
 
Name of strain, plasmid, or 
primer 
 
Relevant characteristics or sequence 
 
Source or reference(s) 
 
 
   p65R 
   p63R 
   p6566 
   p6364 
 
 
Expression vector (pET101D) with Bpro_5565, ampR 
Expression vector (pET101D) with Bpro_5563, ampR 
Expression vector (pET21a) with Bpro_5566 and Bpro_5565, ampR 
Expression vector (pCOLADuet) with Bpro_5564 and Bpro_5563, kanR 
 
 
This study 
This study 
This study 
This study 
 
PCR primers a 
   VcmoF (SalI) 
   VcmoR (XbaI) 
   ocmoF 
   vxR 
   isoF 
   isoR 
 
Protein overexpression 
   66F 
   66H 
   65F 
   65R 
   63F 
   63R 
   E6566F (BamHI) 
   E6566R (XhoI) 
   C6364F (EcoRI) 
   C6364R (HindIII) 
 
 
5’-CCCTCTAGACAACATCAAGGGCATCGAG-3’ 
5’-CCCGTGGACTTCTTCGCTGGTGGCAATG-3’ 
5’-GAAATCCAGACCGATACCGA-3’ 
5’-TTGACCGTAATGGGATAGGT-3’ 
5’-TGCCGCTGACAACAACAC-3’ 
5’-ATCAATGCCTTTGGAGTGC-3’ 
 
 
5’-CACCATGAAACCTTCAACCGAGGC-3’ 
5’-AGCAGCCTTAAACCATTGGG-3’ 
5’-CACCATGACCCTGGCAACACAAGA-3’ 
5’-TTAGCGGATCTCAAAACCTGG-3’ 
5’-CACCATGAATTACCGCTGCGCCCA-3’ 
5’-TCAAGGCTGCAGCACCACG-3’ 
5’-CCCGGATCCATGACCCTGGCAACACAAGA-3’ 
5’-CCCCTCGAGTCAAGCAGCCTTAAACCATT-3’ 
5’-CCCGAATTCATGAAACGCGTACAAGA-3’ 
5’-CCCAAGCTTTCTTCAAGGCTGCAGCA-3’ 
 
bp b 
427 
 
823 
 
139 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This study 
This study 
This study 
This study 
Jennings (2005) 
Jennings (2005) 
 
 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
  
a nucleotide sequences for restriction enzyme sites are underlined 
b bp: resulting amplicon sizes in base-pairs. 
amp = ampicillin; kan = kanamycin; tet = tetracycline 
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Table 3.1 (continued) 
 
Name of strain, plasmid, or 
primer 
 
Relevant characteristics or sequence 
 
Source or reference(s) 
 
    
Reverse transcription PCR 
   RT-RpoF 
   RT-RpoR 
   RT-ISOF 
   RT-ISOR 
   RT-p450F 
   RT-p450R 
   RT-GSTF 
   RT-GSTR 
   RT-CMOF 
   RT-CMOR 
   RT-HYDF 
   RT-HYDR 
   RT-ALDF 
   RT-ALDR 
   RT-HADF 
   RT-HADR 
 
 
 
5’-GCCTATTCCTATACCGAACGC-3’ 
5’-GTAGACTTCCTGCTCCTTGAC-3’ 
5’-GAAATTCAGCACTCCAAAGGC-3’ 
5’-TCTTGTAGAAACCTTCGGCG-3’ 
5’-ACCCCGTGCATTACTGTAAG-3’ 
5’-CAAGGGAAATCAAACAGCGTC-3’ 
5’-TTGAACGGGTGGAGATTGAC-3’ 
5’-AGCTGTAGTTGGCAATATCGG-3’ 
5’-GAAATCCAGACCGATACCGA-3’ 
5’-TCCGGGTCTTTGACAATCTC-3’ 
5’-GCAAACAACATCACCACCAG-3’ 
5’-AGGAACGGGAACACATGCT-3’ 
5’-AATCTCGGCATCCAGTTACC-3’ 
5’-GGCTTCATTCGGGTCAAAAG-3’ 
5’-AGATGGTCAGCAAGATGTGG-3’ 
5’-AAGTGATCGAAGGAGTTGGTC-3’ 
 
 
bp b 
387 
 
397 
 
370 
 
411 
 
572 
 
330 
 
419 
 
322 
 
 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
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3.3 Analytical methods. 
TCE, cDCE, VC, DCA, ethene and epoxyethane were analyzed by 0.1-mL 
headspace samples injected (using a locking gas-tight syringe [VICI Pressure-Lok® 
Series A]) into a gas chromatograph (GC, Perkin-Elmer Autosystem) equipped with a 
flame-ionization detector (FID) and a 8-ft x 1/8-inch stainless-steel column packed with 
1% SP-1000 on 60/80 Carbopack B (Supelco) that was operated isothermally at 160°C. 
For detecting cDCE-epoxide, headspace samples up to 2 mL were injected. Oxygen and 
carbon dioxide levels were measured with a Perkin-Elmer GC equipped with a thermal-
conductivity detector and a 80-inch × 1/8-inch column packed with 60/80-mesh 13X 
molecular sieve (Supelco), operated at 90˚C. Substrate levels were quantified by 
comparison to standards prepared using known-amount additions in serum bottles 
containing phosphate buffer.  
Cyclohexanol, CYHX and CAP were analyzed by GC after extraction of aqueous 
samples with EtOAc (1:1 = sample: EtOAc), and 2 µL of the organic layer was injected 
into a GC (Hewlett Parkard HP5890 Series II) equipped with an FID and a SPB™-5 
column (15 m × 0.53 mm × 1.5 µm; Supelco). The column temperature was maintained 
at 50°C for 2 min, then ramped 15°C/min to 215°C.  The injector and detector 
temperatures were both 250°C. Standards for these substrates were made gravimetrically 
and extracted using EtOAc for GC measurements. 
DCAL, DCET, styrene and styrene oxide concentrations were analyzed by GC 
after extraction of aqueous samples with Et2O (2:1 = sample:Et2O), and 3 µL of organic 
extract was injected into a GC (Hewlett Parkard HP5890) equipped with an FID and a 
  
 
53 
 
DB-5ms column (30 m × 0.53 mm × 1.0 µm; Agilent Technologies) that was operated 
with column at 40°C for 4 min, then ramped 40°C/min to 200°C until all had been eluted. 
The injector and detector temperatures were 200°C and 250°C, respectively. Standards 
for these substrates were made gravimetrically and extracted using Et2O for GC 
measurements.  
For EtOH and acetaldehyde measurements, direct aqueous injection (3 µL) was 
made to the GC (HP5890) with FID and DB-5ms column, operated with similar program 
conditions described above with a longer final temperature (200°C) to remove excess 
water. Prior to analyses, samples were centrifuged to remove cell debris and kept on ice 
between measurements to ensure stability of EtOH and acetaldehyde. Standards for both 
EtOH and acetaldehyde were made by adding 45.2 µL and 42.7 µL of substrates into 9.54 
mL and 9.95 mL of distilled water, respectively.   
The concentrations of acetate, succinate, chloride, 6-HHA and glycolate, were 
measured using a Dionex Ion Chromatograph (AS50) equipped with Dionex AS14A 
analytical and guard ion-exchange columns with suppressed conductivity detection in an 
isocratic CO2-free, 40-mM NaOH eluent at 1 ml/min for 15 minutes. NaOH eluent was 
primed with high-purity helium before use. Samples were centrifuged to remove cell 
debris prior to analyses. Standards for chloride concentrations were prepared 
gravimetrically through known amount of additions into volumetric flasks. 
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3.4 Disruption of chmo by homologous recombination.  
As an aid to selecting for successful recombinants after mating, the inserts contain 
(among other genes) an antibiotic-resistance gene that confers resistance upon the 
recombinant to an antibiotic to which the wild-type is not natively resistant.  Thus, 
preliminary to attempting homologous recombination with JS666, we needed to ascertain 
its native resistance to various antibiotics. To determine the antibiotic resistance of strain 
JS666, WT cells were grown on ¼-TSA plates containing selected antibiotic gradients 
(maximum concentration of antibiotics tested, µg/mL): rifampicin (100), kanamycin (50), 
streptomycin (100), ampicillin (100), chloramphenicol (20), and tetracycline (20).   
Strain JS666 was plated on ¼-TSA plates containing a rifampicin gradient (up to 
100 μg/mL) and showed resistance to it, but sensitivity to kanamycin, ampicillin, 
chloramphenicol, streptomycin and tetracycline, even though some genes that are known 
to be involved in chloramphenicol resistance exist in strain JS666 (Bpro_0389 and 
Bpro_3811). We tested E. coli strains used in this study for their sensitivity to different 
antibiotics (maximum concentrations tested: rifampicin, 50 μg/mL; kanamycin, 50 
μg/mL; ampicillin, 100 μg/mL; chloramphenicol, 20 μg/mL; tetracycline, 20 μg/mL), and 
all E. coli strains with the broad-host range vectors were resistant to kanamycin but 
sensitive to the other antibiotics tested.  
To prepare the suicide vector, pVIK110 was extracted from E. coli SY327 
pVIK110 using the PureYield plasmid purification kit (Promega). An internal fragment 
of chmo was PCR-amplified from JS666 genomic DNA using the VcmoF and VcmoR 
primer pair (Tm = 60°C) with a Mastercycler Gradient (Eppendorf). The resulting 
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amplicons and pVIK110 were cut using XbaI and SalI restriction enzymes (Fermentas), 
ligated and transformed into chemical-competent E. coli S17-1 λpir cells using heat-
shock treatment. Chemical-competent E. coli S17-1 λpir cells were prepared using a 
rubidium chloride method (Douglas, 1983).  
JS666 cells were harvested by centrifugation, suspended in ¼-TSB and left to 
grow unshaken 24-48 hours before mating was conducted. The conjugation frequency of 
a suicide plasmid in strain CJ2 was reported to be low, which may be caused by 
unsuitable growth temperature for the donor strain (mating temperature = 25°C) or 
extracellular polysaccharide production (Park et al., 2007). To improve vector transfer to 
the recipient strain, the donor strain was grown at 30°C and the mating was conducted in 
¼-TSB for more than 24 hours. E. coli S17-1 λpir pVcmo cells were grown in LB broth 
at 30°C overnight before the cells were harvested and suspended in ¼-TSB. Suicide 
vector containing the internal chmo fragment, pVcmo, was transferred into rifampicin-
resistant JS666 by conjugational mating with E. coli S17-1 λpir pVcmo cells on ¼-TSB 
at 23°C for another 24-48 hours. 100-µL aliquots of the bacterial mixtures were 
subsequently spread on ¼-TSA plates containing 60 µg/mL rifampicin and 30 µg/mL 
kanamycin (TRK plates) and were left to grow for 5-7 days at 23°C. The resulting 
colonies were carefully transferred to another fresh TRK plate. The transconjugants (KO) 
were confirmed by PCR with isoF-isoR, ocmoF- vxR and 65F-65R (or RT-CMOF and 
RT-CMOR) primer pairs (Tm = 60°C) and run on 1% TBE or TAE gel.  The first primer 
set (isoF-isoR) is used to identify that the colonies are strain JS666. The second set 
(ocmoF-vxR) looks for the presence of the insert within the interrupted chmo gene – 
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thereby proving that the colony is KO.  The third primer set hybridizes to the chmo 
sequences before and after the insert, resulting a 572-bp amplicon for WT and none for 
KO (because of an extra 9.3-kbp insert and short PCR extension time). The resulting 
amplicons were excised and purified for sequencing. See Appendix A for more details on 
sequencing results. KO colonies were then transferred into ¼-TSB containing 30 µg/mL 
kanamycin before transferring into a 160-mL bottle with 50-mL MSM containing 10 mM 
succinate, 26 µmol/bottle cDCE (or a nominal concentration of 520 µM) and 30 µg/mL 
kanamycin. Occasionally, KO cultures were checked for purity by streaking on a fresh ¼-
TSA plate and several colonies were selected for PCR-testing using ocmoF-vxR and 
isoF-isoR primer sets, looking specifically for KO characteristics.   
 
3.5 Complementation  
The intent of these studies was to re-insert the chmo gene back onto the chmo-
negative mutant strain and see what functions lost to the KO strain were thereby restored.   
chmo-knockout mutant strains were grown on MSM containing 10 mM succinate. The 
cells were then harvested and suspended in ¼-TSB and left to grow at 23°C for 24-48 
hours without shaking. E. coli S17-1 λpir cells containing pJcmo plasmid were grown in 
LB broth with 10 µg/mL tetracycline at 30°C. The conjugation technique was similar to 
the method of creating KO strains, except the bacterial mixtures were spread on ¼-TSA 
plates containing 60 µg/mL rifampicin and 5 µg/mL tetracycline (TRT plates). Colonies 
that grew on the plate were transferred onto a fresh TRK plate. Subsequently, the 
  
 
57 
 
colonies that grew on the TRK plate were streaked on a fresh TRT plate. The 
complement strain was confirmed by PCR with isoF-isoR, ocmoF-vxR and 65F-65R 
primer pairs (Tm = 60°C) and by sequencing the resulting amplicons.  
 
3.6 Growth and substrate-utilization experiments. 
Both WT and KO strains were first grown in 5 mL ¼-TSB with 1.3 µmol/bottle 
cDCE. Aliquots of 0.1 mL were transferred into 5 mL MSM containing 1.3 µmol/bottle 
cDCE with either 10 mM succinate, 10 mM acetate, 1 mM CYHX or 10 mM EtOH. This 
step was to ensure similar initial conditions for the subsequent experiments. Then, 
approximately 0.2-mL aliquots of WT cells from each substrate (10 mM succinate, 10 
mM acetate, 1 mM CYHX or 10 mM EtOH) were transferred into fresh 100-mL MSM 
containing the respective substrates with added cDCE levels of of 132 µmol/bottle, 52 
µmol/bottle or none. For KO cultures, approximately similar amounts of cells from 
acetate-grown (with 1.3 µmol/bottle cDCE) cultures were used as innocula. A similar 
experiment was conducted with CAP. WT and KO cultures were grown in 100-mL MSM 
with 1 mM CAP along with cDCE (106 µmol/bottle, 52 µmol/bottle or none).  cDCE 
concentrations and optical densities of the cultures at 600 nm (OD600) were monitored. 
All experiments were conducted with biological duplicates.  
In a preliminary experiment, WT and KO cultures were also tested on their 
capabilities of growth on cyclohexanol. 5 mL of the succinate-grown cultures (with 
cDCE exposure) were transferred into 95-mL fresh MSM with 0.5 mM cyclohexanol in 
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160-mL serum bottles. Cyclohexanol concentrations were monitored with time and any 
production of cyclohexanone was noted.   
To assay possible TCE, VC, DCA and ethene transformations, WT and KO 
cultures were grown in 1-L serum bottles containing 400-mL MSM plus 1 mM CAP and 
208 µmol/bottle (nominal concentration of 520 µM) of cDCE. When the OD600 reached 
0.3 – 0.5 or at mid-cDCE degradation, the cells were harvested by centrifugation, washed 
once with MSM, and resuspended into 160-mL serum bottles containing 50 mL MSM. 
TCE, DCA, VC and ethene were delivered accordingly, and the quantities of these 
hydrocarbon compounds were monitored (headspace sampling) with time. Any formation 
of epoxyethane was also noted. TCE- and VC-epoxides were short-lived and have not 
been synthesized for this study; therefore their formations were not monitored. DCA is 
transformed into 2-chloroethanol and its production was not monitored. The experiments 
were conducted with biological duplicates.  Remaining substrate levels were estimated by 
comparison to standards prepared by addition of known amounts of TCE, DCA, VC and 
ethene to 160-mL serum bottles containing 50-mL MSM.  
 
3.7 Overexpression of enzymes involved in cyclohexanol metabolism. 
To overexpress genes in the cyclohexanol operon of JS666, each individual gene 
was cloned into the expression vector pET101/D-TOPO® (Invitrogen). Putative chnB 
(chmo, Bpro_5565) and chnD (Bpro_5563) genes were PCR-amplified from WT 
genomic DNA by using PfuUltra II Fusion HS DNA polymerase (Agilent Technologies, 
Inc.) and 65F-65R and 63F-63R primer pairs (Tm = 60°C), respectively. The resulting 
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amplicons were cloned into the expression vector pET101/D-TOPO and further 
transformed into E. coli BL21 Star™ (DE3). For a hexahistidine-tagged putative α/β 
hydrolase-fold (chnC, Bpro_5566), 66F forward primer was coupled with 66H reverse 
primer (Tm = 60°C) and chnC gene was PCR-amplified from WT genomic DNA by using 
PfuUltra II Fusion HS DNA polymerase. Similarly, the resulting amplicons were cloned 
into the pET101/D-TOPO vector and the construct was transformed into E. coli BL21 
Star™ (DE3).  
To overexpress the complete cyclohexanol operon, both chnC and chnB (chmo) 
genes were cloned in tandem into a cloning vector, pET21a(+) (Novagen), and both chnA 
and chnD genes were cloned in tandem into pCOLADuet™-1 (Novagen). The chnC-
chmo gene pair was PCR-amplified by using the E6566F-E6566R primer pair (Tm = 
60°C), which contains BamHI and XhoI restriction sites, respectively. The amplified 
PCR product obtained and pET21a(+) were then excised with FastDigest®, BamHI, and 
XhoI (Fermentas) and ligated, resulting in the recombinant plasmid designated p6566. 
The chnA-chnD gene pair was PCR-amplified by using C6463F-C6463R primer pair (Tm 
= 60°C), which contains EcoRI and HindIII restriction sites, respectively. The resulting 
amplicons were excised with FastDigest®, EcoRI and HindIII (Fermentas) and ligated 
into pCOLADuet™-1, resulting in pC6463. Initially, these two plasmid constructs were 
co-transformed into a single E. coli strain, however the strain grew well only at 37°C and 
all of our whole-cell studies were conducted at 30°C or room temperature.  We have 
decided to transform and test them separately. All sequences were checked with the 
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NCBI database and any error was corrected using QuickChange Multi Site-Directed 
Mutagenesis Kit (Agilent Technologies).    
 
3.8 Enzymatic assays. 
3.8.1 CHMO enzymatic assays. 
 For assaying overexpression of the chmo gene in E. coli, whole-cell studies were 
adopted based on previous studies (Iwaki et al., 2002b; Alexander, 2010).  E. coli Bl21 
Star™ strains containing p65R or p6566 were grown in LB broth supplemented with 100 
µg/mL ampicillin and 1 µg/mL riboflavin on a rotary shaker at 30°C. When the optical 
density reached 0.4 – 0.5, IPTG was added to the media (to yield a concentration of 0.1 
mM), and the cultures were left shaken for 5 minutes before the substrates were added 
and subsequent incubation to assay growth was conducted at 23°C. The disappearance of 
the substrates and the appearance of products were monitored. Substrates tested were 
CYHX, cDCE, styrene and DCAL, and the expected products were CAP, cDCE-epoxide 
and DCAA, respectively. Cell cultures that were not induced and E. coli strains without 
the plasmids were used as controls.  
 
3.8.2 Hydrolase enzymatic assays 
For ChnC (hydrolase, Bpro_5566) overexpression, a method similar to that 
described above for CHMO assays was used. In another separate experiment, E. coli Bl21 
Star™ strains containing p66H were grown in LB broth supplemented with 100 µg/mL 
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ampicillin at 30°C. When the optical density reached 0.4 – 0.5, 0.1 IPTG was added 
(yielding 0.1 mM) to the media, and the cultures were left shaken for 5 minutes before 
the substrate, such as 10 µL CAP, 0.5 mL epoxyethane or 5 µL chemically-synthesized 
cDCE-epoxide, was injected into 20-mL cultures in 160-mL serum bottles. For assay 
with styrene oxide, approximately 5 µL was injected into 50-mL cultures in 160-mL 
serum bottles. Subsequent incubation to assay growth was conducted at 23°C.  
Another hydrolase from strain JS666 (Bpro_4478) was also tested with 
chemically-synthesized cDCE-epoxide (Chan et al., 2010).  The gene was cloned in 
p15TV-L plasmid (containing ampicillin resistance gene), and the plasmid was 
transformed into E. coli BL21 Star™ cells. In a preliminary experiment, the cells were 
grown in LB broth containing 100 µg/mL ampicillin at 30°C. When OD600 reached 0.5 – 
0.6, IPTG was introduced (yielding 0.5 mM), and they were left shaken at 23°C 
overnight. For control cells, IPTG was not added to the separate cultures. The cells were 
then harvested and washed once with phosphate buffer. The pellets were then 
resuspended into 20 mM phosphate buffer supplemented with 1 mM succinate. Chloride 
ions were measured after an hour of incubation and three hours after the first 
measurement. At 5-hour incubation, 1 mM succinate was added to both induced and 
uninduced cultures.  Final readings were taken after the cultures were left shaken 
overnight.  
The experiment was repeated by growing the cells in LB broth containing 0.5% 
glucose and 100 µg/mL ampicillin at 30°C. When OD600 reached 0.5 – 0.6, IPTG was 
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introduced (yielding 1 mM). After 4-hour induction at 30°C, the cells were harvested by 
washing them twice in phosphate buffer to remove traces of chloride ions (LB broth 
contains 10 g/L NaCl). The cells were resuspended in 20 mM phosphate buffer and 
chemically synthesized cDCE-epoxide (in acetonitrile) was introduced to the cultures. 
Uninduced cells were assayed for background activity and chloride release. Phosphate 
buffer with no cells was used as blank control.  
 
3.8.3 Dehydrogenases enzymatic assays 
E. coli BL21 Star™ (DE3) strains containing either p6364 or p63R were grown 
on LB broth with 0.5% glucose and 30 µg/mL kanamycin or 100 µg/mL ampicillin, 
respectively, at 30°C. An E. coli cell culture with no plasmid was used as negative 
control. When the culture’s optical density (OD600) reached 0.4 – 0.5, IPTG was supplied 
(yielding 1 mM) to induce the production of the proteins, and the cultures were left 
shaken overnight at 23°C. The cultures were then harvested by centrifugation and washed 
once with phosphate buffer. The pellets were resuspended in 20 mM phosphate buffer 
(pH 7.5) and aliquots (10-mL) of the culture (containing approximately 20 mg of cells) 
were transferred into 25-mL serum bottles, and substrates were subsequently added. 
Uninduced cells were used as control. Among substrates tested for ChnD (long-chain 
dehydrogenase) activity were cyclohexanol, 6-HHA, EtOH, acetaldehyde, glycolate and 
DCET. With the overexpressed tandem of ChnA (cyclohexanol dehydrogenase) with 
ChnD, cyclohexanol, 6-HHA, EtOH, and acetaldehyde were tested. To add acetaldehyde, 
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a stock solution was first created:  155 µL acetaldehyde was injected into 23.2 mL 
phosphate buffer using a cold syringe (kept at 4°C) to make a 5.25 g/L stock.  
 
 
3.8.4 P450 enzymatic assays 
 P450 and its adjacent genes (ferredoxin and ferredoxin reductase) were cloned in 
IPTG-inducible pET101D-TOPO vector and transformed into E. coli Rosetta2 (DE3) 
(Shin, 2010). The strain was grown in LB broth containing 100 µg/mL ampicillin and 20 
µg/mL chloramphenicol until OD600 reached 0.4 – 0.5 at 30°C. IPTG was subsequently 
added (yielding 0.5 mM) to the cultures, and they were left shaken at 23°C overnight. 
The cells were then harvested and washed twice with phosphate buffer to remove any 
remaining chloride ions. The pellets were then resuspended into 20 mM phosphate buffer 
supplemented with 5 mM succinate. Aliquots (20-mL) of the culture were transferred into 
160-mL serum bottles and 0.5 µL of cDCE was then added. Uninduced cells and no-
cDCE induced cells were used as background controls. Samples for cDCE measurement 
were taken twice by drawing out 2 mL of headspace and injecting to GC/FID with 
packed column. Samples of mixed culture (2-mL) were also removed at each time-point 
for chloride measurements. cDCE levels were calibrated gravimetrically through 
additions of known amounts (0.1098, 0.1172, 0.1145 mg of cDCE) into serum bottles 
containing known amounts of buffer (19.72, 20.27, 20.01 mg phosphate buffer). 
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3.9 Starvation studies 
cDCE-grown, strain JS666 cultures were transferred into 50-mL MSM containing 
CYHX (1-2 mM) or succinate (10 mM) and grown to an OD600 of 0.4-0.5.   Aliquots (20-
mL) of the CYHX-grown or succinate-grown cultures were transferred into 580 mL 
MSM containing 1 mM of CYHX or 10 mM succinate, respectively, and the 
concentration of CYHX and OD600 of succinate-grown cultures were monitored.  
When the actively degrading CYHX (at 0.3 – 0.5 mM), cells were harvested by 
centrifugation, washed and resuspended with fresh carbon-free MSM (5 mL). The cells 
were then injected into 160-mL serum bottles containing 45 mL MSM. The succinate-
grown cells were harvested when OD600 reached approximately 0.5 – 0.7, and similarly 
the cells were washed, resuspended (in 5-mL fresh carbon-free MSM) and injected into 
160-mL serum bottles containing 45 mL MSM. Substrates were either added immediately 
or after 24 hours of carbon starvation. CYHX-grown cells were fed with 1 mM CYHX as 
a control, cDCE only, or cDCE with 1 mM succinate.  Approximately 2 µL of neat cDCE 
was injected into the 50-mL cultures that received cDCE.  
A similar amount of cDCE was injected to two 160-mL serum bottles containing 
succinate-grown cells in 50 mL MSM. Then, 1 mM succinate was added to one of the 
bottles and none to the other. Concurrently, other aliquots of succinate-grown cells in 50 
mL MSM were also fed with 0.2 mM CYHX and 26 µmol/bottle cDCE (520 µM nominal 
concentration). All experiments were conducted in duplicate. All culture bottles were 
shaken inverted at 160 rpm and incubated aerobically at 23°C. 
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3.10 iTRAQ 
3.10.1 Protein extraction.  
Both WT and KO strains were grown in 2 mM CAP, with or without cDCE (52 
µmol/bottle = 520 µM nominal concentration) in 100-mL MSM. The utilization of the 
substrates by both strains was monitored using gas chromatography as previously 
described. The cultures were harvested when the cells were actively degrading cDCE 
and/or CAP. The cells were centrifuged and washed with phosphate buffer once. The 
pellets were then resuspended in 20 mM phosphate buffer (pH 7.5), and these cells were 
French-pressed at 20,000 psi. In between pressings, the French-press cell was rinsed with 
distilled water thrice, 70% ethanol once, and distilled water thrice. The French-press cell 
and the lysates were kept cold at 4°C. Small amounts of WT and KO pellets were kept at 
-80°C for later RNA extractions. Subsequent procedures (i.e. protein quantitation, 
digestion, iTRAQ labeling, fractionation, chromatography, spectrometry and data 
processing) were performed by James McCardle, Wei Chen and Sheng Zhang at The 
Proteomics and Mass Spectrometry Core Facility, Cornell University. Details of the 
procedures are included in Appendix C.  
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3.10.2 Reverse transcription polymerase chain reaction (RT-PCR) 
10 mL of WT and KO cultures from the iTRAQ studies were harvested and total 
RNA was extracted using the Qiagen Allprep RNA/DNA Mini Kit and treated twice with 
RNase-free DNase I (Qiagen and Promega). Extracted total RNAs were measured and 
checked for DNA contamination using an Agilent RNA Nano chip analyzed in an Agilent 
2100 Bioanalyzer.  
100 ng of RNA was used as a template for the reverse transcription reaction. The 
first strand of complementary DNA (cDNA) was primed using a cocktail of gene-specific 
primers (2 pmol/primer, 8 primers total).  A two-step RT-PCR protocol was used: a 
mixture of RNA template and primers was incubated at 65°C for 5 min and then chilled 
on ice. Reverse transcriptase and its provided buffer (Bio-rad iScript) were mixed into the 
previous contents and mixed, centrifuged and incubated at 42°C for 60 min. The reaction 
was terminated by incubation at 85°C for 5 min. The concentrations of synthesized 
cDNAs were measured and checked for purity using a NanoDrop 2000C (Thermo 
Scientific). For RT-PCR, 300 ng of cDNA was used as template with RT-PCR primers 
listed in Table  3.1. Melting temperature used for the PCR reaction was 60°C, and the 
reaction was conducted using 30 or 35 cycles.  
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CHAPTER 4 
4. RESULTS 
 
4.1 Disruption of the chmo gene in JS666 
The role of CHMO in JS666 was studied through disruption of the chmo gene. 
Plasmid pVIK110 with an internal fragment of the chmo gene was used to create 
translational fusion as a consequence of integration of the entire plasmid into the target 
gene (Figure 4.1) (Kalogeraki and Winans, 1997). PCR was used to confirm that the 
transconjugants contained an insert at the designated location and the resulting amplicons 
were sequenced (Appendix A and Figure  4.2). 
 
 
 
 
 
 
 
 
Figure  4.1. Suicide vector was integrated into the genome of JS666 through 
homologous recombination. Primers ocmo and vxR were used to confirm the 
integration of the plasmid into the genome at the designated location. Km is 
kanamycin resistance gene. R6K is the origin of replication. The resulting protein is 
a CHMO-LacZ fusion. 
lacZ 
Km R6K 
lacZ R6K Km 
chmo 
vxR ocmo
 
JS666 genome 
JS666 genome (after insertion) 
pVcmo 
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Figure  4.2. Example of PCR on WT and KO strains using three different primer 
pairs: isoF-isoR pair, which targets a JS666-specific sequence in the gene encoding 
isocitrate lyase (aceA); RTcmoF-RTcmoR pair, which targets sequences upstream 
and downstream of the location of the insert within the chmo gene; and ocmoF-vxR 
pair, which targets a part of chmo gene (upstream from sequence of VcmoF) and 
lacZ gene of the suicide vector. M: Lambda DNA/HindIII marker; Lane 1-3: WT; 
and Lane 4-6: KO; bp: base-pairs. 
  
 
Preliminary results indicated that a portion of the chmo gene downstream of the 
insertion point was transcribed in the KO strain (Giddings, 2010) (primers for the chmo 
gene were initially designed to target a sequence that is downstream from the insert; 
cDNA corresponding to transcripts from this downstream region were detected with these 
primers).  Then, the KO cultures were plated on ¼-TSA plates and several colonies were 
randomly chosen and PCR-assayed using the ocmoF-vxR primer pair. The results were 
positive (results not shown).   
bp         M          1             2              3           4            5             6 
            aceA    chmo      ocmo     aceA       chmo      ocmo 
2322 
2027 
 
564  
~823 
~572  
Resulting 
amplicon 
estimated 
sizes in bp  
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An attempt to produce a chmo-complementary strain from the KO strain was also 
successful (results not shown). A complete chmo gene was cloned into a high-copy 
number vector (pJB866) containing a tetracycline-resistance gene. The construct was 
transformed into the KO strain using a conjugation method similar to that used to produce 
the KO strain. Colony PCR was used to confirm the transformation. Transfers from these 
colonies, however, were capable only of growing on TSB; several attempts to culture 
them on MSM with succinate were unsuccessful. Overproduction of CHMO, usage of 
multiple antibiotics (kanamycin and tetracycline), and additional high-copy number of 
the large plasmid (9 kbp) may have affected the fitness of the complementary strain 
(Smith and Bidochka, 1998).  
 
4.2 The growth of WT and KO strains on different substrates. 
The primary purpose of this set of experiments was to ascertain what metabolic 
capabilities – if any – had been lost in the KO strain, versus the WT strain.  Additionally, 
we hoped: (i) to determine which growth co-substrates might best induce cDCE-
degradation; (ii) to investigate the inhibitory effects of cDCE on bacterial growth; and 
(iii) to determine the extent to which cDCE degradation (producing potentially toxic 
metabolites) matters to observed cDCE toxicity, versus the mere presence of cDCE. 
Both WT and KO cells were first grown in TSB with cDCE (1.3 µmol/bottle) 
before transferring into MSM with succinate, acetate, CYHX or EtOH – each with or 
without co-presence of cDCE. The WT cultures grew on all four substrates, and the KO 
cultures grew only on succinate or acetate. When WT and KO cultures were grown on 
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acetate, the presence of cDCE had virtually no effect. It did not impact bacterial growth 
by either strain, nor was cDCE degraded by either (Figure  4.3).  While final cell densities 
were apparently highest in WT cultures at the higher cDCE level, the size of the error 
bars on those particular values makes impossible the drawing of any conclusion to that 
effect.  In essence, both strain types behaved as though cDCE were irrelevant, when both 
were provided with – and growing on – acetate.  
On the other hand, when cultures were growing on succinate, high concentrations 
of cDCE slowed down growth of both strains. At the higher concentration of cDCE (132 
µmol/bottle), minimal growth was observed in WT or KO cultures provided with 
succinate (Figure  4.4).  Unlike what was observed with acetate, the WT cultures provided 
with succinate did exhibit cDCE degradation at the lower cDCE level; however, it was 
not sustained with additional, added cDCE. This bottle exhibited the “bad behavior” with 
respect to cDCE degradation so often observed with JS666. The observation with 
succinate-grown WT cultures indicates that high concentrations of cDCE (and/or possibly 
the presence of cDCE metabolites produced from cDCE oxidation) inhibit growth, 
although succinate was supplemented in excess (10 mM).   We currently have no sure 
explanation for the lack of cDCE toxicity in acetate-fed cultures, versus the obvious 
toxicity observed in succinate-fed cultures.  Since cDCE was transformed in succinate-
fed WT cultures at the lower cDCE level, it might also have been partially transformed in 
them at the higher cDCE level – at least to an extent that toxic metabolites resulted. 
However, we have never seen any evidence of cDCE transformation by the KO strain, 
although it is possible that the KO strain partially metabolizes cDCE to a highly 
inhibitory intermediate (e.g., an epoxide) that accumulates, yet does not represent a 
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significant loss of the fed level of cDCE. This could occur, for example, if genes involved 
in steps other than the initial step of cDCE degradation were adversely affected in the KO 
strain. It is also possible that the explanation lies in some physiological difference 
between acetate and succinate metabolisms — possibly differences in their 
transmembrane transport mechanisms that could account for the observations, since high 
levels of cDCE would likely disrupt membrane function. 
Neither CYHX nor EtOH could support growth by the KO strain (Figure  4.5 and 
Figure  4.6); nor was cDCE apparently degraded by the KO strain in these bottles. On the 
other hand, when WT cultures were provided with CYHX and EtOH as co-substrates, the 
cells relatively quickly exhibited cDCE degradation – and sustained it through multiple 
additions, even at the higher cDCE level (Figure  4.5 and Figure  4.6).  (The apparent 
decrease in cDCE degradation rate in the EtOH-fed cultures with the lower cDCE level at 
later time-points is explainable by oxygen depletion).   
 WT cultures grown with co-presence of CAP started degrading cDCE after 6-8 
days of incubation (Figure  4.7), whereas WT cultures that co-utilized EtOH or CYHX 
began using cDCE after only 1-2 days of incubation. The densities of the WT cultures 
grown on CAP were higher than those of EtOH or CYHX cultures when cDCE-
degradation started. The WT cultures grown on CAP and cDCE showed higher final 
culture density than cultures grown on CAP only, suggesting that cDCE was utilized for 
bacterial growth (Figure  4.7).  In KO cultures fed CAP, there was no cDCE degradation. 
Final densities in bottles fed CAP-only were similar in KO and WT cultures, but final 
densities were lower in the KO cultures in presence of cDCE than in absence of cDCE, 
suggesting conditions impeding bacterial growth.  The final density for KO culture 
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amended with highest amount of cDCE was the lowest among the three, suggesting that 
high concentrations of cDCE may cause high stress to the cells. Again, since there was no 
evidence of cDCE transformation in the KO cultures, the observed inhibition of growth 
caused by cDCE is presumed not the result of inhibitory metabolites. However, it is 
difficult to rule such out, because enzymes other than CHMO might be capable of 
producing inhibitory levels of cDCE metabolites without resulting in a detectable 
fractional loss of the high, initial cDCE level.  Still, there is no basis from these data to 
support such a hypothesis. 
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Figure  4.3. Growth of WT and KO strains on MSM and 10 mM acetate supplied 
with or without cDCE. Bars depict standard errors of experimental biological 
duplicates. Solid lines with closed markers are cDCE, and dotted lines with opened 
markers are OD600. Cultures were supplied with 132 µmol/bottle cDCE (square 
markers), 52 µmol/bottle cDCE (triangle markers) or no cDCE (star markers). 
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Figure  4.4. Growth of WT and KO strains on MSM and 10 mM succinate supplied 
with or without cDCE. Bars depict standard errors of experimental biological 
duplicates. Solid lines with closed markers are cDCE, and dotted lines with opened 
markers are OD600. Cultures were supplied with 132 µmol/bottle cDCE (square 
markers), 52 µmol/bottle cDCE (triangle markers) or no cDCE (star markers). 
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Figure  4.5. Growth of WT and KO strains on MSM and 1 mM CYHX supplied with 
or without cDCE. Bars depict standard errors of experimental biological duplicates. 
Solid lines with closed markers are cDCE, and dotted lines with opened markers are 
OD600. Cultures were supplied with 132 µmol/bottle cDCE (square markers), 52 
µmol/bottle cDCE (triangle markers) or no cDCE (star markers).  
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Figure  4.6. Growth of WT and KO strains on MSM and 10 mM EtOH supplied with 
or without cDCE. Bars depict standard errors of experimental biological duplicates. 
Solid lines with closed markers are cDCE, and dotted lines with opened markers are 
OD600. Cultures were supplied with 132 µmol/bottle cDCE (square markers), 52 
µmol/bottle cDCE (triangle markers) or no cDCE (star markers). 
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Figure  4.7. Growth of WT and KO strains on MSM and 1 mM CAP supplied with 
or without cDCE. Bars depict standard errors of experimental biological duplicates. 
Solid lines with closed markers are cDCE, and dotted lines with opened markers are 
OD600. Cultures were supplied with 106 µmol/bottle cDCE (square markers), 52 
µmol/bottle cDCE (triangle markers) or no cDCE (star markers). 
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 WT and KO cultures were tested on their capabilities of growth on cyclohexanol 
(Figure  4.8). After a few days of incubation, the first measurements were taken, and the 
WT culture had produced 0.04 mM CYHX. After 10 days of further incubation, the 
production of CYHX by WT culture was almost doubled from the first reading and no 
formation of CYHX was observed in the KO bottle. The production of CAP in WT 
culture was not observed in the time frame of the experiment.  
 
 
 
Figure  4.8. Preliminary results for WT and KO cultures tested with 0.5 mM 
cyclohexanol. Formation of CYHX was detected only in WT culture.  
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4.3 Transformation of other ethenes and of 1,2-dichloroethane. 
One of many purposes of the knockout study was to determine whether 
inactivation of the chmo gene would affect the transformation of other ethenes and of 
DCA by strain JS666. Figure  4.9 shows the transformation of other substrates by WT 
culture that was previously grown on CAP (with cDCE present), then harvested, washed, 
and resuspended in MSM with the individual test substrates. At the beginning of the 
experiment, DCA was supplied at a nominal concentration of 160 µM, and the WT 
culture immediately transformed DCA. After two DCA supplements, a higher amount of 
DCA than the initial concentration was applied to the WT cultures. WT cells degrading 
DCA showed co-metabolic-like (slowed) phenotypical behavior after a total addition of 
approximately 75 µmol of DCA. VC was also readily degraded by WT cells. Almost 
98.9% of VC supplied was transformed by WT cells in approximately 21 hours. With a 
second addition of VC, the VC-transforming rate steadily decreased (Figure  4.9). 
Similar phenomena were observed in WT cultures transforming TCE or ethene. 
These 50-mL WT cultures reached their maximum transformation capacity after 
transforming 0.05 µmol of TCE and 2.4 µmol of ethene. The formation of epoxyethane 
was observed in ethene-fed bottles. The plateau may be due to formation of reactive 
metabolites, such as epoxides, chlorinated aldehydes and chlorinated acetates that may 
slow the degradation rates. KO cultures, in contrast, showed no ability to transform these 
compounds (Figure  4.9).  
In previous studies in our laboratory, strain JS666 administered TCE or VC as 
sole substrates exhibited slow, declining rates of transformation, and the later addition of 
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cDCE improved their degradation (Liu, 2009). At low concentration levels of TCE, 
JS666 cultures provided with both TCE and cDCE demonstrated a competitive inhibition 
between the two substrates, but high levels of TCE have proven to be quite inhibitory. It 
is possible that the oxidation of TCE or VC can cause detrimental effects to the cells, and 
by adding a growth co-substrate (e.g. cDCE), cells are able to repair the damage, 
synthesize new cells, provide an energy source and supply a source of reducing agents. 
Providing JS666 with both DCA and cDCE also affects cDCE’s maximum degradation 
rate, but only slightly affects degradation of DCA (Liu, 2009).  
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Figure  4.9. Transformation of other ethenes and of DCA by WT and KO cultures. 
Bars depict standard errors of experimental biological duplicates.   
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4.4 Cloning and characterization of the operon involved in 
cyclohexanol metabolism. 
Four genes in the operon involved in cyclohexanol metabolism were cloned in 
IPTG-inducible plasmids as individual genes or in tandem. [Note: see earlier Figures 2.6 
and 2.7 for relative positions of the genes in the operon.]  The constructed plasmids in E. 
coli BL21 Star™ (DE3) cells contained chnB (p65, the monooxygenase), chnC (p66, the 
hydrolase), chnD (p63, a long-chain dehydrogenase), chnCB (p6566, the hydrolase and 
monooxygenase in tandem), or chnAD (p6364, the short- and long-chain dehydrogenases 
in tandem). Attempts to amplify the whole operon (approximately 5.0 kbp, including 414 
bp upstream of chnC) at once using Pfu DNA polymerase were unsuccessful. This may 
be due to the uneven length and GC distribution of forward and reverse primers. Enzyme 
activities were all conducted in whole-cell E. coli. A summary of results from enzymatic 
assays is presented in Table  4.1, with detailed results following. 
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Table  4.1. Summary of substrates tested on different overexpressed enzymes. The 
study was conducted in whole-cell E. coli. (+) indicates an activity was observed, 
(++) indicates high activity was observed, (-) indicates no activity was observed and 
(0) both induced and uninduced cells transformed the substrate. N.T means not 
tested. 
Clones a p63R p6364 p65R p66H p6566 P450 b 4478 
cDCE N.T. N.T. - N.T. - ++ N.T. 
cDCE-epoxide N.T. N.T. N.T. - - N.T. - 
epoxyethane N.T. N.T. N.T. - - N.T. - 
cyclohexanol + + N.T. N.T. N.T. N.T. N.T. 
CYHX N.T. N.T ++ N.T ++ - N.T. 
CAP N.T. N.T. N.T. ++ ++ N.T. N.T. 
6-HHA ++ ++ N.T. N.T. N.T. N.T. N.T. 
glycolate - N.T N.T. N.T. N.T. N.T. N.T. 
styrene N.T. N.T. - N.T. - N.T. N.T. 
styrene oxide N.T. N.T. N.T. - - N.T. N.T. 
DCET - N.T - N.T N.T N.T N.T 
EtOH + + N.T. N.T. N.T. N.T. N.T. 
acetaldehyde 0 0 N.T. N.T. N.T. N.T. N.T. 
DCAL + N.T. 0 N.T. N.T. N.T. N.T. 
a  p63R = alcohol dehydrogenase (Bpro_5563);  p6364 = alcohol and short-chain dehydrogenases 
(Bpro_5563 and Bpro_5564);   p65R = CHMO (Bpro_5565);    p6566 = CHMO and hydrolase 
(Bpro_5565 and Bpro_5566); P450 = cytochrome P450 and its adjacent genes (Bpro_5299 – 
Bpro_5301);   4478 = hydrolase (Bpro_4478, another hydrolase outside the cyclohexanol 
operon).  Position of genes in the cyclohexanol operon in the direction of transcription: hydrolase, 
CHMO, short-chain dehydrogenase and alcohol dehydrogenase (Figure 2.7). 
 
b All of these constructs were transformed into E. coli BL21 Star (DE3), except P450, which is 
transformed into E. coli Rosetta2 (DE3) 
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4.4.1 CHMO enzymatic assay 
 In this experiment, CHMO (or ChnB) utilized CYHX after 12 hours with 
production of CAP (Figure  4.10). In E. coli p6566, CYHX was completely transformed, 
and the lack of CAP accumulation suggests it was immediately hydrolyzed by hydrolase 
(ChnC). In a separate experiment, CAP was delivered to E. coli p6566 and was 
completely utilized (presumably by ChnC) within several hours (Figure  4.10). There was 
no activity on cDCE in strains containing ChnB (p65) or ChnC-ChnB (p6566), 
confirming the study by another research group (Alexander, 2010). CHMO was also 
tested on styrene (data not shown), and no production of styrene oxide was observed. 
Thus, while we successfully demonstrated that we had cloned a functional CHMO, it 
simply did not show activity on cDCE. 
An aldehyde is another possible substrate for CHMO, and perhaps this explains 
the upregulation of chmo by cDCE in JS666. DCAL was reported as one of the major 
oxidation products of P450 (Shin, 2010), and it is possible that DCAL could be converted 
into DCAA by CHMO. A whole-cell assay was conducted to test this hypothesis; 
however, interpretation of results was complicated by the transformation of DCAL to 
DCET by E. coli controls, whereas the goal of this assay was to see the formation of 
DCAA from DCAL.  In a separate assay (data not shown), E. coli p65R cells were tested 
with CYHX and DCAL. In induced E. coli p65R cells, the conversion of DCAL to DCET 
was rapid (up to 70% conversion after 7 hours when CYHX conversion to CAP was only 
25%. Formation of DCAA from DCAL in the E. coli cells harboring CHMO was not 
observed.  
In the usual whole-cell enzymatic assays, the test substrate is added after the cells 
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(induced or uninduced) are harvested, washed and suspended in buffer solution. 
However, in this chmo assay, the test substrate was added immediately after IPTG-
induction in rich media. Attempts to obtain active CHMO through the usual enzymatic 
assay were unsuccessful.  
 
4.4.2 Hydrolases 
Lactone hydrolase catalyzes breakage of the C-O bond, forming hydroxyl acid. A 
putative hydrolase (Bpro_5566 or ChnC) was postulated to break the C-O bond of CAP, 
forming 6-HHA. In a separate experiment to that described above, hydrolase activities 
were assayed by conducting whole-cell experiments. E. coli cells harboring p66h 
(hydrolase) were assayed with 2 mM of CAP, and the disappearance of the substrate was 
recorded (Figure  4.11). The induced cells completely utilized CAP within 16 hours of 
incubation (and perhaps even much earlier, as the CAP was completely depleted by the 
time of first measurement after the experiment was initiated).  The slight reduction of 
CAP in uninduced cells may due to the leaky T7-promoter of the E. coli (DE3) cells after 
incubating the cells to stationary phase.  The pET vector system (Novagen, Inc.), which is 
used in numerous protein expression studies, including our study, is a powerful 
expression tool. Even in the absence of IPTG, detectable levels of targeted protein 
production were observed due to leaky T7-promoter (Novy and Morris, 2001). Novagen 
has recommended the addition of 0.5 – 1.0 % glucose to the growth medium for host 
strains containing pET plasmid constructs to reduce basal expression of the proteins 
(Novy and Morris, 2001).  
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(a) 
 
(b) 
Figure  4.10. Transformation of CYHX and CAP by whole-cell E. coli p65R 
(CHMO) or p6566 (hydrolase and CHMO in tandem). (a) The induced E. coli p65 
cells were given CYHX () and formation of CAP () was monitored. 
Uninduced E. coli p65 cells tested with CYHX were used as control (- -- -). (b) The 
induced E. coli p6566 cells were given CYHX () or CAP (). Induced E. 
coli BL21 cells containing no plasmid were given CYHX () or CAP () 
as negative control. 
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Figure  4.11. E. coli p66h (hydrolase) cells subjected to different substrates and 
conditions: CAP, induced (×) and not induced (- -×- -); styrene oxide, induced 
() and not induced (- -- -); epoxyethane, induced () and not induced (- 
-- -). 
 
Other substrates tested on E. coli expressing the hydrolase (p66H) were 
epoxyethane and styrene oxide (Figure  4.11), and chemically-synthesized cDCE-epoxide 
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(headspace injection on packed column) and styrene oxide was monitored by GC-FID 
(Et2O extract on megabore capillary column). In all of these cases, slight disappearances 
of all substrates were observed in both induced and uninduced E. coli cells (Figure  4.11 
and Figure  4.12). Results from whole-cell assays of E. coli containing p6566 (hydrolase 
and monooxygenase, in tandem) with and without 0.1 mM IPTG-induction agreed with 
the results with that of hydrolase only.  The significant disappearance of cDCE-epoxide 
in both cell cultures suggests an abiotic transformation of epoxides (Appendix B).  
 
 
 
Figure  4.12. E. coli p66h (hydrolase) cells subjected to different conditions: cDCE-
epoxide, induced (solid lines, triangle marker) and not induced (dotted lines, square 
marker). Closed symbols represent peaks at 2.8 min and opened symbols represent 
peaks at 3.5 min in raw peak-area (PA) units. 
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Another hydrolase from strain JS666 (Bpro_4478) has been reported to show 
dehalogenase activity on haloacetates (Chan et al., 2010) and was tested with chemically 
synthesized cDCE-epoxide. Preliminary results indicated that chloride was released in all 
of the cultures – whether this hydrolase was induced or not (Figure  4.13). High initial 
chloride background apparently resulted from the previous growth media (LB contains 10 
g/L NaCl), even though the cells were washed once with phosphate buffer. 
 
 
Figure  4.13.  Preliminary results for whole-cell E. coli (containing Bpro_4478 gene, 
hydrolase) assay with chemically-synthesized cDCE-epoxide. Chloride ions were 
released in both IPTG-induced () and uninduced cultures (- -- -).  1 mM 
(final concentration) succinate was added at 5-hour mark.  
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synthesized cDCE-epoxide in phosphate buffer (pH 7.5) suggests that there was a 
significant, abiotic dechlorination of epoxide (Appendix B). Furthermore, the release of 
chloride cannot be proven to be from cDCE-epoxide alone. The resulting synthesis of 
epoxide by peracid may contain other chlorinated-organic byproducts other than 
chlorobenzoate that may interfere with the results (Ray et al., 2008). This work would 
have to be further explored with a purified, biologically synthesized epoxide (e.g., by E. 
coli containing p450 and its adjacent genes) and purified hydrolase (Shin, 2010).  
 
 
Figure  4.14. cDCE-epoxide GC peak areas at 2.8 min (closed symbols) and 3.5 min 
(opened symbols) versus time in raw peak-area (PA) units. E. coli cells 
overexpressing Bpro_4478 (hydrolase) were grown with induction with IPTG 
(diamond symbol, solid lines) and without induction (triangle symbols, dashed lines). 
A bottle with no cells was used as blank control (circle symbols, blue lines).  
  
0
5
10
15
20
0 5 10 15
cD
C
E-
ep
ox
id
e 
(P
A
) 
x 
10
5 
Time (hour) 
  
 
91 
 
4.4.3 Dehydrogenases 
Two dehydrogenases are located downstream of chmo transcription: a short-chain 
dehydrogenase (chnA, Bpro_5564) and a long-chain, putative alcohol dehydrogenase 
(chnD, Bpro_5563). ChnA shares 39% amino acid identity with cyclohexanol 
dehydrogenase, encoded by a chnA gene from Acinetobacter sp., which has been shown 
to catalyze the transformation of cyclohexanol to CYHX.  ChnD shares 40% amino acid 
identity with 6-HHA dehydrogenase from strain 9871.  
The dehydrogenase assays were conducted in E. coli whole-cells containing 
p6364 (the tandem of the two JS666 dehydrogenases) or p63R (the putative alcohol 
dehydrogenase) at 23°C. Test substrates included cyclohexanol, EtOH, acetaldehyde, 6-
HHA, glycolate, DCAL and DCET. Cyclohexanol was degraded in E. coli cells 
containing either p6364 or p63R, with both strains transforming approximately 30% of 
cyclohexanol to CYHX after 2 days (Figure 4.15). No formation of CYHX was observed 
in uninduced cells and negative controls (induced and uninduced E. coli cells with no 
plasmids). The putative alcohol dehydrogenase gene (Bpro_5563) and the tandem of the 
two dehydrogenases genes (Bpro_5564 and Bpro_5563) were cloned into two different 
vectors (pET101D and pCOLADuet, respectively). It is probable that each clone 
produced a different amount of Bpro_5563 (ChnD). The activities of these two clones 
were the same, but the alcohol transformation rates between ChnA and ChnD may be 
different. The cloning of chnA (encodes ChnA, Bpro_5564), by itself, into pET vector 
was unsuccessful, so we do not have the opportunity to compare these enzymes 
individually. Thus, we cannot rule out the possibility that ChnA also contributed to 
transformation of the alcohols by the tandem clone.   
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   (a)      (b)  
Figure  4.15. Transformation of cyclohexanol to CYHX by E. coli strains containing 
either p63R (alcohol dehydrogenase) or p6364 (short-chain and alcohol 
dehydrogenases in tandem). (a) The induced () and uninduced (- -- -) E. coli 
p63R cells were given cyclohexanol and the formation of CYHX by induced cells (—
—) was monitored.  The induced () and uninduced (- -- -) E. coli cells 
with no plasmid tested with cyclohexanol were used as negative control. (b) The 
induced E. coli p6364 cells were given cyclohexanol () and formation of 
CYHX by induced cells (——) was monitored. Uninduced E. coli p6364 cells were 
used as control (- -- -).  
  
 
6-HHA was also degraded by the induced E. coli cells containing either p63R or 
p6364 (Figure 4.16). After 20-hour incubation, only 12% and 8% of 6-HHA initial 
concentration remained in the E. coli cells cultures containing p63R and p6364, 
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coworkers (2002), 6-oxohexanoate was spontaneously oxidized to adipate. When all E. 
coli cultures were tested with glycolate (a hydroxy acid), no apparent degradation was 
observed (Figure 4.16). 
 
(a) 
 
       (b) 
Figure  4.16. Enzymatic assays by whole-cell E. coli containing p63R (alcohol 
dehydrogenase) or p6364 (short-chain and alcohol dehydrogenases in tandem), 
tested with (a) 6-HHA and (b) glycolate. Blue lines and square symbols () 
represents E. coli p63R cells and black lines and triangle symbols () represents E. 
coli p6364 cells. The IPTG-induced cells are represented by solid lines, and 
uninduced cells by dashed lines.  IPTG-induced () and uninduced (- -- -) E. 
coli BL21 cells were used as negative controls. 
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Alcohol dehydrogenases catalyze the interconversion of alcohol and aldehyde. E. 
coli cells containing p63R or p6364 were tested with EtOH or acetaldehyde. EtOH 
(approximately 10 mM) was assayed with these two dehydrogenases, with the production 
of acetaldehyde monitored. The cells were incubated with EtOH for approximately 10 
hours and acetaldehyde was detected in all cultures (Figure  4.17). The induced cells 
containing p63R or p6364 produced higher amounts of acetaldehyde than the rest of the 
cell cultures. These induced E. coli p63R and p6364 cells produced 1.5 mM and 1.6 mM 
acetaldehyde, respectively, after 3 hours of incubation. The cultures were then left for an 
additional 6.5 hours, and the final concentration of acetaldehyde produced by E. coli 
p63R cells was 3.2 mM while with E. coli p6364, the production remained constant.  
In acetaldehyde assays (approximately 10 mM), all E. coli cultures immediately 
reduced it to EtOH with no distinction between induced and uninduced cell cultures or 
the negative controls (Figure  4.18).  Our results suggested that the enzymatic reaction has 
shifted more towards formation of EtOH until the equilibrium between EtOH and 
acetaldehyde has been reached. The addition of succinate may indirectly consume the 
NAD+ pool in the cells causing the shift.  
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(a) 
 
(b) 
Figure  4.17.  Production of acetaldehyde (b) in whole-cell E. coli cultures containing 
p63R (alcohol dehydrogenase) or p6364 (short-chain and alcohol dehydrogenases in 
tandem) that were assayed with EtOH (a). Blue lines and square symbols () 
represents E. coli p63R cells and black lines and triangle symbols () represents E. 
coli p6364 cells. The IPTG-induced cells are represented by solid lines, and 
uninduced cells by dashed lines. IPTG-induced () and uninduced (- -- -) E. 
coli BL21 cells were used as negative controls.  
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(a) 
 
(b) 
Figure  4.18.  Production of EtOH (b) in whole-cell E. coli cultures containing p63R 
(alcohol dehydrogenase) or p6364 (short-chain and alcohol dehydrogenases in 
tandem) that were assayed with acetaldehyde (a). Blue lines and square symbols () 
represents E. coli p63R cells and black lines and triangle symbols () represents E. 
coli p6364 cells. The IPTG-induced cells are represented by solid lines, and 
uninduced cells by dashed lines. IPTG-induced () and uninduced (- -- -) E. 
coli BL21 cells were used as negative controls. 
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Transformation of DCAL to DCET was noticed in all cultures tested (Figure  4.19). 
E. coli p6364 cells were not tested with DCAL and DCET. Initial concentration of DCAL 
supplied to the induced E. coli p63R cells was 5.3 mM, and approximately 4.2 mM of 
DCET was measured after 20 hours of incubation.  The loss of mass balance may be due 
to the inconsistent Et2O extractions and different sensitivities of DCAL vs. DCET GC 
peaks. DCET gives a higher peak area than from the equivalent concentration of DCAL, 
thus making DCET easier to quantify at lower concentration. When the cells were 
assayed with DCET, the formation of DCAL was not observed. It could be that the 
kinetic equilibrium of the reversible dehydrogenase strongly favors the alcohol over the 
aldehyde, as was the case with acetaldehyde assays. 
 
 
 
 
 
  
 
98 
 
 
(a) 
 
(b) 
Figure  4.19. Transformation of DCAL (a) to DCET (b) in whole-cell E. coli 
containing p63R (alcohol dehydrogenase) that have been IPTG-induced (——) 
and not induced (- -- -). IPTG-induced () and uninduced (- -- -) E. coli 
BL21 cells were used as negative controls.  
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4.4.4 Cytochrome P450 
P450 and its associated enzymes (ferredoxin and ferredoxin reductase) have been 
successfully cloned into E. coli and overexpressed (Shin, 2010). In our study, we 
monitored the concentration of chloride produced during P450 reaction with cDCE by the 
clone in whole-cell assays. A brownish phenotype was observed in induced cells as a 
result of excess formation of iron by ferredoxin (Bpro_5299) and ferredoxin reductase 
(Bpro_5300). 2-mL of headspace was drawn for cDCE measurement. The initial data-
point for cDCE was calculated from known addition (its concentration was otherwise 
“over-range” with respect to the detector). Induced cells degraded 4.5 µmol of cDCE 
after 2 days and only 2.2 µmol of chloride was produced, when theoretically 9.0 µmol 
chloride should be produced from complete mineralization (Figure  4.20). The remaining 
balance was postulated to reside in accumulated, chlorine-containing intermediates 
(including the possible suicide complex postulated by Shin). When the same culture was 
incubated for 10 days, 2.6 µmol of chloride was measured after 4.6 µmol of cDCE 
degraded, still representing only 28% of the chlorine in the cDCE that had been degraded. 
Formation of two DCE-epoxide peaks was observed early-on, with the first peak 
(at 2.8 min) smaller than the second peak (3.5 min). This is contrary to what was seen 
from the chemically-synthesized DCE-epoxide, which gave a much higher former peak 
than latter peak (Appendix B). Over more extended incubation, cDCE-epoxide was 
depleted, possibly accounting for most of the extra yield of chloride between Day 2 and 
Day 10. We do not have a suitable calibration for cDCE epoxide to determine the 
magnitude of the peak epoxide value accumulated early-on. However, if we assume that 
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the extra chloride observed between Days 2 and 10 all resulted from the epoxide that 
remained at the cessation of cDCE degradation (Day 2), then a rough estimation is that 
the peak epoxide level corresponded to a maximum of about 4% of the cumulative cDCE 
degraded.  Of course, it is highly possible that other, non-epoxide involved pathways 
contributed to this latent chloride release. 
 
 
Figure  4.20. Epoxidation of cDCE by E. coli Rosetta2 (DE3) strain containing 
pJS597 (p450, ferredoxin and ferredoxin reductase). cDCE degradation () 
and  chloride formation () were monitored in IPTG-induced cultures. 
Production of epoxide (3.5-min peak) is indicated by ( ── ) in raw peak-area 
(PA) units and production of epoxide at 2.8 min is below the y-axis range. Chloride 
formation in uninduced cells was also monitored (), as well as induced cells 
with no cDCE for background chloride release () and uninduced cells with no 
cDCE   (+).  
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The formation of chloroacetate was monitored, but not detected (i.e. another 
postulated cDCE-degradation byproduct, from abiotic transformation of chloroacetyl 
chloride in water).  Some of the missing mass of chloride may be due to formation of 
stable DCAL, which was not monitored in the experiment. The abiotic release of chloride 
was slow, considering that the cDCE conversion had essentially stopped within 2 days 
and chloride ions were still released for many days thereafter. 
 
4.5 cDCE degradation by strain JS666 after a carbon-starvation period. 
A lag period before cDCE degradation by strain JS666 has been observed 
previously when cultures have been grown to a high density on a non-cDCE substrate or 
after a period of cDCE starvation when previously grown on cDCE (Jennings et al., 2009; 
Giddings, 2012). In this study, the responses of strain JS666 to various environmental 
conditions were investigated.  These included observations of the following: (i) lag in 
cDCE degradation after  previous growth on various non-cDCE substrates; (ii) lag in 
cDCE degradation after previous growth on various non-cDCE substrates followed by 
24-h starvation; and (iii) the possible benefits of co-presence of alternative substrate 
during subsequent exposure to cDCE after a period of starvation.  
CYHX-grown cultures were harvested when the cells were actively degrading 
CYHX (at a concentration of 0.3 mM). After the cells were resuspended without 
starvation in 50 mL MSM and fed cDCE-only (26 µmol/bottle), they exhibited a variable 
lag period of 4-8 days before cDCE degradation commenced (Figure  4.21). CYHX in the 
control bottles was degraded immediately, which indicates that the cells were healthy – 
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i.e., the centrifugation, washing and resuspension steps did not interfere with the 
outcomes. Cultures that had been grown on CYHX, washed, resuspended, starved for 24 
h, then given cDCE and 1 mM succinate also did not exhibit any significant lag leading 
to cDCE degradation (Figure  4.21).  
Succinate-grown JS666 cells were harvested, washed and resuspended in 50 mL 
MSM (OD600 = 0.66). Without any intended starvation, cDCE (2 µL) was injected into 
the serum bottles under three different conditions of co-substrate (0.2 mM CYHX, 1 mM 
succinate, or none), and the degradation of cDCE was monitored. All cell cultures started 
to utilize cDCE after 15 days. Cultures that were given 0.2 mM CYHX degraded cDCE 
first, followed by cultures that were supplemented with succinate, and then by cultures 
that were given cDCE-only (Figure  4.22). Similar observations were made with 
succinate-grown cultures subjected to 24-hour carbon starvation. cDCE was degraded 
after 15 days in the cell cultures supplemented with CYHX or succinate, and required 
somewhat longer for cDCE degradation to begin when fed cDCE-only (Figure  4.22). 
Similar lag before cDCE-degradation was also observed in previously glycolate-grown 
cultures (Giddings, 2012).  
These results, coupled with the observations of others (Jennings et al., 2009; 
Giddings, 2012), suggest that lag to cDCE degradation depends foremost upon what 
substrate the cells were grown in (cDCE or CYHX, versus succinate or glycolate), but 
also upon whether some readily degradable co-substrate is present during the lag period 
(perhaps to provide NADPH and/or energy and carbon for enzyme synthesis and repair).  
The 24-h starvation period was less important than was previous growth substrate or 
identity/presence of co-substrate during the subsequent lag period.  
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(a) 
 
(b) 
Figure  4.21. (a) The cDCE degradation by CYHX-grown JS666 cultures without 
carbon-source starvation and (b) after being subjected to 24-hour starvation.  The 
resuspended cells were given 1 mM CYHX (●) as control, cDCE with 1 mM 
succinate (- -▲- -) or cDCE only (□). Bars indicate standard errors for 
biological duplicates.  
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(a) 
 
(b) 
Figure  4.22. (a) The cDCE degradation by succinate-grown JS666 cultures without 
carbon-source starvation and (b) after being subjected to 24-hour starvation.  The  
cells  were  given  cDCE only  (□),  cDCE with 1 mM succinate (- -▲- -) or cDCE 
with 0.2 mM CYHX (●).  Bars depict standard errors of experimental 
biological duplicates.   
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4.6 Proteome changes in both WT and KO cultures as assessed using 
iTRAQ 
Both WT and KO cultures were grown in 2 mM CAP with the presence or 
absence of 52 µmol/bottle cDCE (520 µM nominal concentration). The concentrations of 
these compounds were monitored, and the cells were harvested when both of the cultures 
were actively degrading CAP and/or cDCE. CAP was chosen as secondary carbon source 
because both WT and KO strains can utilize it while allowing WT cells to sustain the 
“good” cDCE-degradation phenotypical behavior (Figure  4.7). KO cultures grown on 
CAP-only were highly active and immediately degraded CAP when it was supplied. 
During protein extraction, in order to minimize protein cross-contamination from WT to 
KO samples, WT cultures grown on CAP-only were French-pressed first, followed by 
WT on CAP and cDCE, KO on CAP-only, and KO on CAP and cDCE.  
The samples were digested with trypsin, labeled individually with iTRAQ reagents, 
and analyzed simultaneously by LC-MS/MS. The peptides from the four culture-types 
were labeled with reporter groups as follows: 
• 114.1 (WT on cDCE + CAP);  
• 115.1 (WT on CAP only);   
• 116.1 (KO on cDCE + CAP);   
• 117.1 (KO on CAP only).  
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There were 1302 proteins identified based on 5627 peptides using the Mascot 
program for all four samples. More than 60% of the total proteome identified consisted of 
acidic proteins. Intensities of the reporter ions from iTRAQ tags upon fragmentation were 
used for quantification, and the relative quantitation ratios were normalized to the median 
ratio for the 4-plex in each set of experiments. The amounts of RNA polymerase (β 
subunit) were around the same throughout the four samples, inferring that the levels of 
housekeeping proteins, involved in the basic functioning of the cells, were similar 
(Table  4.2). 515 protein entries in the WT system were identified by only one peptide. 
These peptides were checked by Mascot software and were found not to have any 
immediate association with other proteins within the same proteome. Each protein ratio is 
assigned an error factor (EF), which allows calculation of its 95% confidence interval 
(CI).  The lower limit of the 95% CI = protein ratio/EF; the upper limit of 95% CI = 
protein ratio*EF. In this iTRAQ report, a ratio of 115/114 that is less than one (WT 
cultures grown in CAP vs. grown in cDCE+CAP) implies protein whose presence is 
correlated to cDCE-degradation (or at least to its presence).  Alternatively, one can 
examine the ratio of 116/114 (KO grown on cDCE+CAP vs. WT grown on cDCE+CAP) 
to attempt separation of the effects of mere presence of cDCE (in KO) from the effects of 
actual cDCE degradation (in WT).  
The principal objective of the iTRAQ study was to determine whether the process 
of knocking out the chmo of JS666 had affected translation of adjacent genes.  Can we 
assume that insertion of the vector sequence within chmo has affected only the 
production of CHMO protein?  Results show that detectable levels of peptides from all 
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genes of the cyclohexanol operon were detected in both WT and KO strains, with the 
exception of the short-chain dehydrogenase (ChnA), which was not detected in any of the 
four culture samples (WT or KO). Five peptides associated with CHMO that are 
upstream and downstream of the plasmid insertion point were identified in KO cultures, 
and two of them yielded weak spectra or negative intensities. CHMO peptide fragments 
in the KO culture are not unexpected, since there is no stop codon at that point in the 
region to prevent transcription, though a functional CHMO should not result.   
If we examine the genes adjacent to chmo, we see that abundances of peptides 
from the upstream hydrolase (Bpro_5566, ChnC) were reduced in KO cultures to 28% 
and 25% of abundances in corresponding WT cultures (i.e., iTRAQ ratios from labels 
116/114 and 117/115).  On the other hand, abundances of peptides encoded by chmo 
(Bpro_5565) were reduced in KO cultures to only 14% and 5% of abundances in 
corresponding WT cultures.  Five peptides in KO samples were attributed the 
downstream alcohol dehydrogenase (Bpro_5563, ChnD). Abundances of peptides from 
ChnD were reduced in KO cultures to 10% and 18% of abundances in corresponding WT 
cultures.  These relative levels suggest that translation of genes in the operon downstream 
of the insert were more affected than was translation of the adjacent, upstream hydrolase.  
While we do not have proteome data corresponding to the short-chain dehydrogenase 
(ChnA), its intermediate position between chmo and chnD would predict similar reduced 
abundance levels.   
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Table  4.2. Ratios of selected proteins identified in iTRAQ study. 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_5301 P450  1.587 7 1.193* 0.180 7 1.524* 0.370 7 1.180* 
Bpro_5566 hydrolase, ChnC  10.493 3 1.819* 0.282 3 1.653* 0.485 3 1.283* 
Bpro_5565 CHMO, ChnB 2.994 9 [1.182] 0.140 6 [2.421] 0.148 7 1.371* 
Bpro_5563 zinc-binding alcohol dehydrogenase, ChnD  0.770 5 1.104* 0.100 5 1.535* 0.139 5 1.319* 
Bpro_5186 HAD, type II  0.155 12 [1.212] 0.142 12 1.160* 0.150 12 1.142* 
Bpro_0056 HAD, type II 0.804 2 1.023* 0.651 2 1.007* 0.828 2 1.030 
Bpro_2101 isocitrate lyase  2.494 9 [1.088] 2.114 9 1.075* 2.177 9 [1.102] 
Bpro_0645 GST b,c 0.724 1 --- 0.017 1 --- 0.024 1 --- 
Bpro_0646 PNPox b 1.165 1 --- 0.450 1 --- 0.401 1 --- 
Bpro_4442 RNA polymerase subunit beta, RpoB 1.088 22 1.077* 0.949 22 1.090* 0.909 22 [1.088] 
Bpro_0086 2,5-dioxopentanoate dehydrogenase NAD+ 0.738 3 1.022* 0.702 3 1.059* 0.654 3 1.234 
Bpro_4478 hydrolase b 0.507 1 --- 0.806 1 --- 1.033 1 --- 
Bpro_4561 glyoxylate carboligase b 0.293 1 --- 0.335 1 --- 0.335 1 --- 
Bpro_4563 2-hydroxy-3-oxopropionate reductase 0.239 2 1.094* 0.051 5 3.652* 0.060 4 3.210* 
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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Since the KO strain is quite capable of growth on CAP, the approximately 70-
75% reduction in abundance of the hydrolase (Bpro_5566, ChnC), which was shown in 
enzyme assays to be active on CAP, is either insufficient to cause deleterious effect on 
growth, or else there are other hydrolases in JS666 that serve this same purpose. On the 
other hand, the approximately 80-90% reduction in abundance of the alcohol 
dehydrogenase (Bpro_5563, ChnD) in the KO strain appears to exert a much greater 
effect, since the KO strain cannot grow on EtOH. Of course, peptide abundance does not 
tell the whole story; protein conformation matters, and the proteomics results do not 
address this potentially important factor. In the end, what we know for sure is that chmo 
was knocked out, and downstream translation of the alcohol dehydrogenase (and by 
deduction, the short-chain dehydrogenase also) was reduced. 
Jennings et al. (2009) identified proteins elevated by cDCE (listed in Table 2.1), 
including GST-like protein (Bpro_0645), Type II HAD (Bpro_5186), 2-hydroxy 3-
oxopropionate reductase (Bpro_4563) and glyoxylate carboligase (Bpro_4561). The 
authors also reported cDCE-induced transcripts, such as CHMO (Bpro_5565), hydrolase 
(Bpro_5566), P450 (Bpro_5301), ABC transporters and several hypothetical proteins 
(Table 2.2). Most noteworthy is the much higher abundance (i.e., low ratios 115/114, 
116/114, and 117/114) of HAD (Bpro_5186) protein in WT cultures degrading cDCE 
than in any of the other cultures. HAD expression appears to correlate well with cDCE 
degradation and has been proposed as a marker for it in JS666 (Giddings, 2012). 
Hydrolase (ChnC), which was demonstrated to have activity with CAP in our 
study, was highly reduced in WT cells degrading CAP+cDCE vs. WT cells degrading 
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CAP only. The WT cells supplied with both substrates utilized them concurrently while 
the WT cells supplied with CAP only, solely rely on CAP as the growth substrate. The 
reduction in hydrolase abundances in both KO cultures implies that the insert impacted 
the expressions of neighboring genes in the cyclohexanol operon. Alcohol dehydrogenase 
(ChnD) was also reported in lower abundances in KO strains than in both WT strains. 
There were higher levels of P450 peptides in cDCE-degrading WT cells than in both KO 
strains; however, levels were 60% higher in CAP-grown WT cultures.  The lower 
abundance of P450 in cDCE-degrading cells, versus CAP-only WT cells may be due to 
inactivation of the protein as a result of covalent-binding of the cDCE-intermediates to 
the heme-containing proteins (Costa and Ivanetich, 1982).  
The presumed presence of chlorinated alcohols and alkanals (aldehydes) resulting 
from cDCE degradation might be expected to affect the abundances of several alcohol 
and aldehyde dehydrogenases (Table  4.3). When comparing cDCE-degrading WT 
cultures and cDCE-exposed KO cells (116/114), a ratio that is less than 1 may infer that 
the protein expression levels were elevated by the presence of cDCE-metabolites and not 
just by cDCE only. Aldehyde dehydrogenases may be involved in the conversion of 
DCAL to DCAA (Sharpe and Carter, 1993) and based on our iTRAQ data, Bpro_3952 
with 23 associated peptides is the primary candidate. Bpro_2298, which was modestly 
elevated in WT culture degrading cDCE+CAP vs. the rest of the cultures tested, shares 
24% amino acid identity with ChnE from strain NCIMB9871, while Bpro_0086 (ChnE 
homolog) shares 51% (Figure 2.7). An aldehyde dehydrogenase in JS666 (Bpro_4570) 
has 77% identity with chloroacetaldehyde dehydrogenase of Xanthobacter autotrophicus 
GJ10, however this enzyme was not reported in our iTRAQ results.  
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Table  4.3. Ratios of aldehyde and alcohol dehydrogenases during cDCE metabolism. 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_3952 aldehyde dehydrogenase  0.385 23 1.081* 0.055 22 1.380* 0.081 23 1.228* 
Bpro_2290 aldehyde dehydrogenase  1.141 6 1.046* 1.057 6 1.038* 1.061 6 1.061 
Bpro_3422 aldehyde dehydrogenase  1.379 2 1.178 1.038 3 1.136 1.014 2 1.081 
Bpro_4691 aldehyde dehydrogenase b 0.849 1 --- 1.334 1 --- 1.329 1 --- 
Bpro_2298 aldehyde dehydrogenase  0.824 2 1.036 0.828 2 1.481 0.854 2 1.387 
Bpro_4702 aldehyde dehydrogenase  0.934 2 1.064 1.377 2 1.482 1.655 2 1.057* 
Bpro_3129 zinc-binding alcohol dehydrogenase b,c 0.387 1 --- 0.906 1 --- 0.757 1 --- 
Bpro_2526 iron-containing alcohol dehydrogenase  0.546 3 1.178* 0.834 3 1.070* 1.081 3 1.074 
Bpro_0360 zinc-binding alcohol dehydrogenase b 0.735 1 --- 1.176 1 --- 1.132 1 --- 
Bpro_5563 zinc-binding alcohol dehydrogenase ChnD  0.770 5 1.104* 0.100 5 1.535* 0.139 5 1.319* 
Bpro_3853 zinc-binding alcohol dehydrogenase  0.800 7 1.055* 1.907 8 1.113* 1.987 8 1.120* 
Bpro_3259 zinc-binding alcohol dehydrogenase  0.806 5 [1.053] 0.710 4 1.051* 0.789 5 1.060* 
Bpro_2634 zinc-binding alcohol dehydrogenase  1.122 5 1.043* 5.900 5 1.201* 5.295 5 1.187* 
Bpro_4700 iron-containing alcohol dehydrogenase  1.129 4 1.094 1.604 4 1.123* 1.857 4 1.114* 
Bpro_2565 zinc-binding alcohol dehydrogenase  1.536 4 1.157* 1.400 4 1.126* 1.438 4 1.182* 
Bpro_3062 zinc-containing alcohol dehydrogenase  2.949 2 1.173 1.519 2 1.230 1.545 2 1.170 
Bpro_2135 zinc-binding alcohol dehydrogenase  3.422 4 1.170* 0.901 4 1.042* 0.859 4 [1.068] 
a p = number of peptides associated with the protein; EF = error factor    b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
  
 
112 
 
The levels of several alcohol dehydrogenases were also elevated by cDCE-
metabolites (Table  4.3). These enzymes may catalyze the interconversion of DCET and 
DCAL. The transformation of chloral hydrate to TCET by alcohol dehydrogenases has 
been reported in many studies (Friedman and Cooper, 1960; Newman and Wackett, 1991; 
Forkert et al., 2005); nevertheless the exact functions of the aldehyde reduction during 
degradation of chlorinated ethene compounds were not elaborated. Bpro_5563 (ChnD), 
an enzyme that has been a subject in our study, showed moderately-high elevated 
abundances (1.3-fold, EF = 1.104, 5 peptides) in WT cells degrading CAP+cDCE vs. WT 
cells degrading CAP, and up to 10-fold when compared to KO cells grown in 
CAP+cDCE. This enzyme has been demonstrated to transform DCAL to DCET in our 
enzymatic assay. An ortholog of an alcohol dehydrogenase (Bpro_3129) is S-
(hydroxymethyl)glutathione dehydrogenase, which catalyzes the conversion of S-
hydroxymethyl glutathione (GS-CH2OH) to S-formyl glutathione (GS-CHO). Bpro_3129 
was elevated in abundance in WT cells degrading CAP+cDCE, versus WT cells 
degrading CAP only (115/114); however, this finding is based on identification of only 
one peptide in the sample.   
WT cultures degrading both cDCE and CAP had 2-hydroxy-3-oxopropionate 
reductase, and glyoxylate carboligase up-to 4-fold more than WT degrading CAP only 
(Table  4.4). These two enzymes catalyze the two-step conversion of glyoxylate to D-
glycerate (Figure  4.23). The transformation of glyoxal into glycolate can be catalyzed by 
glyoxalase I (Bpro_3549, encoded by gloA) and hydroxyacyl glutathione hydrolase 
(Bpro_2055, encoded by gloB), which both were elevated in WT degrading cDCE and 
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CAP vs. WT degrading CAP only, however for each of these enzymes only one peptide 
was identified in the sample. The primary function of these two enzymes is the two-step 
transformation of methylglyoxal into D-lactate. In JS666, we can speculate that these 
enzymes may be beneficial for channeling glyoxal into the TCA cycle. The induction of 
genes involved in gloxylate conversion was observed in an E. coli strain overexpressing 
monooxygenase and hydrolase (Lee et al., 2010). This confirmed the hypothesis of 
cDCE-epoxide hydrolysis, which yields the formation of glyoxal (Rui et al., 2004a; Lee 
et al., 2010). One of the possible roles for an D-2-hydroxyacid dehydrogenase 
(Bpro_4156, EC: 1.1.1.81) is the conversion of D-glycerate to hydroxypyruvate and 
interconversion of glycolate and glyoxylate. This enzyme was 1.1-fold elevated in cDCE-
degrading WT cultures vs. CAP-grown WT cultures;  however, this finding is based on 
only one peptide identified in the sample. The MS/MS intensity peaks for the associated 
peptide were at least 104. 
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Figure  4.23. Pathways involved in glyoxal and glyoxylate transformation. Green, 
orange and red arrows indicate protein expressions elevated, moderately elevated 
and reduced by cDCE in WT cultures, respectively.  
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Table  4.4. Proteins involved in proposed glyoxal transformation pathway. 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_4561 glyoxylate carboligase b 0.293 1 --- 0.335 1 --- 0.335 1 --- 
Bpro_4562 hydroxypyruvate isomerase b,c 0.009 1 --- 0.059 2 1.989 0.053 2 2.182 
Bpro_4563 2-hydroxy-3-oxopropionate reductase 0.239 2 1.094* 0.051 5 3.652* 0.060 4 3.210* 
Bpro_2055 hydroxyacylglutathione hydrolase 0.785 2 1.052 1.162 2 1.086 1.065 2 1.163 
Bpro_3549 glyoxalase I b,c 0.830 1 --- 0.524 1 --- 0.637 1 --- 
Bpro_0187 glycolate oxidase FAD binding subunit b 1.153 1 --- 1.757 1 --- 1.404 1 --- 
Bpro_4156 D- 2-hydroxyacid dehydrogenase b,c 0.861 1 --- 0.982 1 --- 1.052 1 --- 
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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4.6.1 Knockout system proteome 
Kanamycin was not added in the second transfer to avoid the expression of stress-
related proteins due to the presence of kanamycin instead of cDCE. Despite this, the 
abundance level of kanamycin-resistance protein (neomycin phosphotransferase) was 
elevated in both KO cultures. Another protein associated with the insert that was seen in 
the KO cultures was the OriT binding protein (Appendix D). Five peptides associated 
with CHMO that are upstream and downstream of the insertion point were identified in 
KO cultures, and two of them yielded weak spectra or negative intensities. No formation 
of LacZ was reported, consistent with the sequence results (Appendix A) because of a 
one-nucleotide addition in the insert. Both nagR and nagR2 knockout CJ2 strains were 
reported to produce LacZ (Jeon et al., 2006). An enzyme encoded downstream of the 
chmo gene in the cyclohexanol operon (i.e. zinc-binding alcohol dehydrogenase, ChnD) 
was identified in the KO cultures, with five peptides attributed to it, which further 
confirms the earlier quantitative PCR results (Giddings, 2010) and transcription data 
(Figure  4.24). The degradation of CAP by hydrolase (Bpro_5566) has been demonstrated 
through enzymatic assay. Both iTRAQ and RT-PCR data indicate that this hydrolase, 
while significantly present in both KO cultures, was not elevated in abundance compared 
to levels in the two WT cultures.  This means that either the reduced protein levels were 
nonetheless sufficient to support CAP degradation in the KO strain, or else CAP catalysis 
can be achieved as well by other hydrolases in JS666.  
From iTRAQ data and RT-PCR work (Figure  4.24), it can be judged that there 
was insignificant cross-contamination across the samples — always a concern in such 
  
 
116 
 
work. WT is kanamycin-sensitive and KO was initially grown in media containing 
kanamycin. Kanamycin resistance in the KO strains is catalyzed by neomycin 
phosphotransferase (GI number: 108796622). This protein was identified by one peptide, 
and its MS/MS intensity peaks were 6772, 944, 79372 and 32096 for 114, 115, 116 and 
117, respectively (115/114 = 0.19; 116/114 = 10.142; 117/114 = 4.632). The presence of 
small peaks in the 114 and 115 samples of neomycin phosphotransferase may be due to 
background noise and impurities of iTRAQ reagents (Wiese et al., 2007) or minimal 
percentage error of impurities even after correction. The iTRAQ report shows CHMO 
protein was reduced almost 7-fold in KO cultures compared to WT cultures (Table  4.2). 
Furthermore, based on RT-PCR work, where primers were designed to target the intact 
region of the native chmo before and after the KO insertion point, intact chmo amplicons 
were not seen in KO samples even after 35 cycles. The detection limit of the gel is 
approximately 10 ng as indicated by the marker at 564 bp. Alcohol dehydrogenase 
(ChnD), a gene in the same operon, was 10-fold lower in KO cultures vs. cDCE-
degrading WT cultures; nevertheless RT-PCR work shows chnD amplicons in all 
samples (30 and 35 cycles).  
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(ii)  
Figure  4.24. RT-PCR of 35 cycles using 300 ng of cDNA template and corresponding 
primer pairs for WT and KO cultures grown for iTRAQ study. cDNA was 
synthesized with a mixture of gene-specific reverse primers. M: Lambda 
DNA/HindIII marker; 1: WT grown in CAP and cDCE; 2: WT grown in CAP; 3: 
KO grown in CAP and cDCE; 4: KO grown in CAP; 5: water blank.  
 
In Figure  4.24, multiple amplicons were observed in lane 2 (hydrolase) with 35-
cycles but not with 30-cycle RT-PCR (data not shown). This implies that there were 
unintentional priming sites or high levels of chnD transcripts. The proteome level of 
hydrolase in CAP-grown WT cultures was 10-fold higher than in cultures grown on 
   (i) 
    M                     chmo   alcohol dehydrogenase 
  1       2        3        4       5       1         2        3        4      5  
 bp      M           isocitrate lyase      hydrolase 
              1       2        3        4       5        1       2        3        4      5  
2322 
2027 
564  
2322 
2027 
564  
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cDCE and CAP. The absence of hydrolase amplicons from KO strains in RT-PCR but 
detectable protein in iTRAQ may be due to lack of correlation between transcripts and 
proteins. mRNA in bacteria degrades rapidly (within minutes) whereas  proteins can 
survive much longer (Taniguchi et al., 2010). The additional sequence of the insert in the 
polycistronic mRNA may hinder the formation of secondary structure of original mRNA 
at 5’-end, thus limiting its stability, which leaves mRNA open for endoribonuclease E’s 
attack (Rauhut and Klug, 1999).  The chnC (hydrolase) gene is at the 5’-terminal of the 
polycistronic mRNA, followed by the chnB (chmo) gene. 
 
4.6.2 Stress related to the presence of cDCE and its degradation  
cDCE exposure to cells led to expression of stress related proteins, associated 
with heat shock and oxidative stress. In the cDCE-degrading WT culture, a heat-shock 
protein, Hsp20 (Bpro_1199) was elevated in abundance almost 2-fold when compared to 
the CAP-degrading WT culture.  Conversely, this enzyme was elevated 2-fold in both 
KO cultures compared to the cDCE-degrading WT culture. Glutaredoxins were 
moderately elevated in cDCE-degrading WT cultures compared to CAP-grown WT 
cultures (Table  4.5). Thioredoxin reductase (Bpro_3801) was elevated in WT cells 
degrading cDCE+CAP vs. WT cells degrading CAP and this enzyme is responsible in 
reducing thioredoxin. Both glutaredoxin and thioredoxin catalyze the reversible oxidation 
of two vicinal protein-SH groups to a sulfide bridge and thioredoxin system provides 
defense against oxidative damage due to oxygen metabolism (Holmgren, 1989).  
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Results reported for peroxidases, which provide protection against oxidative 
stress, were varied. The abundance of heme peroxidase (Bpro_2396) was reduced 2.4-
fold in cDCE-degrading WT cultures when comparing to CAP-grown WT cultures. Yet, 
this enzyme was elevated 2.4-fold when compared to KO cultures in the presence of 
cDCE and CAP. Jennings et al. (2009) reported 14.8-fold upregulation of heme 
peroxidase transcripts. Another peroxidase was elevated up-to 3-fold in both KO strains 
when compared to the cDCE-degrading WT cultures. The protein levels of 
catalase/peroxidase ortholog (KatG, Bpro_0678, hydroperoxidase I) were similar across 
all four cultures tested. KatG was elevated in alkane-grown M. chubuense cells 
(proteomics) (Coleman et al., 2011). The expression of a universal stress protein 
(Bpro_3227) was reduced in cDCE-degrading WT cultures even though Jennings et al. 
(2009) reported 3-fold transcript upregulation. Unfolded and destabilized proteins caused 
by stresses can be repaired by bacterial chaperones. DnaK was elevated 1.3-fold more in 
the cDCE-degrading WT cultures than in WT cultures growing on cDCE and CAP 
(Table  4.5).  
Both WT cultures produced approximately similar relative amounts of molecular 
chaperones (GroEL and Cpn10, Table  4.5), which perhaps were constitutively expressed 
by the cells regardless of the presence or absence of the solvents. A DnaK homolog and 
Cpn10 were identified in M. chubuense strain NBB4 by comparing spot patterns on 2D 
gels (Coleman et al., 2011). The expression of global regulator for starvation conditions 
(encoded by dps) was reduced when comparing cDCE-degrading WT cells with the rest 
(Table  4.5) but in E. coli with a monooxygenase-and-glutathione system, Dps were 
induced in both proteomics and transcriptomics works (Lee et al., 2006; Lee et al., 2010). 
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Sigma 70 (encoded by RpoD) was repressed in cDCE-degrading WT cultures vs. CAP-
grown cultures (Table  4.5). It serves as a housekeeping sigma factor that is responsible 
for transcribing most genes in cells.  Transcription of rpoD was reduced during stationary 
growth phase when compared to that of in the exponential phase in E. coli (Rahman et 
al., 2008) and in Streptococcus agalactiae (Sitkiewicz and Musser, 2009), which may 
indicate a slowing of gene transcription. 
  
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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Table  4.5. Ratios of selected proteins involved in biological stresses. 
Table 4.5 (continued) 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_3126 molecular chaperone DnaK 0.802 20 [1.091] 0.593 20 1.075* 0.627 20 1.062* 
Bpro_2031 
ATP-dependent protease ATP-binding 
subunit ClpX 
0.864 2 1.231 0.935 2 1.422 0.753 2 1.742 
Bpro_1400 Ferritin and Dps 1.148 2 1.098 3.526 2 1.151 3.733 2 1.176 
Bpro_0759 chaperonin GroEL 1.040 38 [1.128] 0.553 37 [1.099] 0.677 37 [1.094] 
Bpro_0760 chaperonin Cpn10 GroES 1.039 7 1.076 0.541 7 1.052 0.647 7 1.093 
Bpro_1032 heat shock protein HtpX b,c 1.290 1 --- 1.153 1 --- 1.067 1 --- 
Bpro_1303 heat-inducible transcription repressor b,c 1.138 1 --- 1.167 1 --- 1.246 1 --- 
Bpro_1199 heat shock protein Hsp20 0.551 10 1.064* 1.970 10 1.054* 2.175 10 1.061* 
Bpro_3187 Hsp33 protein b,c 0.927 1 --- 1.019 1 --- 1.140 1 --- 
Bpro_2651 putative heat shock protein 0.943 2 1.280 0.487 3 1.349 0.485 2 1.017* 
Bpro_0614 heat shock protein 90 b,c 1.255 1 --- 1.003 1 --- 1.330 1 --- 
Bpro_3337 DNA mismatch repair protein MutS 1.362 3 [1.229] 0.846 3 1.136 0.999 3 1.105 
Bpro_3097 sigma 70 (RpoD) 1.423 5 1.046* 1.128 5 1.136 1.166 5 1.055* 
Bpro_2396 heme peroxidase 2.414 2 1.066 0.407 2 1.057 1.345 2 1.009 
Bpro_0678 catalase/peroxidase HPI b 0.979 1 --- 1.054 1 --- 0.939 1 --- 
  
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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Table 4.5 (continued) 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_4841 peroxidase 1.051 3 1.056 2.994 3 1.074* 2.870 3 1.063* 
Bpro_2856 glutaredoxin  0.836 5 1.066* 1.427 5 1.295* 1.468 4 1.129* 
Bpro_0848 glutaredoxin-like protein b,c  0.676 1 --- 0.747 1 --- 0.802 1 --- 
Bpro_0643 NADPH-glutathione reductase  0.862 2 1.124 0.869 2 1.075 0.843 2 1.274 
Bpro_2337 
phosphoadenylylsulfate reductase 
(thioredoxin) b,c 
0.949 1 --- 0.578 1 --- 0.676 1 --- 
Bpro_2263 thioredoxin  0.847 7 1.136* 1.059 7 1.172 1.016 7 1.244 
Bpro_3369 thioredoxin b,c 1.267 1 --- 0.846 1 --- 0.889 1 --- 
Bpro_4628 thioredoxin  1.031 4 1.291 1.246 4 1.128* 1.184 4 1.056* 
Bpro_3801 thioredoxin reductase  0.732 5 1.049* 0.966 5 1.041 1.015 5 1.037 
Bpro_3227 universal stress protein 1.708 4 1.069 1.886 4 1.097 2.157 4 1.106 
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Proteins related to reduced glutathione (GSH) synthesis are summarized in 
Figure  4.25 and Table 4.6. GSH is a tripeptide that consists of cysteine, glutamate and 
glycine. There are several hypothesized functions of bacterial GSTs during degradation 
of chlorinated ethenes. 4-aminobutyrate aminotransferase (Bpro_2912) was significantly 
elevated in WT cells degrading CAP+cDCE vs. WT cells degrading CAP. The elevation 
of this enzyme indicates that the cells may have been producing more L-glutamate from 
α-ketoglutarate and 4-aminobutanoate (Figure  4.25 and Table 4.6). The enzyme 
(Bpro_4540) involved in synthesis of GSH from γ-glutamylcysteine and glycine was 
moderately elevated in WT cultures degrading cDCE vs. WT cultures degrading CAP-
only. In addition, NADPH-dependent glutathione reductase (Bpro_0643) involved in 
conversion of glutathione disulfide to GSH was also fairly elevated in WT degrading 
cDCE vs. all other cultures, which suggests that the production of GSH in cell cultures 
degrading cDCE was increased. The enzyme converts glutathione disulfide to GSH and is 
regulated by the LysR regulator in the upstream gene. In an E. coli strain expressing 
monooxygenase and glutathione systems, glutamate-cysteine ligase (encoded by gshA, 
JS666 homolog: Bpro_4583) was induced in both proteomic and transcriptomic studies 
(Lee et al., 2006; Lee et al., 2010). In JS666, another glutamate-cysteine ligase 
(Bpro_3399) was identified and had elevated expression in cDCE-degrading WT cultures 
vs. CAP-degrading WT cultures. 
The GST-like protein and PNPox are transcribed in the opposite direction. GST 
(Bpro_0645) was elevated the cDCE-degrading cells compared to the others. This protein 
was identified by only one peptide, and its MS/MS intensity peaks were 117817, 62390, 
2302 and 2854 for 114, 115, 116 and 117, respectively. Cysteine desulfurase (IscS) plays 
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a central role in the delivery of sulfur to a variety of metabolic pathway and its relative 
abundance in WT degrading cDCE and CAP was not significant, versus the other three 
conditions, even though it was fairly elevated in both proteomic and transcriptomic works 
of E. coli cells co-expressing TOM-Green and IsoILR (Lee et al., 2006; Lee et al., 2010).  
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Figure  4.25. Synthesis pathway for reduced glutathione (GSH) in strain JS666.  
Green and orange respectively arrows indicate protein abundaces highly and 
moderately elevated in WT cultures grown in cDCE and CAP vs. CAP only.  
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Table  4.6. Ratios of proteins involved in GSH synthesis and several GST-like proteins. 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_2912 4-aminobutyrate aminotransferase 0.407 5 1.311 1.022 5 1.085 1.445 5 1.071 
Bpro_3399 glutamate-cysteine ligase b,c 0.803 1 --- 1.161 1 --- 1.085 1 --- 
Bpro_2178 cysteine desulfurase IscS 0.907 2 1.038 0.689 2 1.076 0.912 2 1.030 
Bpro_2417 
glutathione-dependent formaldehyde-
activating, GFA  
0.708 8 1.184* 2.187 8 1.101* 2.310 8 1.084* 
Bpro_0824 GST-like 1.612 6 1.090* 1.164 6 1.081* 1.178 6 [1.070] 
Bpro_2563 putative GST-related protein  1.924 6 1.119* 1.538 4 1.013* 1.284 5 1.044* 
Bpro_0643 NADPH-glutathione reductase  0.862 2 1.124 0.869 2 1.075 0.843 2 1.274 
Bpro_0645 GST-like b,c 0.724 1 --- 0.017 1 --- 0.024 1 --- 
Bpro_0243 GST -like  0.976 3 1.025 1.034 3 1.052 1.053 3 1.002* 
Bpro_4661 GST -like b,c 0.961 1 --- 1.156 1 --- 1.309 1 --- 
Bpro_4540 glutathione synthetase b,c 0.804 1 --- 1.027 1 --- 1.136 1 --- 
Bpro_0387 GST-like b 0.733 1 --- 0.412 1 --- 0.486 1 --- 
Bpro_2168 lactoylglutathione lyase b,c  0.913 1 --- 1.349 1 --- 1.239 1 --- 
Bpro_2055 hydroxyacylglutathione hydrolase 0.785 2 1.052 1.162 2 1.086 1.065 2 1.163 
Bpro_2874 serine hydroxymethyltransferase b,c 0.921 1 --- 0.700 1 --- 0.850 1 --- 
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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4.6.3 Central metabolism 
The genome of JS666 contains a complete glycolytic pathway, a tricarboxylic 
acid (TCA) cycle and a glyoxylate bypass. It also contains a pentose phosphate pathway, 
missing a gene that confers 6-phosphogluconolactonase. Two ribulose bisphosphate 
carboxylase homologs are also present in the genome (Mattes et al., 2008).  
Fatty acids are the main components of bacterial lipids. The degradation of CAP 
yields adipate, which is further oxidized through β-oxidation to generate acetyl-CoA and 
succinyl-CoA. These two intermediates are fed into the TCA or glyoxylate cycles to 
generate precursor metabolites. The thiolase-mediated conversion of 3-oxoadipyl-CoA to 
succinyl-CoA (via Bpro_1231)  was elevated up-to 8-fold in WT cells degrading cDCE 
and CAP when compared to the both KO cultures and 1.1-fold when compared to WT 
cells degrading CAP (Table 4.7). A similar enzyme is involved in conjugation of acetyl-
CoA to acyl-CoA groups. In E. coli containing monooxygenase and glutathione systems, 
cDCE repressed fatty acid synthesis, gluconeogenesis, and the TCA cycle (Lee et al., 
2006). In cDCE-degrading WT cells, cDCE-degradation caused an elevation of malate 
synthase, which converts glyoxylate to malate, by 2-fold when comparing to the WT 
degrading CAP or to both KO cultures.  
Abundance of isocitrate lyase was reduced 2-fold in cDCE-degrading WT cells 
versus non-cDCE-degrading cells (both WT and KO), suggesting an ample (and 
spontaneous) production of glyoxylate from chloroglycolate (Figure  4.26), which is a 
result of dehalogenation of dichloroacetate by HAD. The abundance of glycolate oxidase, 
responsible for transformation of glycolate (a possible product of cDCE-epoxide 
hydrolysis) to glyoxylate was reduced approximately up-to 1.75-fold in cDCE-degrading 
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WT cells when compared to the other three conditions. D-2-hydroxyacid dehydrogenase 
(Bpro_4156) may act as a glyoxylate reductase that can catalyze similar reaction as 
glycolate oxidase. The abundance of pyruvate dehydrogenase, which catalyzes the 
production of acetyl-CoA from pyruvate, was higher in WT than in KO strains. A 
summary of central metabolism pathways is depicted in Table 4.7 and Figure  4.26. 
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Table  4.7. Ratios of selected important proteins involved in central metabolism. 
Locus Tag Protein Description 115/114 pa EFa 116/114 pa EFa 117/114 pa EFa 
Bpro_3592 aconitate hydratase  0.870 7 1.041* 1.794 8 1.073* 1.929 8 1.042* 
Bpro_0187 glycolate oxidase FAD binding subunit b 1.153 1 --- 1.757 1 --- 1.404 1 --- 
Bpro_2942 isocitrate dehydrogenase  0.765 9 [1.294] 0.933 9 1.027* 0.763 9 [1.119] 
Bpro_2101 isocitrate lyase  2.494 9 [1.088] 2.114 9 1.075* 2.177 9 [1.102] 
Bpro_4517 malate synthase G  0.556 8 [1.062] 0.594 8 1.124* 0.684 8 1.204* 
Bpro_0160 phosphoenolpyruvate carboxykinase  0.452 7 1.314* 0.666 7 [1.350] 0.792 7 1.142* 
Bpro_3665 phosphoenolpyruvate carboxylase  0.789 16 [1.064] 1.444 16 1.055* 1.324 16 [1.089] 
Bpro_3184 phosphopyruvate hydratase  1.001 9 1.082 0.742 9 1.086* 0.754 9 1.081* 
Bpro_2672 pyruvate dehydrogenase subunit E1  1.209 4 1.068* 0.585 4 1.043* 0.699 4 1.108* 
Bpro_4634 pyruvate kinase b,c 0.936 1 --- 0.347 1 --- 0.403 1 --- 
Bpro_3602 succinate dehydrogenase subunit A  0.921 7 [2.794] 1.483 8 [12.001] 1.025 7 1.303 
Bpro_4681 succinyl-CoA synthetase subunit α 0.333 4 [1.377] 1.123 4 1.216 1.016 4 1.100 
Bpro_4682 succinyl-CoA synthetase subunit β  0.914 17 1.057* 1.078 18 [1.964] 1.050 17 1.067* 
Bpro_3605 type II citrate synthase  1.165 12 1.095* 2.990 9 1.284* 3.170 13 1.253* 
Bpro_1231 β-ketoadipyl CoA thiolase 0.888 9 1.079* 0.124 9 1.354* 0.134 8 1.327* 
a p = number of peptides associated with the protein; EF = error factor 
b manual checking done with BLASTP 
c MS/MS intensity peaks ≥ 104 
(*) indicates ratio that is significantly different from 1 at a 95% confidence level. Error factors with brackets [ ] indicate that the peptide 
match ratios do not appear to come from a sample with a normal distribution. 
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Figure  4.26. Selected important central metabolic pathways (gluconeogenesis, TCA and glyoxylate pathways). Green 
and orange arrows respectively indicate highly and moderately elevated protein expressions in WT cultures grown in 
cDCE and CAP vs. CAP only. Red arrows indicate reduced expression, and proteins that were not reported are 
represented by black arrows. 
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CHAPTER 5 
5. DISCUSSION 
 
5.1 Investigating the roles of the chmo gene and genes in the 
cyclohexanol operon during cDCE degradation by strain JS666 
One of the aims of this study was to determine the involvement of the chmo gene 
during cDCE degradation by knocking out the chmo homolog of JS666 and conducting 
CHMO enzymatic assays. CHMO, an FMO from strain JS666, showed activity on 
CYHX; nonetheless, no activity was confirmed with cDCE. This confirms the work of 
Alexander (2010), and certainly suggests that CHMO is not involved in the first step of 
cDCE degradation.  However, different cellular environments in both E. coli and JS666 
strains may have contributed to the outcome of the experiments.  
Overlays of 2D gel images comparing proteins extracted from cDCE-grown and 
non-cDCE-grown cells, and subsequent analysis of differing proteins by mass-
spectrometry, revealed the presence of multiple spots with slightly different isoelectric 
points for CHMO, HAD and GST (Jennings et al., 2009). This suggests that these 
upregulated proteins were modified post-translationally, which could include the covalent 
attachment of phosphate, lipids or proteins to the amino acids.  It is possible that 
modification is necessary for cDCE epoxidation by CHMO.  Nevertheless the 
observation that CHMO-catalyzed conversion of CYHX to CAP proves that the protein 
was functional.  We note that no cDCE activity was observed in cell extracts of JS666, 
suggesting that this activity is not easily assayed in vitro (Nishino, 2011).   Lack of a 
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positive result with E. coli overexpressing CHMO cannot prove that CHMO is not 
involved in cDCE epoxidation; it merely fails to prove involvement.  
The chmo-knockout study demonstrated that the KO strain was incapable of 
growing on cDCE, CYHX, cyclohexanol and EtOH after several days of incubation. Our 
enzymatic assays with dehydrogenases (ChnA and ChnD), encoded by genes downstream 
of chmo, demonstrated that these enzymes are capable of transforming cyclohexanol to 
CYHX and EtOH to acetaldehyde.  This suggests some impairment of ChnA and/or 
ChnD in the KO strain, in addition to the intended loss of functional CHMO. 
Several pieces of evidence indicate that the genes downstream of chmo were 
transcribed and translated in the KO strain: (i) Quantitative- and RT-PCR studies showed 
transcription of a sequence of chmo after the insert and of chnD; (ii) iTRAQ data 
identified CHMO peptides after the insert, as well as those from ChnD; and (iii) no 
palindromic transcription termination sequence is present in the suicide vector, implying 
that transcription would be expected to continue until the RNA polymerase hit the next 
termination sequence, which is located after the chnD gene.  
Though there is evidence that genes downstream of chmo (and peptides from the 
altered chmo) continued to be expressed in the KO strain, it does not mean that levels of 
expression, translation, and resulting enzyme function were unimpaired in the 
cyclohexanol operon and other operons that share similar regulation.  Indeed, the iTRAQ 
results showed an 80-90% reduction in the abundance of ChnD protein in the KO strain, 
compared to WT.  Since peptides from the altered chmo were also about 90% reduced in 
abundance in the KO, this suggests that the downstream, short-chain dehydrogenase 
(chnA) was probably similarly affected, since it is located between chmo and chnD on the 
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JS666 genome.  Peptides from chnC (the hydrolase adjacent upstream of chmo) were also 
reduced in abundance in the KO, but less so.   Since the KO strain is quite capable of 
growth on CAP, the approximately 70-75% reduction in abundance of this hydrolase 
(Bpro_5566, ChnC), which was shown in enzyme assays to be active on CAP, is either 
insufficient to cause deleterious effect on growth, or else there are other hydrolases in 
JS666 that serve this same purpose.  
The impaired translation of genes downstream of an insert has been noted in other 
studies.  For example, the inactivation of cyclopentanone 1,2-monooxygenase (cpnB) in 
Comamonas sp. NCIMB9872 resulted a mutant strain incapable of utilizing 
cyclopentanone and cyclopentanol (Iwaki et al., 2002b), and yet the cyclopentanol 
dehydrogenase gene (cpnA) is located downstream of cpnB. In our study, the relatively 
low abundance of ChnD (though still detectable) might explain the KO strain’s inability 
to grow on EtOH.  Also, protein conformation matters to function, and iTRAQ studies 
cannot tell us whether the resulting, detectable ChnD was even functional in the KO 
strain  
ChnD is responsible for metabolizing 6-HHA to 6-oxohexanoate; therefore, one 
has to reconcile the impairment of ChnD in the KO with the KO’s observed capability to 
grow on CAP.  The first step in CAP degradation is hydrolase-mediated conversion to 6-
HHA.  We speculate that any of all of the following might be true:  
• The abundances of ChnC and ChnD, though reduced in the KO, were 
nonetheless sufficient for the conversions of CAP and 6-HHA, 
respectively, but that higher amounts of ChnD are needed to initiate the 
degradation of EtOH or cyclohexanol. 
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• There was not only a decrease in abundance of ChnD in the KO, versus 
the WT, but also a change in ChnD conformation affecting its function.  It 
might have retained activity on 6-HHA, but not on cyclohexanol or EtOH. 
• ChnA (undetected in both WT and KO strains through iTRAQ) was far 
more impaired in the KO than was ChnD, and that ChnA normally has a 
greater role in cyclohexanol and EtOH degradation than does ChnD.  We 
were unable to conduct separate over-expression studies with ChnA to 
assay its function separate from that of ChnD.   
• 6-HHA is a straight-chain fatty acid that can be further metabolized by 
other enzymes, apart from ChnD, through multiple pathways (Kunz and 
Weimer, 1983).  Loss of ChnD (and presumably of ChnA) function might 
have been critical to degradations of cyclohexanol and EtOH, but not to 
degradation of 6-HHA.  
The transformation of DCAL into DCET by ChnD was demonstrated in our study 
through whole-cell enzymatic assays. The interconversion of DCAL and DCET (or 
DCAA) could be further tested through purifying the dehydrogenases and conducting 
enzymatic assays with different cofactors (i.e. NAD+, NADH or NADPH). This should 
eliminate the background conversion of DCAL to DCET in E. coli cells and configure the 
conversion of DCET to DCAL by supplementing with excess NAD+. In our enzymatic 
assay, succinate was supplied to the E. coli, and this could have decreased the 
NAD+/NADH ratio. The co-administration of succinate in excess with cDCE in WT cells 
was shown to slow down cDCE-degradation. Succinate usage supplies excess NADH that 
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may shift the degradation from DCAL towards formation of DCET instead of DCAA. 
This might stall cDCE-degradation before DCET is transformed back into DCAL.  
In this study, we also investigated the possible role of hydrolase (ChnC) as an 
epoxide hydrolase. Negative results from hydrolysis assays of different epoxides with 
ChnC perhaps imply involvement of other hydrolases or perhaps abiotic hydrolysis of the 
epoxides. Preliminary evidence from another hydrolase (Bpro_4478) was insufficient to 
conclude anything about involvement of epoxide hydrolases as detoxification agents.   
Even though the downstream genes are transcribed and translated, the protein 
abundances (i.e. ChnD, P450) were found to be low in the KO strain that was exposed to 
cDCE. We speculate that this may be due to the regulatory network’s being affected by 
the knockout. Bpro_5567 is a putative Fis-family transcriptional regulator, a gene 
upstream of chmo that is transcribed in the opposite direction.  Fis is a small DNA-
binding and -bending protein that can enhance the promoter activity if the promoter has a 
Fis-binding capability in the presence of other activators.   
 
5.2 Strain JS666’s responses to different substrates and conditions 
High concentrations of cDCE and the presence of metabolites produced by cDCE 
oxidation partially inhibited the growth of strain JS666, even in the presence of co-
substrates such as succinate or CAP as reported in Figure 4.4 and Figure 4.7, 
respectively. The explanations for the inhibitory effect of cDCE on growth may be due to 
membrane stress caused by high concentrations of cDCE and/or the presence of 
inadequate amounts of bacterial detoxification agents or repair mechanisms to handle the 
damaging effects of oxidative metabolites. The growth of strain CJ2 was also retarded by 
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a high initial concentration of naphthalene (78 µM), but grew well at naphthalene 
concentrations ≤ 55 µM. In their investigations, the researchers also showed that the 
metabolites produced as a result of naphthalene oxidation also caused growth inhibition 
(Pumphrey and Madsen, 2007). The degradation of cDCE produces several chlorinated 
metabolites, such as cDCE-epoxide, DCAL and DCAA, before they are completely 
mineralized (2 moles of chloride ion produced per a mole of cDCE consumed). These 
metabolites (e.g., cDCE-epoxide) may be more reactive than the parent compound itself. 
Metabolites produced as a result of aromatic oxidation by other bacteria, for example, are 
more soluble than their parent compounds and prone to form adducts to the DNA and 
proteins (Schweigert et al., 2001).  
Strain JS666’s adaptation to the toxicity of cDCE and/or its metabolites (e.g., 
cDCE-epoxide) may cause delay in cDCE degradation. Epoxide catabolic genes in strain 
JS666 have yet to be identified. Epoxyalkane:coenzyme-M transferase catalyzes the 
transformation of epoxyethane and VC-epoxide to acetyl-CoA in Mycobacterium strains 
and many other VC degraders (Coleman and Spain, 2003b; Coleman and Spain, 2003a; 
Danko et al., 2006; Mattes et al., 2007). BLASTP search for similar enzymes in strain 
JS666 failed to return any highly matched proteins. In addition, other detoxification 
mechanisms in strain JS666 have not yet been established. Highly induced GST-like 
protein (Bpro_0645) has shown no activity with cDCE (Jennings et al., 2009), and neither 
hydrolase tested in this showed any promising results. Giddings (2012) also observed an 
immediate increase of gst transcripts after exposure of JS666 to EtOH or DCA when 
there was no associated degradation, suggesting that GST may be involved in stress due 
to presence of solvent, rather than to metabolites. Other possible roles for GST that have 
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yet to be tested include metabolite-detoxification by conjugating to epoxide or DCAL 
(Dowsley et al., 1995).  
In our cDCE-starvation study, the observed lag time could possibly be related to a 
microbial acclimation phase, where necessary transcriptional expression and enzymatic 
induction are achieved. P. putida strain JS644 exhibited an extended lag period prior to 
growth on p-nitrophenol. The cause of the delay was due to an uninduced  p-nitrophenol 
monooxygenase, which was dependant on the accumulation of hydroquinone, a p-
nitrophenol metabolite (Nishino and Spain, 1993). Giddings (2012) observed low 
targeted transcript levels of JS666 (i.e. aceA, gst, chmo, pnpox, rpoB, had and p450)  
following cDCE starvation, and they rose simultaneously as cDCE-degradation resumed.   
The addition of succinate provided mixed results in alleviating the extended lag in 
strain JS666. In CYHX-grown cultures, the addition of succinate helped inititate cDCE 
degradation. A similar phenomenon was observed during co-metabolic propene oxidation 
in ethene-grown Mycobacterium sp. strain E3 cultures and in VC metabolism in 
Nocardioides sp. strain JS614 (Mattes et al., 2007). Succinate-grown Ralstonia pickettii 
PKO1 readily utilized benzene when 1.25 mM succinate was supplied (Bucheli-Witschel 
et al., 2009). This implies that the JS666’s growth on CYHX induced enzymes 
responsible for cDCE-degradation, and that addition of succinate (1 mM) provided ATP 
and/or NADH (or NADPH) for initial attack on cDCE – or carbon for enzyme 
synthesis/repair. The demand for NADH (or NADPH) in the initial catabolic step is 
greater than the NADH demand for cellular maintenance and respiration, as observed 
also in bacteria expressing toluene monooxygenases. Toluene oxygenation requires a net 
consumption of NADH for the initial ring cleavage (Johnson et al., 2006). On the other 
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hand, succinate-grown cultures of JS666 did not start degrading cDCE until after 15 days 
(Figure  4.22). JS666 has been observed to have an extended lag period to cDCE-
degradation when grown previously on acetate or glycolate. When the strain was grown 
on cDCE with 10 mM succinate as co-substrate, the cultures exhibited “bad behavior” 
with respect to cDCE-degradation. When CYHX or EtOH was supplied as co-substrate, 
the cells quickly exhibited cDCE-degradation and sustained it through multiple additions. 
Excess succinate (10 mM) may disrupt the NAD+/NADH ratio in the cells, shifting the 
cDCE-degradation pathways towards unfavorable ones. This hypothesis has yet to be 
tested.  
 
5.3 Monitoring translational changes in strain JS666 during aerobic 
cDCE degradation 
iTRAQ was conducted to determine whether the proteins encoded downstream of 
chmo were translated and to explore the proteome changes during cDCE degradation. 
This study complements previous proteomic and transcriptomic analyses conducted by 
Jennings et al. (2009). In our study, the concentration of CAP was limited to 2 mM so 
that the cells would readily degrade both CAP and cDCE simultaneously, avoiding 
diauxic metabolism.  The peptide samples were tagged with an excess label and were let 
sit for at least an hour to ensure complete tagging before hydrolysis. The presence of 
small peaks in the 114 and 115 samples of neomycin phosphotransferase and OriT may 
be due to background noise and impurities of iTRAQ reagents (Wiese et al., 2007) or 
minimal percentage error of impurities even after correction. 
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The had gene has been suggested as a good bioindicator for monitoring cDCE and 
DCA degradations (Giddings, 2012). Giddings observed that had transcripts were 
upregulated when either cDCE or DCA was degraded and downregulated when 
degradation stopped.  The increased abundance of HAD by cDCE was also confirmed by 
our iTRAQ data. Even though P450 catalyzes the initial attack on cDCE and DCA, the 
gene encoding it was reported to have a low degree of upregulation (Giddings, 2012). In 
RT-PCR study, Alexander (2010) reported mixed levels of p450 transcription by the cells 
exposed to cDCE compared to cells grown on other substrates. The reduction of P450 
abundance (in our iTRAQ study) in cDCE-degrading cells may be due to the formation of 
a damaging and reactive enzyme-substrate complex, which is a dead-end product due to 
an irreversible porphyrin N-alkylation with one carbon atom of the ethenes (de Visser et 
al., 2004). The formation of a suicide complex could reduce the abundance of the P450 in 
the cells.   In any event, protein abundance does not necessarily correlate with transcript 
abundance. Given that transcription of p450 is not all that highly upregulated by cDCE 
(only 3.5-fold) (Jennings et al., 2009), it is unsurprising if differences in the standing crop 
of P450 protein among cultures do not perfectly reflect previously reported differences in 
transcript abundance. 
A study on stress-related proteins in engineered E. coli strains suggested that the 
presence of these proteins improves cDCE metabolism (Lee et al., 2010). The data 
suggest that the response to cDCE degradation is similar to the response to reactive 
oxygen species. In the previous omics analyses (Jennings et al., 2009), cDCE elevated the 
abundances of GST, which was reported as modestly elevated in  our iTRAQ study. 
Proteins involved in GST system were moderately elevated by cDCE-degradation and 
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these GST-like proteins identified in the iTRAQ results may be responsible for 
glutathione conjugation to cDCE or cDCE-derivatives. GST-like protein (Bpro_0387), 
which shares 37% amino acid identity (coverage at C-terminal) with IsoILR1 of 
Rhodococcus AD45, was found to be fairly elevated in cDCE-degrading cells.  
Cells’ exposure to toxic substances can cause both elevation and reduction of 
abundances of many ribosomal proteins. Elevated expression of these proteins may be 
due to the presence of misfolded proteins in the cells. Proteases attack misfolded proteins 
for recycling amino acids, and cells have to generate more enzymes to replace inactive 
ones. The induction of DnaK in cDCE-degrading cells helps in the refolding of misfolded 
proteins (Hesterkamp and Bukau, 1998), in addition to preventing proteins’ misfolding 
and aggregation (Agashe and Hartl, 2000). In KO cultures, the increase in abundance of 
ribosomal subunit proteins may be a general response to translational limitations caused 
by the addition of the insert and extra genes (Wood and Peretti, 1990).   
Overall, iTRAQ study enhanced our understanding of proteome changes caused 
by the presence of cDCE and its reactive products in strain JS666.  It generally supported 
the previous study by Jennings et al. (2009).  Its more important contribution, however, 
was to provide information concerning transcription and translation of potentially 
important genes adjacent to the chmo insert in the KO strain.  From this, it was found that 
translation of an upstream chnC (encoding a hydrolase) was lowered significantly, though 
apparently not so impaired as to prevent the KO strain from growing on CAP.  On the 
other hand, translation of a downstream chnD (encoding an alcohol dehydrogenase) – and 
by inference the short-chain dehydrogenase (ChnA) whose encoding gene is between 
chmo and chnD – was decreased 80-90% in the KO.  Though detectable, the lower ChnD 
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and/or ChnA abundances (or effects on their conformation) in the KO strain might 
explain the loss of its ability to degrade (and grow on) EtOH.   By extension, this 
suggests a role for ChnD and/or ChnA in cDCE degradation, although likely not in 
carrying out the first step in the process.   Though we could not demonstrate a role for 
CHMO in cDCE degradation, we cannot be said to have proven there is none. 
 
5.4 Updated cDCE-degradation pathways 
Multiple cDCE-degradation pathways have been proposed (Jennings et al., 2009) 
and updated with the discovery of the oxidative function of cyctochrome P450 (Shin, 
2010). Figure  5.1 presents the updated pathways, reflecting results from this dissertation 
research and earlier studies. 
In initial attack, cDCE is broken down into DCAL and cDCE-epoxide by P450. 
DCAL can be further degraded to DCAA by aldehyde dehydrogenase(s). Originally, the 
activity of dehydrogenase was confirmed by enzyme assay in JS666 cell extract; 
however, the specific dehydrogenase was not determined (Jennings et al., 2009). From 
the iTRAQ report, the aldehyde dehydrogenase that may be responsible for oxidizing 
DCAL is Bpro_3952. DCAA is then transformed into chloroglycolate by haloacid 
dehalogenases (Bpro_0530 and Bpro_5186) or hydrolase (Bpro_4478) before 
spontaneous conversion to glyoxylate (Goldman et al., 1968; Chan et al., 2010). It is also 
possible that DCAL can be conjugated to glutathione by GST, which has yet to be tested 
(Dowsley et al., 1995). Our enzymatic assay with ChnD demonstrated the conversion of 
DCAL to DCET. The DCET-to-DCAL transformation by the same enzyme has not been 
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tested and is a subject for future study. The metabolic pathway for DCET (other than the 
oxidation to DCAL) is still not known in JS666. 
There are two potential pathways for cDCE-epoxide metabolism: (i) hydrolysis 
either abiotically or by a hydrolase to 1,2-dichloroethane-1,2-diol; or (ii) glutathione 
conjugation by GSTs. Both of these pathways are hypothesized to form glyoxal. We can 
also speculate the two-step conversion of glyoxal to glycolate is catalyzed by glyoxalase I 
(Bpro_3549) and hydroxyacylglutathione hydrolase (Bpro_2055), as their putative 
functions are primarily conversion of methylglyoxal to D-lactate (Clugston et al., 1998).  
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Figure  5.1. Updated proposed cDCE-degradation pathway(s) by strain JS666. ChnD (Bpro_5563) = zinc-binding 
alcohol dehydrogenase; Bpro_3952 = aldehyde dehydrogenase; Bpro_4478 = hydrolase; Bpro_3549 = glyoxylase I; 
Bpro_2055 = hydroxyacylglutathione hydrolase (glyoxylase II); Bpro_0187 = glycolate oxidase; Bpro_4156 = D-2-
hydroxyacid dehydrogenase.  Blue arrows indicate pathways that have been demonstrated with enzymatic assays (in 
whole-cell E. coli or JS666 cell extracts –  marked with *). Black arrows indicate pathways that are deduced from 
iTRAQ study. Dotted arrows indicate pathways that have not been yet elucidated. 
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CHAPTER 6 
6. CONCLUSIONS 
6.1 Summary and conclusions 
We conclude the following: 
(i) Knocking out chmo in JS666 conclusively prevented the KO from degrading 
either cDCE or CYHX (as would be expected);  however, it also prevented 
degradation of cyclohexanol and EtOH.  Degradation and growth on CAP 
(encoded by a hydrolase gene, chnC, upstream of the KO insert) was 
unaffected.  This strongly suggests a role for chmo and/or either of two 
dehydrogenases encoded downstream of it in the cyclohexanol-degradation 
operon. 
(ii) iTRAQ studies showed that translation of the adjacent upstream chnC 
(encoding an hydrolase) was lowered significantly, though apparently not so 
impaired as to prevent the KO strain from growing on CAP.  On the other 
hand, translation of a downstream chnD (encoding a dehydrogenase) – and by 
inference the short-chain dehydrogenase chnA whose encoding gene is 
between chmo and chnD – was decreased 80-90% in the KO.  Though 
detectable, the lower ChnD and/or ChnA abundances (or effects on their 
conformation) in the KO strain might explain the loss of its ability to degrade 
(and grow on) EtOH.   By extension, this suggests a role for ChnD and/or 
ChnA in cDCE degradation, although likely not in carrying out the first step in 
the process.  
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(iii) CHMO itself was not demonstrated to be directly involved in the epoxidation 
of cDCE. So far, we have determined no direct role for this enzyme in cDCE-
degradation by strain JS666, though it cannot be said we have proven there is 
none. 
(iv) Hydrolase (Bpro_5566, ChnC) has been successfully cloned and demonstrated 
activity with CAP, but no activity was yet found with epoxides. ChnD 
(Bpro_5563, zinc-binding alcohol dehydrogenase), encoded by a gene 
downstream of chmo gene, is capable of transforming DCAL to DCET. It is 
also active with EtOH and 6-HHA. 
(v) We speculate that the elevation of chmo expression in the presence of cDCE 
may be due to the presence of chlorinated alkanal (i.e. DCAL) that induces 
any operon encoding alcohol dehydrogenases (i.e. ChnA and ChnD), 
including the cyclohexanol operon of JS666. [Note: DCAL is one of the 
products of cDCE oxidation by P450, as demonstrated by Shin (2010)].  
(vi) We speculate that knocking out chmo may have disrupted the NAD+/NADH 
ratio, affecting the DCET/DCAA transformation ratio, shifting the reaction 
towards unfavorable pathways and slowing cDCE oxidation (in the time-
frame of our experiments).  
(vii) We speculate that knocking out chmo affected the regulatory systems that the 
JS666 strain shares between cyclohexanol and p450 operons. 
(viii) When WT and KO cultures were grown on acetate, the presence of cDCE had 
virtually no effect. It did not impact bacterial growth by either strain, nor was 
cDCE degraded by either. 
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(ix) When the strain was grown on cDCE with 10 mM succinate administered as 
co-substrate, the cultures exhibited “bad behavior” with respect to cDCE-
degradation. When CYHX or EtOH was supplied as co-substrate, the cells 
quickly exhibited cDCE-degradation and sustained it through multiple cDCE 
additions.    
(x) High concentrations of cDCE and the presence of metabolites produced by 
cDCE oxidation partially inhibited the growth of JS666, even in the presence 
of co-substrates such as succinate or CAP. JS666’s adaptation to the toxicity 
of cDCE and/or its metabolites (e.g., cDCE-epoxide) may cause delay in 
cDCE degradation. 
(xi) The observed (cDCE-degradation) lag time in the starvation study or in the 
cells that were previously grown in acetate, succinate or glycolate could 
possibly be related to a microbial acclimation phase, where necessary 
transcriptional expression and enzymatic induction are achieved. 
(xii) The addition of succinate provided varied results in alleviating the extended 
lag in JS666. Succinate-grown cultures of JS666 when supplied with cDCE 
did not start degrading cDCE until after 15 days. On the other hand, in 
CYHX-grown cultures, the addition of succinate helped inititate cDCE 
degradation. This implies that the growth on CYHX induced enzymes 
responsible for cDCE-degradation and addition of succinate provided ATP 
and/or cofactors for initial attack on cDCE or carbon for enzyme 
synthesis/repair. 
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(xiii) Detoxification mechanisms of cDCE-metabolites in strain JS666 have not 
been fully studied. Other possible roles for GST (Bpro_0645) that have yet to 
be tested include metabolite-detoxification by conjugating to epoxide or 
DCAL. 
(xiv) iTRAQ revealed several proteins that may be involved in cDCE-degradation 
pathways, such as an aldehyde dehydrogenase (Bpro_3952) and enzymes 
involved in glyoxal metabolism. This also supports the idea of glyoxal 
formation from hydrolysis of cDCE-epoxide.  
(xv) Our iTRAQ study also confirms that HAD, not P450, is a prime candidate for 
bioindicator for cDCE-degradation, even though P450 initiates the attack on 
cDCE.  
(xvi) Isocitrate lyase expression was reduced in cDCE-degrading cells indicating 
that possible flux of glyoxylate formation through dehalogenation of DCAA 
and hydrolysis of cDCE-epoxide.  
(xvii) Several proteins involved in glutathione synthesis were moderately elevated 
by cDCE-degradation. Proteins involved in glyoxylate metabolism were 
highly elevated in the WT cells degrading CAP+cDCE vs. WT cells degrading 
CAP.  
(xviii) cDCE-degradation pathways in JS666 were updated with new information 
gathered from our enzymatic and iTRAQ studies.   
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6.2 Suggestions for future studies 
6.2.1 Improving overexpression of enzymes in the cyclohexanol operon 
and others. 
The dehydrogenases’ activities can be better characterized by conducting the 
assays with purified enzymes. The purified enzymes should be then tested with substrates 
such as acetaldehyde, EtOH, 2-chloroethanol, DCET, chloroacetaldehyde, and DCAL, 
among others. This will avoid the interconversion of aldehydes to alcohols by the E. coli 
cells as demonstrated in our results. Apart from cyclic ketones, CHMO also should be 
tested on hydrazine, tertiary amines and organic sulfur compounds, expanding the roles 
of CHMO from strain JS666 in biocatalysis and bioremediation processes. CHMO can be 
co-expressed with molecular chaperones and subsequently purified for a better 
characterization of the enzyme. The induction of GST (Bpro_0645) in omic studies is yet 
to be elucidated. The purified enzyme should be tested with cDCE-epoxide, DCAL and 
other chlorinated aliphatic byproducts.   
From iTRAQ work, several cDCE-induced proteins may be involved in cDCE 
degradation, such as aldehyde dehydrogenase (Bpro_3952) and several hydrolases 
(Bpro_4478 and Bpro_5259).  Preliminary results with Bpro_4478 showed no activity 
with cDCE-epoxide (above the significant activity of the controls), nonetheless the 
epoxide should also be tested with purified enzyme. In strain JS666, an adjacent gene to 
the P450 system is a pyrrolo-quinoline-quinone containing alcohol dehydrogenase (PQQ, 
Bpro_5302) which shares 50% amino-acid identity with an alcohol dehydrogenase from 
Pseudomonas stutzeri. This enzyme was postulated to catalyze the oxidation of 
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chloroethanol (Dijk et al., 2004) and can be tested in future studies, alongside aldehyde 
dehydrogenase (Bpro_4570).  
The fate of DCAL in strain JS666 should be further investigated. This will 
provide clear evidence on how the pathways are shifting. Several co-substrates can be 
administered along with DCAL to study the effects of different substrates on DCAL 
degradation and will further answer why EtOH sped up the cDCE degradation while 
succinate slowed it down, when both substrates provide reduced cofactors for cDCE 
degradation.  
 
6.2.2 Epoxidation of chlorinated compounds by chemically-synthesized 
hydroperoxyflavin 
The epoxidation of cDCE by hydroperoxyflavin can be tested by reacting 
chemically synthesized 4a-hydroperoxy 5-ethyl 3-methyllumiflavin (compound 6.1.1 in 
Figure  6.1) and cDCE. The synthesis of compound 6.1.1 can be viewed in the original 
paper by Kemal and Bruice (1976) through a series of chemical syntheses. Figure  6.1 
shows an example of epoxidation of an alkene by flavin hydroperoxide by reacting 2,3-
dimethyl 2-butene and compound 40.1 in CHCl3 yielding up to 50% of epoxialkane and 
18% of flavin’s corresponding alcohol (Bruice et al., 1983). This study will confirm the 
epoxidation ability of FMOs (including CHMO). If the chemical epoxidation from the 
above-mentioned experiment were successful; and in order to understand the 
unsuccessful attempts of cDCE epoxidation by CHMO, several considerations should be 
further analyzed: (i) the conformation of the CHMO, (ii) post-translational modification 
of the enzyme and (iii) the optimal conditions for the enzymatic assays.  
  
149 
 
 
N
N
NH
N O
O
O
O
H
+
N
N
NH
N O
O
O
H
+
O
6.1.1
 
Figure  6.1. 4a-hydroperoxy 5-ethyl 3-methyllumiflavin was reacted with 2,3-
dimethyl 2-butene producing corresponding epoxide and flavin’s corresponding 
alcohol (Bruice et al., 1983). 
 
6.2.3 Protein and mRNA relationships during cDCE-oxidation by strain 
JS666 
 Transcriptional and translational changes in both WT and KO strains can be better 
understood by coupling iTRAQ with microarray studies. From both transcriptomic and 
proteomic analyses, we will gain comprehensive understanding about the initial response 
of both strains towards cDCE and its degradation products, the correlation between 
proteins and mRNAs and enzymatic activity on cDCE, its products and on different 
biological conditions such as pH, temperature and oxidative substrates.  
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CHAPTER 7 
7. APPENDICES 
Appendix A: Sequencing results for chmo-knockout mutant 
The original chmo gene sequence is presented below. Underlined is ocmoF primer 
sequence and the highlighted sequence is the internal part that has been cloned into 
pVIK110 (suicide vector): 
atgaccctggcaacacaagacagccacccaacccagaccgactacgacgcggtggtcgtgggtgccggcttcggcggactctacat
gctgcacaaactgcgcaacgagctcggcatgaacgttcgcgtctttgacaaggccggcgacgtcggcggcacctggtactggaacc
gctaccccggcgccctgtccgacaccgagagctttgtgtactgctactcattcgacaaagccctgctgcaggaatggcagtgggaca
cgcgctacgtcacgcagccgcagattctgtcttacctgaaccacgtggcggaccggctggacctgcgccgcgacatcgagttcaaca
ccggcgtcacgggcgcccggtttgatgaaaagcgcaatctctgggaaatccagaccgataccgataaaaccgtcacggccagata
cctgatcacggcactgggcctgctgtcggccaccaacgtgcccaacatcaagggcatcgagactttccagggtgcgcaataccata
ccggcgcctggcctgaaggcgttgatttcaagggcaagcgggtcggcgtcattggcaccggctccaccggccttcaggtgatcacgg
ctctcgccccgcaggccagccacctgacggtattccagcgctcgccgcagtacagtgtgccggtcggcaacggcccggtcagcccg
gactacgtcaagtccgtcaaacagaactacgagcagatctggaaggacgtgcgcagctcggtggtggccttcggcttcaaggagag
cagcgtgccggccatgagcgtgtcggaagaagagcgccgcgccgtttaccagaaagcctgggacaccggcggcggctttcgcttca
tgtttgaaaccttttgcgacattgccaccagcgaagaagccaacgaaaccgccgctgcgttcattcgcggcaagatcgccgagattg
tcaaagacccggaaactgcccgcaagctgacaccgaccgacctgtatgccaagcggccgctgtgtgacagcggctactacgccatt
tacaaccgtgacaatgtcgccttggtcgatgtcaaggcgaccccgattaccgaaatcacgcccaggggcatcaagacgtcggacgg
cgtggaacacgaattggacgtgctgatcttcgccaccggctttgacgcggtggacggcaactacaccaaaattgacctgcgcgggc
gcaacggcaagacgatcaaggacaagtggaaagccggcccgaccagctacctgggcgtggcgagcgcggactacccgaacttgt
tcatgatcctcggacccaacggccccttcaccaacctcccgccgagcatcgagacgcaggtcgagtggatctccgatctgatcaagc
acatgaacgacaccggccgccagctcgttgaagccacccacgaaggcgaagacggctggaccgccacctgcaacgaaattgccg
gctacacgctgttcccgaaagccgattcgtggatcttcggcgcgaacatcccgggcaaagccaggacagtgatgttttacctggccg
gcctgggagcctacactcaaaaactgaacgaggtgacgagcaccggctacccaggttttgagatccgctaa 
 
A part of pVIK110 sequence is provided below. The double-underlined sequence is 
the VXR primer sequence in reverse. The underlined sequences are restriction enzyme 
sites used for cloning (XbaI and SalI, respectively): 
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gaattcccgggagagctcgatatcgcatgcggtacctctagaagaagcttgggatccgtcgaccggggatccgtcgacctgcagcc
aagcttnnngtcgttttacaacgtcgtgactgggaaaaccctggcgttacccaacttaatcgccttgcagcacatccccctttcgcca
gctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagcctgaatggcgaatggcgctttgcctggtttc
cggcaccagaagcggtgccggaaagctggctggagtgcgatcttcctgaggccgatactgtcgtcgtcccctcaaactggcagatg
cacggttacgatgcgcccatctacaccaacgtaacctatcccattacggtcaatccgccgtttgttcccacggagaatccgacgggtt
gttactcgctcacatttaatgttgatgaaagctggctacaggaaggccagacgcgaattatttttgatggcgttaactcggcgtttcat
ctgtggtgcaacgggcgctgggtcggttacggccaggacagtcgtttgccgtctgaatttgacctgagcgcatttttacgcgccggag
aaaaccgcctcgcggtgatggtgctgcgttggagtgacggcagttatc 
 
After recombination, the sequence of the chmo gene will be theoretically as follows, 
where the resulting PCR band will be from the dotted- to the double-underlined 
sequences.  
atgaccctggcaacacaagacagccacccaacccagaccgactacgacgcggtggtcgtgggtgccggcttcggcggactctacat
gctgcacaaactgcgcaacgagctcggcatgaacgttcgcgtctttgacaaggccggcgacgtcggcggcacctggtactggaacc
gctaccccggcgccctgtccgacaccgagagctttgtgtactgctactcattcgacaaagccctgctgcaggaatggcagtgggaca
cgcgctacgtcacgcagccgcagattctgtcttacctgaaccacgtggcggaccggctggacctgcgccgcgacatcgagttcaaca
ccggcgtcacgggcgcccggtttgatgaaaagcgcaatctctgggaaatccagaccgataccgataaaaccgtcacggccagata
cctgatcacggcactgggcctgctgtcggccaccaacgtgcccaacatcaagggcatcgagactttccagggtgcgcaataccata
ccggcgcctggcctgaaggcgttgatttcaagggcaagcgggtcggcgtcattggcaccggctccaccggccttcaggtgatcacgg
ctctcgccccgcaggccagccacctgacggtattccagcgctcgccgcagtacagtgtgccggtcggcaacggcccggtcagcccg
gactacgtcaagtccgtcaaacagaactacgagcagatctggaaggacgtgcgcagctcggtggtggccttcggcttcaaggagag
cagcgtgccggccatgagcgtgtcggaagaagagcgccgcgccgtttaccagaaagcctgggacaccggcggcggctttcgcttca
tgtttgaaaccttttgcgacattgccaccagcgaagagtcgacctgcagccaagcttnnngtcgttttacaacgtcgtgactgggaa
aaccctggcgttacccaacttaatcgccttgcagcacatccccctttcgccagctggcgtaatagcgaagaggcccgcaccgatcgc
ccttcccaacagttgcgcagcctgaatggcgaatggcgctttgcctggtttccggcaccagaagcggtgccggaaagctggctggag
tgcgatcttcctgaggccgatactgtcgtcgtcccctcaaactggcagatgcacggttacgatgcgcccatctacaccaacgtaacct
atcccattacggtcaatccgccgtttgttcccacggagaatccgacgggttgttactcgctcacatttaatgttgatgaaagctggcta
caggaaggccagacgcgaattatttttgatggcgttaactcggcgtttcatctgtggtgcaacgggcgctgggtcggttacggccag
gacagtcgtttgccgtctgaatttgacctgagcgcatttttacgcgccggagaaaaccgcctcgcggtgatggtgctgcgttggagtg
acggcagttatc 
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This is the result of the sequence using the forward primer ocmoF.  
>83_1390366__091.ab1 
CACGCNANCTGATACGGCACTGGGCCTGCTGTCGGCCACCAACGTGCCCAACATCAAGGGCATCG
AGACTTTCCAGGGTGCGCAATACCATACCGGCGCCTGGCCTGAAGGCGTTGATTTCAAGGGCAAG
CGGGTCGGCGTCATTGGCACCGGCTCCACCGGCCTTCAGGTGATCACGGCTCTCGCCCCGCAGGCC
AGCCACCTGACGGTATTCCAGCGCTCGCCGCAGTACAGTGTGCCGGTCGGCAACGGCCCGGTCAG
CCCGGACTACGTCAAGTCCGTCAAACAGAACTACGAGCAGATCTGGAAGGACGTGCGCAGCTCGG
TGGTGGCCTTCGGCTTCAAGGAGAGCAGCGTGCCGGCCATGAGCGTGTCGGAAGAAGAGCGCCG
CGCCGTTTACCAGAAAGCCTGGGACACCGGCGGCGGCTTTCGCTTCATGTTTGAAACCTTTTGCGA
CATTGCCACCAGCGAAGAAGTCGACCTGCAGCCAAGCTTGCTCCCGTCGTTTTACAACGTCGTGACT
GGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAA
TAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCTT
TGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCG
ATACTGTCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTGAC
CTATCCCATTNACGGNTCAAAANNTNNNNNTTTNNNNTTNNNTNNNNTTTNTNNNNNNNNNNT
NTNNNNTNNNNNTTNNNTTTATNTTNTTNTTTTTNTNTNNTNNNNNNTTTNNNTNNNNNNTNTN
TNNNNNNNTNNNNNTTTNTTNTNTNNNNTTNNTANNNNNTTTTNNNNNNNNNANNNTANTNN
TTTNTNTNNTNTNNNTNNTNNTNNTNTTTTTNNNTANTTNNNNNNNNTTNTNTNNTNNNNTNNT
NNTNNNTNTNTNTNNNNTTNTTNTTTNTNTTTNTTNNTNTNNNTNNTTTANNNNNNTCTTTTNNT
NTTTATCNNNNTTTTTNNN 
 
And this is using the reverse primer VXR 
>84_1390367__089.ab1 
NGGTAGGCGCATGATACCGTGCATCTGCCAGTTTTGAGGGGACGACGACAGCTATCGGCCTCAGGA
AGATCGCACTCCAGCCAGCTTTCCGGCACCGCGTTCTGGTGCCGGAAACCAGGCAAAGCGCCATTCG
CCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTG
GCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGT
TGTAAAACGACGGGAGCAAGCTTGGCTGCAGGTCGACTTCTTCGCTGGTGGCAATGTCGCAAAAGG
TTTCAAACATGAAGCGAAAGCCGCCGCCGGTGTCCCAGGCTTTCTGGTAAACNGCGCGGCGCTCTTC
TTCCGACACGCTCATGGCCGGCACGCTGCTCTCCTTGAAGCCGAAGGCCACCACCGAGCTGCGCACG
TCCTTCCAGATCTGCTCGTAGTTCTGTTTGACGGACTTGACGTAGTCCGGGCTGACCGGGCCGTTGC
CNACCGGCACACTGTACTGCGGCGAGCGCTGGAATACCGTCAGGTGGCTGGCCTGCGGGGCGAGA
GCCGTGATCACCTGAAGGCCGGTGGAGCCGGTGCCAATGACGCCGACCCGCTTGCCCTTGAAATCA
ACGCCTTCAGGCCAGGCGCCGGTATGGTATTGCGCACCCTGGAAAGTCTCGATGCCCTTGATGTTGG
GCACGTTGGTGGCCGACAGCAGGCCCAGTGCCGTGATCAGGTATCTGGCCGTGACGGTTTTATCGG
TATCGGTCCTGGATTTCAANNNNNNNNNNNTTNTNNNATNTNTCTNNTANANTATANTNCANATT
NTTNTTTTTTNNTNTNTNTTTNTNNNNTTAANTTTTTTTNNCTTANATTTATTTCTAANNNANCNAN
NNTTTNTTANNNANTNAGNTNNNCATTTANNATTTNTTTAANTTANTTTNTNTNNTTTANNTTNNT
ATNTTANTNATTTCNTTNNCATNNNANNNTATTNAANNANNTNNTTATNTTNATNNNTNATTTTNN
NNANTNNTTNANNNTNNTNCNTTCNATNNTTNTNTNTTTTTTATNCAATTNNTTNANATATNTACT
TNATNTTCTATAANTCTATTNTTNAA 
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The result of alignment of the sequence using the ocmoF primer and the resulting band 
sequence gives: 
>lcl|4411 
Length=837 
Score = 1417 bits (767),  Expect = 0.0 
Identities = 790/801 (98%), Gaps = 7/801 (0%) 
Strand=Plus/Plus 
Query  9     CTGAT-ACGGCACTGGGCCTGCTGTCGGCCACCAACGTGCCCAACATCAAGGGCATCGAG  67 
             ||||| |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  433   CTGATCACGGCACTGGGCCTGCTGTCGGCCACCAACGTGCCCAACATCAAGGGCATCGAG  492 
 
Query  68    ACTTTCCAGGGTGCGCAATACCATACCGGCGCCTGGCCTGAAGGCGTTGATTTCAAGGGC  127 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  493   ACTTTCCAGGGTGCGCAATACCATACCGGCGCCTGGCCTGAAGGCGTTGATTTCAAGGGC  552 
 
Query  128   AAGCGGGTCGGCGTCATTGGCACCGGCTCCACCGGCCTTCAGGTGATCACGGCTCTCGCC  187 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  553   AAGCGGGTCGGCGTCATTGGCACCGGCTCCACCGGCCTTCAGGTGATCACGGCTCTCGCC  612 
 
Query  188   CCGCAGGCCAGCCACCTGACGGTATTCCAGCGCTCGCCGCAGTACAGTGTGCCGGTCGGC  247 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  613   CCGCAGGCCAGCCACCTGACGGTATTCCAGCGCTCGCCGCAGTACAGTGTGCCGGTCGGC  672 
 
Query  248   AACGGCCCGGTCAGCCCGGACTACGTCAAGTCCGTCAAACAGAACTACGAGCAGATCTGG  307 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  673   AACGGCCCGGTCAGCCCGGACTACGTCAAGTCCGTCAAACAGAACTACGAGCAGATCTGG  732 
 
Query  308   AAGGACGTGCGCAGCTCGGTGGTGGCCTTCGGCTTCAAGGAGAGCAGCGTGCCGGCCATG  367 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  733   AAGGACGTGCGCAGCTCGGTGGTGGCCTTCGGCTTCAAGGAGAGCAGCGTGCCGGCCATG  792 
 
Query  368   AGCGTGTCGGAAGAAGAGCGCCGCGCCGTTTACCAGAAAGCCTGGGACACCGGCGGCGGC  427 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  793   AGCGTGTCGGAAGAAGAGCGCCGCGCCGTTTACCAGAAAGCCTGGGACACCGGCGGCGGC  852 
 
Query  428   TTTCGCTTCATGTTTGAAACCTTTTGCGACATTGCCACCAGCGAAGAAGTCGACCTGCAG  487 
             |||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| 
Sbjct  853   TTTCGCTTCATGTTTGAAACCTTTTGCGACATTGCCACCAGCGAAG-AGTCGACCTGCAG  911 
 
Query  488   CCAAGCTTGCTCCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAAC  547 
             |||||| |  |   |||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  912   CCAAGC-T--TNNNGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAAC  968 
 
Query  548   TTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCA  607 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  969   TTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCA  1028 
 
Query  608   CCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCTTTGCCTGGTTTC  667 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1029  CCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCTTTGCCTGGTTTC  1088 
 
Query  668   CGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTG  727 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1089  CGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGGAGTGCGATCTTCCTGAGGCCGATACTG  1148 
 
Query  728   TCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTGA  787 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sbjct  1149  TCGTCGTCCCCTCAAACTGGCAGATGCACGGTTACGATGCGCCCATCTACACCAACGTAA  1208 
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Query  788   CCTATCCCATTNACGGNTCaa  808 
             ||||||||||| |||| |||| 
Sbjct  1209  CCTATCCCATT-ACGG-TCAA  1227 
 
 
Starting from: 
gaaatccagaccgataccgataaaaccgtcacggccagatacctgatcacggcactgggcctgctgtcggccaccaacgtgc
ccaacatcaagggcatcgagactttccagggtgcgcaataccataccggcgcctggcctgaaggcgttgatttcaagggcaa
gcgggtcggcgtcattggcaccggctccaccggccttcaggtgatcacggctctcgccccgcaggccagccacctgacggtat
tccagcgctcgccgcagtacagtgtgccggtcggcaacggcccggtcagcccggactacgtcaagtccgtcaaacagaacta
cgagcagatctggaaggacgtgcgcagctcggtggtggccttcggcttcaaggagagcagcgtgccggccatgagcgtgtcg
gaagaagagcgccgcgccgtttaccagaaagcctgggacaccggcggcggctttcgcttcatgtttgaaaccttttgcgacat
tgccaccagcgaagaagtcgacctgcagccaagcttgctcccgtcgttttacaacgtcgtgactgggaaaaccctggcgttac
ccaacttaatcgccttgcagcacatccccctttcgccagctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaac
agttgcgcagcctgaatggcgaatggcgctttgcctggtttccggcaccagaagcggtgccggaaagctggctggagtgcgat
cttcctgaggccgatactgtcgtcgtcccctcaaactggcagatgcacggttacgatgcgcccatctacaccaacgtaacctat
cccattacggtcaa 
 
Underlined nucleotide indicates an insertion. Highlighted sequence indicates the 
alignment results of theoretical and actual sequences. Note that the sequence started 
before the insert (between two bolded sequences). Red nucleotide sequence corresponds 
to that of in the result above. Alignment result using the reverse primer was not shown.  
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Appendix B: Synthesis of epoxides using peracid and 
identification of the GC peaks 
Peracid epoxidation of chlorinated ethenes has been commonly utilized in many 
studies as confirmation of compound elution in gas chromatography methods. TCE, VC 
and DCEs have been reacted with mCPBA and yielded their corresponding epoxides. In 
one study, 1,1-DCE-epoxide was chemically synthesized by reacting its parent compound 
with mCPBA at 60°C for 3 hours (Liebler and Guengerich, 1983). A similar approach 
was used to synthesize trans-DCE-epoxide (Janssen et al., 1988) and cDCE-epoxide 
(Verce et al., 2002).  Epoxide can also be synthesized at low temperature, such as in one 
study where octene-1,2-oxide was synthesized at 0°C (Guengerich and Mason, 1980).  
The chemical synthesis of epoxide is useful to confirm the GC elution times of 
epoxide peaks resulting from oxidation of chlorinated ethenes by monooxygenases. In 
our studies, the distilled mixture from the synthesis was also used to provide epoxide 
substrate for hydrolase enzymatic assays. DCEs were reacted with mCPBA at 50 – 60°C 
until the formation of a white precipitate of chlorobenzoic acid was observed. Several 
peaks were detected through GC-FID (equipped with an 8-ft x 1/8-inch stainless-steel 
column packed with 1% SP-1000 on 60/80 Carbopack B (Supelco), isothermal run at 
160°C, 30 mL/min N2); and by process of elimination, the peaks corresponding to 
expected residual starting materials, impurities and byproducts (e.g., chlorobenzene) 
could be identified, most of which either eluted after the normal monitoring period or not 
at all, with the column employed. After eliminating these, we found there remained two 
unattributed peaks (at retention times of 2.8 min and 3.5 min, with the earlier peak being 
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much larger than the later one), whether the starting substrate was cDCE or tDCE.   Both 
peaks had highly similar, DCE-epoxide-like mass spectra. The presence of two peaks 
may indicate the formation of both cis- and trans-cDCE isomers during synthesis. The 
synthesis of tDCE-epoxide yielded peaks with similar retention times and similar relative 
sizes (Figure B1 and Figure B2). 
 
 
 
Figure  B.1. GC result from product of cDCE epoxidation (headspace of vapor above 
the organic mixture injection to packed column).  Peak assignments: 2.18 min 
(remaining cDCE); 2.49 min (probably MEHQ stabilizer in the cDCE stock, since 
it's present in vapors above cDCE-only); 2.83 min (putative DCE epoxide); 3.54 min 
(putative DCE epoxide).  
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Figure  B.2. GC result from product of tDCE epoxidation (headspace of vapor above 
the organic mixture injection to packed column). Peak assignments: 2.29 min 
(remaining tDCE); 2.84 min (putative DCE epoxide);  3.54 min (putative DCE 
epoxide). 
 
DCE-epoxides were confirmed by GC-MS equipped with a DB-5ms column in 
other studies (Verce et al., 2002; Shin, 2010) and also in our study (Figures B3 and B4). 
The mass spectra of DCE-epoxides were originally reported by Griesbaum and co-
workers (Griesbaum et al., 1975), and similar observations were reported by other 
researchers (Janssen et al., 1988; van Hylckama Vlieg et al., 1996). The mass spectrum of 
cDCE-epoxide contains several significant peaks at lower mass than the molecular ion 
(m/e 112), i.e. at m/e 83 (CHCl2+), 77 (C2H2OCl+), 48 (HCCl+) and 29 (HCO+). The mass 
spectral fragmentation of epoxides may share similarities with their behavior under 
pyrolytic and photolytic conditions. Both pyrolysis and photolysis of epoxyethane 
produce methyl and formyl radicals, presumably through the formation of acetaldehyde. 
Correspondingly, three significant peaks were reported for epoxyethane, at m/e 44 (M+), 
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29 (CHO+) and 15 (CH3+). Detailed review of mass spectrometry of aliphatic epoxides 
can be found elsewhere (Brown et al., 1966).   
Some researchers hypothesize that during epoxidation by peracid, the oxygen 
atom is added in a concerted manner involving a symmetrical transition state (i.e. to both 
olefinic carbons simultaneously), whereas other researchers have provided evidence for 
asymmetrical epoxidation (i.e., initially involving O attack at only one carbon). In that 
case, it is possible that during the insertion of an oxygen molecule, thermal motion 
enables C–C rotation to occur, thus enabling production of both epoxide isomers. One of 
the isomers may be preferential during chemical synthesis — regardless of whether the 
starting material is cDCE or tDCE.   Biological epoxidation, however, might preserve 
isomerism of the initial DCE substrate.  
In addition to the epoxides, chlorobenzene was identified (not shown in Figures 
B1 and B2, which focus only on earlier-eluting peaks) in DCE-epoxide synthesis, which 
was also detected during other peracid reactions (Ray et al., 2008). Another possibility of 
a compound having similar mass to DCE-epoxide is 1,2-dichloroethenol (ClHC=CClOH) 
or 2,2-dichloroethenol (Cl2C=CH2). Incomplete oxygen molecule insertion may result in 
such byproducts; nonetheless this assumption is merely speculative and more 
investigations would have to be made to confirm this. 
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Figure  B.3. Chromatography and spectrometry profiles of the chemically 
synthesized cDCE-epoxide (headspace of vapor above the organic mixture injection) 
by the GC-MS equipped with a DB-5ms column. The arrow shows the first epoxide 
peak with its mass spec profile at the bottom.  
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Figure  B.4. Chromatography and spectrometry profiles of the chemically 
synthesized cDCE-epoxide (headspace of vapor above the organic mixture injection) 
by the GC-MS equipped with a DB-5ms column. The arrow shows the second 
epoxide peak with its mass spec profile at the bottom. 
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The DCE epoxides produced are expected to be relatively stable at neutral pH 
with a reported half-life of about 72 hours (Janssen et al., 1988), as opposed to the half-
lives of VC-epoxide and TCE-epoxide, which are 78 and 21 seconds, respectively (van 
Hylckama Vlieg et al., 1996). Abiotic transformation of VC-epoxide to glycolaldehyde 
was reported by Guengerich et al. (1979). The abiotic release of chloride ions from 
cDCE-epoxide has also been demonstrated (Canada et al., 2002b). In our study, the 
abiotic rearrangement of DCE-epoxide was studied by monitoring the disappearance of 
both GC-peaks and the formation of chloride ions as follows. Ten microliters of DCE-
epoxide synthesis mixture (from cDCE as starting substrate) was injected into 50 mL 
chloride-free phosphate buffer (20 mM, pH 7.2). 1 mL of headspace was drawn out for 
GC measurements (of DCE-epoxides), and 3 mL of liquid was sampled for triplicate 
measurements of chloride ions. After almost 18 hours of incubation, approximately 6 
times the initial chloride concentration was measured (Figure B5). Both putative DCE-
epoxide peaks at 2.8 and 3.5 min were monitored, and after 18 hours, both peaks had 
diminished approximately 30% from their respective, initial values.  The cDCE peak was 
used as internal standard.  
We concluded that, since both peaks have the MS spectrum expected of DCE 
epoxides and both decay abiotically as expected of DCE epoxides, then both likely 
represent DCE epoxides. 
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Figure  B.5. The disappearance of DCE-epoxide peaks at 2.8 and 3.5 min and the 
formation of chloride ions.  
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Appendix C: Protocols for iTRAQ 
C.1  Protein digestion and iTRAQ labeling  
A total of 100 µg protein of each sample was denatured, reduced with 5 mM tris-
(2-carboxylethyl) phosphine at 37 ºC for 1 hour, and the cysteine residues were blocked 
with 8 mM methyl methanethiosulfonate for 10 min at room temperature. Protein 
samples were digested with 10 µg of sequence-grade-modified trypsin at 37ºC for 16 
hours. Efficiency of protein digestion was assessed by SDS-PAGE using undigested and 
digested samples. Tryptic peptides from four different samples (WT grown in cDCE and 
CAP, WT grown in CAP, KO grown in cDCE and CAP, KO grown in CAP) were each 
labeled with iTRAQ reagents 114, 115, 116, and 117, respectively according to the 
manufacturer’s protocols (document #4351918A and 4350831C downloaded from 
http://docs.appliedbiosystems.com/search.taf; Applied Biosystems, Foster City, CA). The 
labeled samples were then combined and fractionated via high pH reverse phase liquid 
chromatography as described below.  
 
C.2 High pH reverse phase (hpRP) fractionation 
The pooled iTRAQ-labeled peptides were pretreated with SCX cartridges (AB 
Sciex, Framingham, MA) and desalted by Sep-Pak SPE for hpRP separation. The hpRP 
chromatography was carried out using a Dionex UltiMate 3000 HPLC system with a 
built-in micro fraction collection option in its autosampler and UV detection (Sunnyvale, 
CA). The iTRAQ-tagged tryptic peptides were reconstituted in buffer A (20 mM 
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ammonium formate pH 9.5 in water), and loaded onto an XTerra MS C18 column (3.5 
µm, 2.1x150 mm, Waters) with 20 mM ammonium formate (NH4FA), pH 9.5 as buffer A 
and 80% ACN/20% 20 mM NH4FA as buffer B. The LC was performed using a gradient 
from 10-45% of buffer B in 30 min at a flow rate 200 µL/min.(Gilar et al., 2005a; Gilar et 
al., 2005b)  Forty-eight fractions were collected at 1 min intervals and pooled into a total 
of 24 fractions based on the UV absorbance at 214 nm. All of the fractions were dried 
and reconstituted in 20 µL of 2% ACN/0.5% FA for nanoLC-MS/MS analysis. Fractions 
were pooled into the final 10 fractions by disparate first dimension fractions (retention 
time multiplexing) as reported recently. All ten pooled peptide fractions were dried and 
reconstituted in 2% ACN, 0.5% formic acid for subsequent nanoLC-MS/MS. 
 
C.3 Nano-scale reverse phase chromatography and tandem mass 
spectrometry (nanoLC-MS/MS)   
The nanoLC-MS/MS analysis was carried out using a LTQ-Orbitrap Velos 
(Thermo-Fisher Scientific, San Jose, CA) mass spectrometer equipped with nano ion 
source using high energy collision dissociation (HCD). The Orbitrap was interfaced with 
an UltiMate3000 RSLCnano system (Dionex, Sunnyvale, CA).  An aliquot of hpRP 
peptide fractions (2.0 – 10.0 µL) was injected onto a PepMap C18 trap column (5 µm, 
300 µm × 5 mm, Dionex) at 20 µL/min flow rate for on-line desalting and then separated 
on a PepMap C-18 RP nano column (3 µm, 75µm x 15cm), and eluted in a 90 min 
gradient of 5% to 38% acetonitrile (ACN) in 0.1% formic acid at 300 nL/min., followed 
by a 3-min ramping to 95% ACN-0.1%FA and a 5-min holding at 95% ACN-0.1%FA. 
The column was re-equilibrated with 2% ACN-0.1%FA for 20 min prior to the next run.  
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The eluted peptides were detected by Orbitrap through a nano ion source 
containing a 10-µm analyte emitter (NewObjective, Woburn, MA).  The Orbitrap Velos 
was operated in positive ion mode with nano spray voltage set at 1.5 kV and source 
temperature at 275 °C. Either internal calibration using the background ion signal at m/z 
445.120025 as a lock mass or external calibration for FT mass analyzer was performed. 
The instrument was operated in data-dependent acquisition (DDA) mode using FT mass 
analyzer for one survey MS scan for precursor ions, followed by ten data-dependent 
HCD-MS/MS scans for precursor peptides with multiple charged ions above a threshold 
ion count of 7500 with normalized collision energy of 45%.  MS survey scanned at a 
resolution of 30,000 (fwhm at m/z 400), for the mass range of m/z 400-1400, and MS/MS 
scanned at 7,500 resolution for the mass range, m/z 100-2000. All data were acquired 
under Xcalibur 2.1 operation software (Thermo-Fisher Scientific).  
 
C.4 Data processing, protein identification and data analysis  
All MS and MS/MS raw spectra from iTRAQ experiments were processed using 
Proteome Discoverer 1.2 (PD1.2, Thermo), and the spectra from each DDA file were 
output as an MGF file for subsequent database search using in-house license Mascot 
Deamon (version 2.3.02, Matrix Science, Boston, MA). The bacterial “protein non-
redundancy” sequence database was used, containing 10,348,164 sequence entries 
downloaded from NCBI (http://www.NCBI.com) on Jan. 21st, 2010. “Combine with 
customized mutant sequences” was used for database search. The default search settings 
used for 4-plex iTRAQ quantitative processing and protein identification in Mascot 
server were:  one mis-cleavage for full trypsin with fixed MMTS modification of 
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cysteine, fixed 4-plex iTRAQ modifications on lysine and N-terminal amines and 
variable modifications of methionine oxidation and 4-plex iTRAQ on tyrosine.  
The peptide mass tolerance and fragment mass tolerance values were 30 ppm and 
100 mmu, respectively. To estimate the false discovery rate (FDR) for a measure of 
identification certainty in each replicate set, an automatic decoy database search was 
performed in Mascot by choosing the decoy checkbox in which a random sequence of 
database is generated and tested for raw spectra along with the real database.  To reduce 
the probability of false peptide identification, the significant scores at 99% confidence 
interval for the peptides defined by a Mascot probability analysis 
(www.matrixscience.com/help/scoring_help.html#PBM) greater than “identity” were 
used as a filter and the resulting peptides are considered to be confidently identified 
peptides and used for protein identifications. Furthermore, proteins identified in all four 
iTRAQ experiments, which contained at least two peptides with a p value of < 0.001 
(expectation value) as determined by Mascot probability analysis were further analyzed. 
Intensities of the reporter ions from iTRAQ tags upon fragmentation were used for 
quantification, and the relative quantitation ratios were normalized to the median ratio for 
the 4-plex in each set of experiments. 
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Appendix D: iTRAQ Reports 
 
 
 
 
 
 
 
 
 
Table  D.1. Selected proteins reported in iTRAQ studies. (*) indicates ratio that is 
significantly different from 1 at a 95% confidence level. Error factors with brackets 
[ ] indicate that the peptide match ratios do not appear to come from a sample with 
a normal distribution;  p is number of peptides; EF = error factor. 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_5301 cytochrome P450  1.587 7 1.193* 0.180 7 1.524* 0.370* 7 1.180* 
Bpro_5566 hydrolase 10.493 3 1.819* 0.282 3 1.653* 0.485* 3 1.283* 
Bpro_5565 flavin-containing monooxygenase FMO  2.994 9 [1.182] 0.140 6 [2.421] 0.148* 7 1.371* 
Bpro_5563 zinc-binding alcohol dehydrogenase  0.770 5 1.104* 0.100 5 1.535* 0.139* 5 1.319* 
Bpro_5186 haloacid dehalogenase, type II  0.155 12 [1.212] 0.142 12 1.160* 0.150* 12 1.142* 
Bpro_0056 haloacid dehalogenase, type II  0.804 2 1.023* 0.651 2 1.007* 0.828 2 1.030 
Bpro_2101 isocitrate lyase  2.494 9 [1.088] 2.114 9 1.075* 2.177 9 [1.102] 
Bpro_0645 glutathione S-transferase-like  0.724 1 --- 0.017 1 --- 0.024 1 --- 
Bpro_0646 pyridoxamine 5'-phosphate oxidase 1.165 1 --- 0.450 1 --- 0.401 1 --- 
Bpro_4442 DNA-directed RNA polymerase subunit beta 1.088 22 1.077* 0.949 22 1.090* 0.909 22 [1.088] 
Bpro_0086 2,5-dioxopentanoate dehydrogenase (NAD+) 0.738 3 1.022* 0.702 3 1.059* 0.654 3 1.234 
Bpro_4478 hydrolase  0.507 1 --- 0.806 1 --- 1.033 1 --- 
           Aldehyde and alcohol dehydrogenases 
         Bpro_3952 aldehyde dehydrogenase  0.385 23 1.081* 0.055 22 1.380* 0.081 23 1.228* 
 
Bpro_2290 aldehyde dehydrogenase  1.141 6 1.046* 1.057 6 1.038* 1.061 6 1.061 
 
Bpro_3422 aldehyde dehydrogenase  1.379 2 1.178 1.038 3 1.136 1.014 2 1.081 
 
Bpro_4691 aldehyde dehydrogenase  0.849 1 --- 1.334 1 --- 1.329 1 --- 
 
Bpro_2298 aldehyde dehydrogenase  0.824 2 1.036 0.828 2 1.481 0.854 2 1.387 
 
Bpro_4702 aldehyde dehydrogenase  0.934 2 1.064 1.377 2 1.482 1.655 2 1.057* 
 
Bpro_3129 zinc-binding alcohol dehydrogenase 0.387 1 --- 0.906 1 --- 0.757 1 --- 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_2526 iron-containing alcohol dehydrogenase  0.546 3 1.178* 0.834 3 1.070* 1.081 3 1.074 
 
Bpro_0360 zinc-binding alcohol dehydrogenase  0.735 1 --- 1.176 1 --- 1.132 1 --- 
 
Bpro_5563 zinc-binding alcohol dehydrogenase  0.770 5 1.104* 0.100 5 1.535* 0.139 5 1.319* 
 
Bpro_3853 zinc-binding alcohol dehydrogenase  0.800 7 1.055* 1.907 8 1.113* 1.987 8 1.120* 
 
Bpro_3259 zinc-binding alcohol dehydrogenase  0.806 5 [1.053] 0.710 4 1.051* 0.789 5 1.060* 
 
Bpro_2634 zinc-binding alcohol dehydrogenase  1.122 5 1.043* 5.900 5 1.201* 5.295 5 1.187* 
 
Bpro_4700 iron-containing alcohol dehydrogenase  1.129 4 1.094 1.604 4 1.123* 1.857 4 1.114* 
 
Bpro_2565 zinc-binding alcohol dehydrogenase  1.536 4 1.157* 1.400 4 1.126* 1.438 4 1.182* 
 
Bpro_3062 zinc-containing alcohol dehydrogenase  2.949 2 1.173 1.519 2 1.23 1.545 2 1.17 
 
Bpro_2135 zinc-binding alcohol dehydrogenase  3.422 4 1.170* 0.901 4 1.042* 0.859 4 [1.068] 
 
 
 
          
 
Proteins from suicide vector 
         108796622 neomycin phosphotransferase 0.190 1 --- 10.142 1 --- 4.632 1 --- 
 
53793959 oriT-binding protein  --- 0 --- 79.075 2 2.407 84.455 2 2.359 
 
 
 
          
 
Ribosomal proteins 
         Bpro_4443 50S ribosomal protein L7/L12  1.470 8 1.243* 0.686 8 1.134* 0.675 8 1.123* 
 
Bpro_4445 50S ribosomal protein L1  1.187 9 1.059* 0.603 9 1.052* 0.669 9 1.062* 
 
Bpro_0259 50S ribosomal protein L2  0.975 5 1.020* 0.605 5 [1.049] 0.677 5 [1.111] 
 
Bpro_1292 50S ribosomal protein L25P  1.186 9 1.063* 0.526 9 1.111* 0.581 8 1.068* 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_0257 50S ribosomal protein L4  1.039 12 1.050* 0.552 12 1.125* 0.635 12 1.049* 
 
Bpro_4113 50S ribosomal protein L13  1.020 8 [1.101] 0.576 7 1.077* 0.557 8 1.102* 
 
Bpro_0487 50S ribosomal protein L5  1.088 9 1.025* 0.638 9 1.061* 0.607 8 1.032* 
 
Bpro_2105 50S ribosomal protein L20  1.126 4 1.068* 0.493 4 1.046* 0.470 4 1.139* 
 
Bpro_0485 50S ribosomal protein L14P  1.017 4 1.245 0.553 4 1.248* 0.625 4 1.197* 
 
Bpro_3034 50S ribosomal protein L9P  1.018 9 1.069 0.560 9 1.084* 0.527 9 1.160* 
 
Bpro_0493 50S ribosomal protein L30P  1.139 3 1.036* 0.502 3 [1.104] 0.592 3 1.057* 
 
Bpro_0256 50S ribosomal protein L3P  1.098 7 1.085* 0.588 6 1.128* 0.650 7 [5.488] 
 
Bpro_3802 50S ribosomal protein L28 1.116 5 1.022* 0.562 5 1.035* 0.590 5 1.040* 
 
Bpro_0838 50S ribosomal protein L27  1.077 3 1.058 0.442 3 1.220* 0.464 3 1.111* 
 
Bpro_1101 50S ribosomal protein L11P methyltransferase  0.787 3 1.207 0.823 3 1.173 0.874 3 1.122 
 
Bpro_0490 50S ribosomal protein L6P  1.053 6 [1.408] 0.493 6 1.155* 0.569 6 1.091* 
 
Bpro_2261 50S ribosomal protein L31P  1.146 4 1.052* 0.479 4 1.120* 0.585 3 1.045* 
 
Bpro_0258 50S ribosomal protein L23P 0.947 2 1.068 0.600 2 1.027 0.470 2 1.021* 
 
Bpro_0494 50S ribosomal protein L15P  0.929 2 1.101 0.584 2 1.241 0.472 2 1.226 
 
Bpro_4444 50S ribosomal protein L10  1.120 2 1.079 0.683 2 1.393 0.662 2 1.026* 
 
Bpro_0839 50S ribosomal protein L21P  1.262 1 --- 0.558 1 --- 0.474 1 --- 
 
Bpro_0027 50S ribosomal protein L19  1.118 2 1.747 2.883 2 1.214 4.030 2 1.115* 
 
Bpro_0260 30S ribosomal protein S19P  0.304 4 [2.160] 0.704 4 1.192* 0.382 4 1.322* 
 
Bpro_2695 30S ribosomal protein S2P  1.099 5 1.120 0.736 5 1.163* 0.721 4 1.065* 
 
Bpro_3570 30S ribosomal protein S20P  0.413 1 --- 1.101 1 --- 0.934 1 --- 
 
Bpro_0499 30S ribosomal protein S11 0.687 3 1.322 0.792 3 1.122 0.677 3 1.185 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_0252 30S ribosomal protein S7  0.928 7 1.032* 0.754 7 1.043* 0.638 7 1.033* 
 
Bpro_0262 30S ribosomal protein S3  0.847 5 1.169 0.624 5 1.130* 0.646 5 1.108* 
 
Bpro_1789 30S ribosomal protein S1  0.521 5 [1.193] 0.902 5 1.039* 0.813 5 1.064* 
 
Bpro_0492 30S ribosomal protein S5  0.996 3 1.463 0.636 3 1.217 0.457 3 1.174* 
 
Bpro_3261 30S ribosomal protein S15 0.959 5 1.021* 0.634 5 1.062* 0.662 5 1.036* 
 
Bpro_0255 30S ribosomal protein S10 0.958 3 1.029 0.703 3 1.014* 0.753 3 1.018* 
 
Bpro_0500 30S ribosomal protein S4 1.042 1 --- 0.594 1 --- 0.620 1 --- 
 
Bpro_4112 ribosomal protein S9 0.980 1 --- 0.758 1 --- 0.755 1 --- 
 
Bpro_2692 ribosome recycling factor  0.992 4 1.052 1.192 4 1.102* 1.178 4 1.091* 
 
Bpro_0771 ribosome biogenesis GTP-binding protein YsxC  0.827 1 --- 1.143 1 --- 1.199 1 --- 
 
 
 
          
 
Central metabolism 
         Bpro_0086 2,5-dioxopentanoate dehydrogenase (NAD+)  0.738 3 1.022* 0.702 3 1.059* 0.654 3 1.234 
 
Bpro_0195 
6-phosphogluconate dehydrogenase, NAD-
binding  1.041 5 1.065 0.726 5 [1.079] 0.745 5 1.090*  
Bpro_1231 Beta-ketoadipyl CoA thiolase  0.888 9 1.079* 0.124 9 1.354* 0.134 8 1.327* 
 
Bpro_1287 fructose-bisphosphate aldolase  1.647 1 --- 0.556 1 --- 0.568 1 --- 
 
Bpro_0753 glucose-6-phosphate isomerase  0.738 2 1.016* 0.801 2 1.133 0.774 2 1.227 
 
Bpro_4517 malate synthase G  0.556 8 [1.062] 0.594 8 1.124* 0.684 8 1.204* 
 
Bpro_0643 NADPH-glutathione reductase  0.862 2 1.124 0.869 2 1.075 0.843 2 1.274 
 
Bpro_0160 phosphoenolpyruvate carboxykinase  0.452 7 1.314* 0.666 7 [1.350] 0.792 7 1.142* 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_3665 phosphoenolpyruvate carboxylase  0.789 16 [1.064] 1.444 16 1.055* 1.324 16 [1.089] 
 
Bpro_4634 pyruvate kinase  0.936 1 --- 0.347 1 --- 0.403 1 --- 
 
Bpro_4827 transketolase  0.833 4 1.100* 0.985 4 1.146 1.037 3 1.056 
 
Bpro_2140 acetyl-CoA acetyltransferase  1.122 18 [1.099] 2.674 21 [2.289] 2.245 20 [2.334] 
 
Bpro_3678 L-lactate dehydrogenase (cytochrome)  1.056 1 --- 0.928 1 --- 0.821 1 --- 
 
Bpro_2055 hydroxyacylglutathione hydrolase  0.785 2 1.052 1.162 2 1.086 1.065 2 1.163 
 
Bpro_0187 glycolate oxidase FAD binding subunit  1.153 1 --- 1.757 1 --- 1.404 1 --- 
 
Bpro_3592 aconitate hydratase 0.870 7 1.041* 1.794 8 1.073* 1.929 8 1.042* 
 
Bpro_2942 isocitrate dehydrogenase 0.765 9 [1.294] 0.933 9 1.027* 0.763 9 [1.119] 
 
 
 
          
 
Proteins involved in biological stresses 
         
 
Bpro_3126 molecular chaperone DnaK 0.802 20 [1.091] 0.593 20 1.075* 0.627 20 1.062* 
 
Bpro_2031 
ATP-dependent protease ATP-binding subunit 
ClpX 0.864 2 1.231 0.935 2 1.422 0.753 2 1.742  
Bpro_1400 Ferritin and Dps 1.148 2 1.098 3.526 2 1.151 3.733 2 1.176 
 
Bpro_0759 chaperonin GroEL 1.040 38 [1.128] 0.553 37 [1.099] 0.677 37 [1.094] 
 
Bpro_1032 heat shock protein HtpX 1.290 1 --- 1.153 1 --- 1.067 1 --- 
 
Bpro_1303 heat-inducible transcription repressor 1.138 1 --- 1.167 1 --- 1.246 1 --- 
 
Bpro_1199 heat shock protein Hsp20 0.551 10 1.064* 1.970 10 1.054* 2.175 10 1.061* 
 
Bpro_2651 putative heat shock protein 0.943 2 1.280 0.487 3 1.349 0.485 2 1.017* 
 
Bpro_0614 heat shock protein 90 1.255 1 --- 1.003 1 --- 1.330 1 --- 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_0948 DNA repair protein RadC 0.772 1 --- 1.260 1 --- 0.929 1 --- 
 
Bpro_3337 DNA mismatch repair protein MutS 1.362 3 [1.229] 0.846 3 1.136 0.999 3 1.105 
 
Bpro_3097 sigma 70 (RpoD) 1.423 5 1.046* 1.128 5 1.136 1.166 5 1.055* 
 
Bpro_3187 Hsp33 protein 0.927 1 --- 1.019 1 --- 1.140 1 --- 
 
Bpro_2396 heme peroxidase 2.414 2 1.066 0.407 2 1.057 1.345 2 1.009 
 
Bpro_0678 catalase/peroxidase HPI 0.979 1 --- 1.054 1 --- 0.939 1 --- 
 
Bpro_4841 peroxidase 1.051 3 1.056 2.994 3 1.074* 2.870 3 1.063* 
 
Bpro_4561 glyoxylate carboligase 0.293 1 --- 0.335 1 --- 0.335 1 --- 
 
Bpro_4563 2-hydroxy-3-oxopropionate reductase 0.239 2 1.094* 0.051 5 3.652* 0.060 4 3.210* 
 
Bpro_4562 hydroxypyruvate isomerase 0.009 1 --- 0.059 2 1.989 0.053 2 2.182 
 
Bpro_3549 glyoxalase I  0.830 1 --- 0.524 1 --- 0.637 1 --- 
 
Bpro_0266 
alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen  0.936 3 1.054 1.417 4 1.3 1.447 4 1.087* 
Bpro_2187 
alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen  0.892 6 1.050* 0.817 6 1.053* 0.868 6 1.031* 
Bpro_2856 glutaredoxin  0.836 5 1.066* 1.427 5 1.295* 1.468 4 1.129* 
Bpro_0848 glutaredoxin-like protein  0.676 1 --- 0.747 1 --- 0.802 1 --- 
Bpro_2337 phosphoadenylylsulfate reductase (thioredoxin)  0.949 1 --- 0.578 1 --- 0.676 1 --- 
Bpro_2263 thioredoxin  0.847 7 1.136* 1.059 7 1.172 1.016 7 1.244 
Bpro_3369 thioredoxin  1.267 1 --- 0.846 1 --- 0.889 1 --- 
Bpro_4628 thioredoxin  1.031 4 1.291 1.246 4 1.128* 1.184 4 1.056* 
Bpro_3801 thioredoxin reductase  0.732 5 1.049* 0.966 5 1.041 1.015 5 1.037 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
           
 
Proteins involved in iron-sulfur cluster assembly 
        Bpro_4271 FeS assembly protein SufD  0.656 1 --- 1.120 1 --- 1.514 1 --- 
Bpro_4109 iron-sulfur cluster insertion protein ErpA  0.793 3 1.079* 0.839 3 1.049* 0.905 3 1.049 
Bpro_3557 (2Fe-2S)-binding  0.865 1 --- 0.890 1 --- 0.984 1 --- 
Bpro_2178 cysteine desulfurase IscS  0.907 2 1.038 0.689 2 1.076 0.912 2 1.030 
Bpro_2335 sulfate adenylyltransferase subunit 1  0.916 5 [1.089] 0.421 4 1.049* 0.558 5 1.138* 
Bpro_2628 sulfur compound chelating protein SoxZ 0.924 2 1.01 0.815 2 1.037 0.915 2 1.084 
Bpro_2337 phosphoadenylylsulfate reductase (thioredoxin)  0.949 1 --- 0.578 1 --- 0.676 1 --- 
Bpro_2182 Fe-S protein assembly chaperone HscA  0.976 2 1.043 0.940 2 1.003* 1.195 2 1.176 
Bpro_2336 sulfate adenylyltransferase subunit 2  1.019 2 1.339 0.444 2 1.095 0.548 2 1.167 
 
 
          Proteins involved in glutathione synthesis 
        Bpro_3399 glutamate-cysteine ligase 0.803 1 --- 1.161 1 --- 1.085 1 --- 
Bpro_2178 cysteine desulfurase IscS 0.907 2 1.038 0.689 2 1.076 0.912 2 1.030 
Bpro_2417 
glutathione-dependent formaldehyde-activating, 
GFA  0.708 8 1.184* 2.187 8 1.101* 2.310 8 1.084* 
Bpro_0824 glutathione S-transferase-like 1.612 6 1.090* 1.164 6 1.081* 1.178 6 [1.070] 
Bpro_2563 putative glutathione S-transferase-related protein  1.924 6 1.119* 1.538 4 1.013* 1.284 5 1.044* 
Bpro_0643 NADPH-glutathione reductase  0.862 2 1.124 0.869 2 1.075 0.843 2 1.274 
Bpro_0243 glutathione S-transferase-like  0.976 3 1.025 1.034 3 1.052 1.053 3 1.002* 
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Table D.1 (continued) 
Locus Tag Protein Description 115/114  p EF  116/114  p EF  117/114  p  EF 
Bpro_4661 glutathione S-transferase-like  0.961 1 --- 1.156 1 --- 1.309 1 --- 
Bpro_4540 glutathione synthetase  0.804 1 --- 1.027 1 --- 1.136 1 --- 
Bpro_0387 glutathione S-transferase-like  0.733 1 --- 0.412 1 --- 0.486 1 --- 
Bpro_2168 lactoylglutathione lyase  0.913 1 --- 1.349 1 --- 1.239 1 --- 
Bpro_2055 hydroxyacylglutathione hydrolase 0.785 2 1.052 1.162 2 1.086 1.065 2 1.163 
Bpro_4156 
D-isomer specific 2-hydroxyacid dehydrogenase, 
NAD-binding 0.861 1 --- 0.982 1 --- 1.052 1 --- 
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